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AOM azoxymethane 
AS activation segment 
bp base pair 
C.elegans Caenorabditis elegans 
cKO conditional knock-out 
D. melanogaster Drosophila melanogaster 
DAB 3,3'-diaminobenzidine 
dpc days post coitum 
E embryonic day 
EDTA Ethylenediaminetetraacetic acid 
EtOH Ethanol 
fx floxed 
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HM hydrophobic motif 
ICM inner cell mass 
KO knock-out 
LATS large antigen tumor suppressor 
LOF loss-of-function 
LS-(0-III) looping stage (0-III) 
MetOH Methanol 
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MOB Mps one binder 
MST mammalian Ste-20 like kinase 
N. crassa Neurospora crassa, red bred mold 
NaCl Sodium Chloride 
NDR nuclear dbf- related 
PBS phosphate-buffered saline 
PBT PBS with 0.1%Tween 
PCR polymerase chain reaction 
PMSF phenylmethylsulfonyl fluoride, serine protease inhibitor 
RT room temperature 
S.cerevisiae Saccharomyces cerevisiae, budding yeast 
S.pombe Schizosaccharomyces pombe, fission yeast 
sax-1 C. elegans gene: sensory axon guidance 1 
SDS PAGE 
sodium dodecyl sulfate polyacrylamide gel 
electrophoresis 
TBS Tris-buffered saline 
TBST Tris-buffered saline with 0.1% Tween 
TE Tris-EDTA 
trc D. melanogaster gene: tricornered 
wt wild type 
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Summary 
NDR kinases are highly conserved from yeast to man. Loss-of-function models of Ndr 
homologs in yeast and fly demonstrate essential functions of the respective kinases. 
Mammalian Ndr1 and Ndr2 are widely expressed and share a high degree of 
sequence identity. Human NDR kinases function in centriole duplication, mitotic 
chromosome alignment, apoptosis and proliferation. Mice that lack functional NDR1 
protein are phenotypically normal, but protein levels of NDR2 are up-regulated in 
Ndr1-null tissues suggesting a compensatory link between both isoforms. Aged Ndr1 
knock-out (KO) mice develop T-cell lymphoma, indicating a tumor suppressive 
function of mammalian NDR kinases. Several reports describe deregulated Ndr 
transcript levels in human cancers but the functional relevance of the expression 
changes has not been addressed.  
The present study reveals that mice carrying a targeted deletion of Ndr2 are 
phenotypically normal but show an up-regulation of NDR1 protein levels. Combined 
loss of Ndr1 and Ndr2 results in embryonic lethality, demonstrating that NDR kinases 
play essential roles in mammalian development. Ndr-null embryos are small and 
developmentally delayed at embryonic day (E) 8 and die around E10. Transcript 
levels of the CDK inhibitors p21 and p27 are up-regulated in Ndr-null embryos at 
E8.5, suggesting that NDR kinases positively regulate proliferation in vivo. Mutant 
somites are small and irregularly shaped. Asymmetric expression of the somite-clock 
genes Lunatic Fringe and Hes7 in mutant embryos indicates that NDR kinases 
contribute to ensure bilateral symmetry in the embryo. In the absence of NDR 
kinases, heart development arrests at the linear heart tube stage and does not 
proceed to cardiac looping. Proper establishment of the left / right axis is a 
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prerequisite for rightward cardiac looping. Cardiac malformation is most likely the 
primary cause for embryonic lethality of Ndr-null embryos. Asymmetric gene 
expression and impaired cardiac looping might reflect a general symmetry defect in 
NDR-deficient embryos. 
Embryonic lethality precludes the analysis of in vivo functions of NDR kinases 
in the adult mouse. To address the role of NDR in the context of tumorigenesis, I 
have generated an intestinal epithelium specific Ndr1/2 double KO (Ndr1-/-
Ndr2Δ/ΔVilCre) mouse line. Ndr1-/-Ndr2Δ/ΔVilCre mice develop rectal prolapse, a symptom 
of chronic inflammation of the colon. Importantly, patients suffering from chronic 
colitis are at increased risk of developing colorectal cancer (CRC).  Although Ndr1-/-
Ndr2Δ/ΔVilCre mice do not spontaneously develop colon cancer, initial studies indicate 
that Ndr1-/-Ndr2Δ/ΔVilCre mice are more susceptible to Azoxymethane (AOM)-induced 
colon carcinogenesis. Therefore, Ndr1-/-Ndr2Δ/ΔVilCre mice could provide a new model 
system to study the molecular mechanisms that underlie the increased risk of CRC 
formation in patients with chronic colonic inflammation. 
In summary, this study demonstrates that mammalian NDR kinases are 
essential for embryonic development. They positively regulate growth, somitogenesis 
and heart development. Whether the defect in bilateral symmetry and the cardiac 
phenotype are causally connected remains to be addressed. Complete loss of NDR 
kinases in the intestinal epithelium causes rectal prolapse and increased 
susceptibility to AOM-induced CRC formation. Lastly, the conditional Ndr double KO 
mouse line represents a valuable tool to address additional in vivo functions of 
mammalian NDR kinases in normal physiology and disease. 
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1 General Introduction 
Almost two decades ago, the Serine/Threonine kinase NDR was isolated in a screen 
designed to identify human homologues of an overlapping pair of C.elegans ESTs 
(expressed sequence tags). The clones had been described as worm homologs of 
human Protein Kinase B and the cell-cycle regulating kinase dbf2 in S.cerevisiae, 
respectively. The screen identified a highly conserved dbf2-related yet distinct protein 
kinase open-reading frame in both Drosophila and human cDNA libraries which was 
termed NDR (nuclear dbf-related) (1).  
Protein kinases are enzymes that catalyze the transfer of a phosphate group 
from adenosine triphosphate (ATP) to serine, threonine or tyrosine residues of 
specific protein substrates (2). Protein phosphorylation serves important regulatory 
functions in the cell. If the substrate is an enzyme, phosphorylation can trigger 
conformational changes that activate or deactivate its catalytic activity (3). 
Alternatively, protein phosphorylation can regulate the cellular localization of a given 
protein or target it for degradation. The human genome encodes 518 protein kinases 
(3) which have been categorized into different families based on the structure of their 
catalytic domains (4). Many protein kinases function in series in so-called signaling 
cascades which relay and amplify signals from the plasma membrane to intracellular 
effectors. Independently of their catalytic activity, certain kinases also serve as 
scaffold or adapter proteins (5-10). 
1.1 Structure and regulation of NDR kinases 
Based on the structure of their catalytic domain, NDR kinases belong to the AGC 
(PKA, PKG, PKC) kinase subgroup (3, 4, 11). They possess an activation segment 
(AS) which is located in catalytic subdomain VII and a hydrophobic motif (HM) in the 
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C-terminus. A unique feature of NDR kinases is their split catalytic domain which is 
separated into two parts (subdomains I-VII and VIII-XII) by a stretch of basic amino 
acids that is thought to auto-inhibit NDR kinase activity (12). Moreover, NDR kinases 
contain an N-terminal binding site for MOB proteins which serve as positive and 
negative regulators of NDR kinase activity (11, 13-19).  
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Figure 1. Primary structure of selected nuclear Dbf2-related (NDR) family members. Eight members of the NDR kinase
family are depicted from unicellular organisms (Saccharomyces cerevisiae (S.c.), Schizosacchararomyces pombe (S.p,) and
Trypanosoma brucei (T.b.)), animals (Caenorhabditis elegans (C.e.), Drosophila melanogaster (D.m.) and Homo sapiens (H.s.))
and plants. The Arabidopsis thaliana (A.t.) sequence, originally termed At2g2047, is referred to as NDR1. Subdomain VIII, which
harbours the activation segment (AS), is shaded in bright grey. The remaining catalytic subdomains are dark grey. The C-
terminally located hydrophobic motif (HM) is shown in green. Solid blue spheres indicate key regulatory phosphorylation sites,
as shown experimentally (H. sapiens NDR1, H. sapiens large tumour suppressor-1 (LATS1), D. melanogaster tricornered (Trc),
S. cerevisiae Cbk1, S. pombe Orb6) or predicted from homology (C. elegans sensory axon guidance-1 (SAX-1), A. thaliana
NDR1, T. brucei PK50). The position of the catalytic lysine that is located in subdomain II is indicated. The insert in the kinase
domain that separates the subdomains VII and VIII contains a putative auto-inhibitory sequence (AIS) and is shown in red. The
N-terminal regulatory domain (NTR) is highlighted in yellow. This figure was generated by me. A slightly modified version
has been published in (13). 
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Although the majority of functional studies has been performed in yeast and fly, the 
regulation of NDR kinase activity has mostly been delineated in mammalian cell 
culture systems (12, 20-25). A schematic summary of NDR activation is shown in 
Figure 2. Catalytic activity of mammalian NDR kinases requires phosphorylation of 
the activation segment (AS) and the hydrophobic motif (HM) (21-25). Both AS and 
HM phosphorylation sites are conserved in all NDR kinase family members identified 
today (13), suggesting that the mechanism of activation by phosphorylation is 
conserved throughout the entire family. While NDR kinases auto-phoshporylate at the 
AS (25), HM phosphorylation is catalyzed by the Ste-20-like kinase family members 
MST1, MST2 and MST3 (10, 23, 26, 27). The MOB1 protein functions as a co-
activator of NDR kinases by stimulating both auto-phosphorylation at the AS (12) and 
HM phosphorylation by the up-stream kinases (21, 26, 27). Its homolog MOB2 acts 
as a negative regulator of NDR kinases and competes with MOB1 for NDR binding 
(16).  
1
T444
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S281
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MOB2MOB1
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Figure 2. Regulation of NDR kinases at the molecular level in humans. Primary structure of human NDR1. Color code of N-
terminal regulatory domain, split catalytic domain and regulatory phosphorylation sites as in Figure 1.The MOB proteins MOB1
and MOB2 bind to the N-terminal regulatory domain (NTR). MOB1 binding stimulates both autophosphorylation at the activation
segment (AS) and phosphorylation of the hydrophobic motif (HM) by up-stream kinases MST1, MST2 and MST3 (21, 26, 27),
MOB2 competes with MOB1 for NDR binding and represses NDR kinase activity (16). Phosphatase PP2A dephosphorylates
both Ser281 and T444. MST1 functions as the up-stream kinase in apoptosis and centrosome duplication (26, 27), MST2 in
mitotic chromosome alignment and MST3 in proliferation (38). Adapted from (13) 
13 
 
1.2 Functions of NDR kinases  
NDR kinases are highly conserved from yeast to man (Figure 1). Knock-out models 
of Ndr homologs in yeast and fly indicate essential functions of the respective kinases 
(reviewed in (13),). Cbk1, the NDR homolog in S. cerevisiae, is indispensable for 
polarized growth and cell separation (28). NDR kinases in S. pombe and N. crassa 
play similar roles in controlling polarized cell growth (reviewed in (29)). Organismal 
loss of the NDR homolog Trc in D. melanogaster is lethal, and mosaic loss of function 
results in a sensory bristle defect with abnormally split and branched bristles (30). Trc 
controls dendritic tiling and branching of Drosophila sensory neuron dendrites (31, 
32). Similarly, the C.elegans NDR homolog Sax-1 regulates mechanosensory tiling 
(33) and contributes to establish and maintain neuronal cell shape (34, 35). Despite 
the insights gained into the biological functions of NDR kinases in yeast, fly and worm, 
their substrates remain unknown.  
Due to an expansion of the kinome, the mammalian genome encodes two 
NDR kinase isoforms, NDR1 and NDR2 which share 86% identical residues (24). 
NDR1 and NDR2 are expressed in broad but distinct patterns in adult mouse tissues 
(24, 36). While NDR1 protein levels are high in thymus, spleen and lymph nodes, 
NDR2 is strongly expressed in colon and brain (36). Every murine tissue analyzed so 
far expresses at least one of the two NDR isoforms (24, 36), suggesting that NDR 
kinases play important roles in mammalian biology. Mammalian NDR localizes to 
centrosomes and regulates centrosome duplication (37). Moreover, it mediates Fas-
receptor induced apoptosis and decreased NDR levels confer partial resistance to 
apoptosis induction (27, 36). MST1 functions as the main HM kinase of NDR in 
centrosome duplication and apoptosis (26, 27). Interestingly, the SARAH domain of 
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MST1 is only required for NDR activation in apoptosis (27) but dispensable for NDR 
regulation in centrosome duplication (26). This finding suggests distinct up-stream 
regulatory pathways of NDR activity in centrosome duplication and apoptosis 
induction. Additionally, NDR1 kinase activity is required for the precise alignment of 
chromosomes in mitosis (38). In this context, NDR is activated by MST2. Recently, 
NDR was shown to regulate G1/S transition downstream of MST3 by directly 
controlling p21 and c-myc protein stability (10). Importantly, this study identifies p21 
as the first endogenous substrate of NDR kinases (10). All of the functions described 
for mammalian NDR today have been identified in tissue cultured cells. Therefore, 
their physiological relevance remains to be confirmed in vivo. 
1.3 Studying in vivo protein function in mouse models  
Despite the obvious physiognomic differences between mice and men, their 
physiology and the underlying molecular pathways are highly conserved between the 
two species. Therefore, the mouse has become a widely appreciated model system 
for studying in vivo functions of mammalian proteins. Many aspects of mammalian 
development have been studied in the mouse and the general concepts appear to be 
conserved between mouse and human. Spontaneous and targeted genetic loss-of-
function (LOF) models in the mouse have helped to discover key molecular pathways 
that are highly relevant to normal human physiology and disease. Two prominent 
examples are the morphogen Sonic Hedgehog (Shh) and the cardiac transcription 
factor Nkx2.5. Disruption of the Shh gene in the mouse causes holoprosencephaly 
(HPE) (39), the most common developmental defect of the forebrain and midface in 
humans. Concurrently, disruption of the Sonic Hedgehog pathway is the major 
common effector of mutations that cause human HPE (40). Moreover, mouse models 
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have significantly contributed to delineate the central role of Hedgehog-signaling in 
several human malignancies (reviewed in (41)). The cardiac transcription factor 
Nkx2.5 was originally identified as a murine homolog of the Drosophila homeobox 
gene NK4 (42). Its expression pattern and the study of Nkx2.5 KO mouse models 
have revealed essential roles of Nkx2.5 in mammalian heart development (reviewed 
in (43)). Today, human Nkx2.5 is known as the most commonly mutated gene in 
congenital heart disease (44-49). These and other examples underscore the 
relevance of developmental studies in the mouse to delineate the genetic basis 
underlying normal human development and disease.  
1.4 Milestones in intrauterine development 
Throughout the course of development, the mammalian embryo has to meet several 
developmental milestones. Failure to do so results in embryonic lethality. In addition 
to the morphological phenotype, the time-point of embryonic lethality has proven to 
be a good indicator of the underlying biological defect (50). Therefore, LOF mouse 
models that result in defective embryonic development are valuable tools to study the 
in vivo function of a given protein, as demonstrated by the present study. The 
following section describes the milestones of intrauterine development that have 
helped to delineate gene product functions based on LOF phenotypes (51, 52).  
Blastocyst formation and implantation 
Approximately one day after fertilization, the zygote undergoes its first cleavage, 
giving rise to two blastomeres. From this stage onwards, embryonic development 
depends on regulatory proteins that orchestrate replication, recombination and 
transcription. Embryos that lack cyclin-dependent kinases 1 (CDK1) are incapable of 
undergoing cell division and arrest at the two-cell stage (53). Loss of components 
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that participate in DNA double strand generation, repair and chromosome remodeling 
leads to developmental arrest at the 4- to 16-cell stage (54-56). During the first days 
following fertilization, the developing embryo moves freely through the oviduct and 
into the uterus. Moreover, embryos generated by in vitro fertilization can easily be 
cultured to the blastocyst stage (E3.5) (52), suggesting that the embryo initially 
develops independently of maternal cues. However, development beyond the 
blastocyst stage requires a physical connection to the mother. The trophoblast cell 
lineage is established from the outer cell layer of the blastocyst, marking the first 
differentiation event in the embryo. Recent studies suggest that the mammalian 
Hippo pathway plays an important role in translating cell position within the blastocyst 
into trophoblast (outside) or inner cell mass (ICM, inside) cell identity (57).  
Figure 3. Implanting blastocyst. At day 4.5 of mouse development, the blastocyst attaches to the uterine epithelium and the
uterus clamps around the blastocyst. Extensive molecular communication via cytokines (IL-1, Interleukin 1; LIH, leukemia-inhibitory 
factor; CSF-1, colony-stimulating factor1), hormones (estrogen) and growth factors (EGF, epidermal growth factor) between the
embryo and the mother is essential for successful implantation.  Taken from (52) 
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Trophoblast cells subsequently adhere to the uterine wall and mediate implantation of 
the embryo around E4.5 (Figure 3). The importance of trophoblast contribution to 
normal development is reflected in the large number of mouse mutants that die at the 
peri-implantation stage due to trophoblast defects (reviewed in (58, 59)). Contrarily to 
the first period of embryonic development, implantation critically depends on 
extensive communication between embryo and mother. In the so-called decidual 
response, the uterus prepares a favorable environment for the embryo (52). On the 
other hand, secretion of IL-1 and other cytokines by the blastocyst is equally 
essential for implantation (60). While trophoblast cells are essential in establishing 
the primary contact with the uterine epithelium, cells from the primitive embryonic 
endoderm contribute to form a functional interface between mother and embryo. The 
primitive endoderm gives rise to extra-embryonic parietal endoderm which migrates 
onto the basal surface of the trophoblast layer and deposits a thick basement 
membrane, so-called Reichert’s membrane. Trophoblast layer, Reicherts’s 
membrane and parietal endoderm form the yolk sac placenta, which supplies the 
embryo with nutrients from maternal blood sinus at the interface of uterine epithelium 
and trophoblast layer. The yolk sac placenta is the principal transport organ between 
mother and embryo until the chorioallantoic placenta starts to function around E10.  
 
Development of the cardiovascular system 
Contrary to various other embryonic systems and organs, the cardiovascular system 
is essential for embryonic survival (51). It comprises three main entities, namely the 
heart, vessels and blood. The majority of these structures is of mesodermal origin. 
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Mesoderm forms during gastrulation, where cells from the epiblast migrate through 
the primitive streak, giving rise to mesoderm and definitive endoderm (Figure 4).   
 
Primitive streak formation around E6.5 marks the onset of gastrulation which 
generates the three definitive germ layers ectoderm, mesoderm and endoderm (61). 
Cell migration is a major morphogenetic hallmark of gastrulation. Consequently, 
genetic ablation of components that are essential for cellular migration, such as the 
extra-cellular matrix component fibronectin and its cellular receptor integrin α5, results 
in mesodermal defects and embryonic lethality by mid-gestation (62, 63). Soon after 
the onset of gastrulation, around E7.5, blood islands start to form in the mesodermal 
layer of the yolk sac. The time-line of murine blood and blood vessel development is 
shown in Figure 5.  
  
Figure 4. The mouse embryo at the onset of gastrulation. At the onset of gastrulation at E6.5, cells from the epiblast (blue)
migrate through the primitive streak to generate mesoderm (orange) and definitive endoderm (not shown). Image taken from
the website of the Department of Biology (BIOL3530) with Dr. Brian E. Staveley, Memorial University of Newfoundland,
Canada 
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Blood islands contain both primitive endothelial and hematopoietic cells. Whether 
they arise from a common progenitor remains subject of debate (64). Endoderm 
derived molecular signals, namely FGF2 (Fibroblast growth factor), Indian Hedgehog 
(IHH) and VEGF (Vascular Endothelial Growth Factor) indisputably play an important 
role in the specification of endothelial and hematopoietic precursors (reviewed in 
(64)). Their importance is underlined by the prominent vascular defects of Vegfα and 
Vefgr2 KO embryos (65, 66). Coalescing blood islands in the yolk sac give rise to 
vascular channels, the precursors of blood vessels. Between E8.5 and E9.5 the 
primitive vascular plexus of the yolk sac undergoes extensive remodeling, a highly 
complex process that requires over 60 known genes (67). Concomitantly, definitive 
hematopoiesis starts in the aorta gonad mesonephros (AGM) of the embryo proper 
which is soon replaced by the liver as a major site of definitive embryonic 
hematopoiesis (68). Compromised liver-hematopoiesis seems to be the reason for 
embryonic lethality of Rb, keratin 8 and c-myb KO mice (69-72).  
The heart develops in parallel to embryonic vasculature and hematopoietic 
cells.  Murine heart development between E6.5 and E10.5 is summarized in Figure 6. 
 
Figure 5. Time-line of murine blood and blood vessel development during embryogenesis. YS: yolk sac; AGM: aorta 
gonad mesonephros. Taken from (114). 
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The cardiogenic regions left and right of the anterior primitive streak give rise to the 
cardiac crescent which becomes apparent at E7.5. The crescent subsequently forms 
two bulges which fuse and become the primitive linear heart tube (73). Heart beat is 
evident at the 3-somite stage and generates plasma flow at early E8 which precedes 
the onset of systemic blood circulation (67). Hemodynamic forces generated by 
cardiac contraction are essential for the remodeling of yolk sac vasculature and 
promote embryonic hematopoiesis (67, 74). Almost immediately after the heart tube 
has formed, it begins to loop (73). Cardiac looping and subsequent chamber 
formation transform the linear heart tube into the four chambered heart. As 
exemplary described above for the cardiac master regulator Nkx2.5, numerous other 
cardiac transcription factors and their contribution to cardiac development have been 
studied in knock-out mouse models (reviewed in (75)). A common theme that has 
emerged from these studies is that severe defects in cardiac looping and chamber 
formation result in embryonic lethality around E10 (76-82). This indicates that proper 
Figure 6. Morphogenesis of the mouse heart. a Myocardial progenitor cells originate in the primitive streak (PS), from where
they migrate to the anterior of the embryo at about embryonic day E6.5. b These cells come to lie under the head folds (HF) and
form the cardiac crescent, where differentiated myocardial cells are now observed (E7.5). c The early cardiac tube forms
through fusion of the cardiac crescent at the midline (ML) (E8). d It subsequently undergoes looping (E8.5). e By E10.5 the
heart has acquired well-defined chambers, but is still a tube (upper panel, ventral view; lower panel, dorsal view). Anterior (A)–
posterior (P) and right (R)–left (L) axes are indicated. AVC, atrioventricular canal; IFT, inflow tract; OFT, outflow tract; PLA
primitive left atrium; PRA, primitive right atrium. Taken from (75)  
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cardiac function is essential for embryonic survival beyond the first half of gestation. 
Less severe cardiac defects that result in poor cardiac function lead to delayed 
embryonic lethality (83-87). In general, mice with structural cardiovascular defects 
tend to die earlier than those with hematopoietic problems (51). This observation 
further supports the hypothesis that hemodynamic force generated by blood flow is at 
least as important as nutrient and oxygen transport during early cardiovascular 
development (88). 
 
Formation of the chorioallantoic placenta 
As mentioned above, the visceral yolk sac constitutes the first principal interface for 
nutrient and waste exchange between mother and embryo (52). At around E10 it is 
replaced by the chorioallantoic placenta which is composed of fetal and maternal 
components. Failure to establish a functional placenta becomes limiting to embryonic 
growth and development between E10 and E11 (51). A schematic representation of 
placental development is shown in Figure 7. The trophoblast layer of the placenta 
arises from trophectoderm cells, the outer layer of the blastocyst. Following 
blastocyst implantation, the ectoplacental cone (EPC), a trophoblast structure, is 
tightly apposed to the maternal decidua. At E8.5, the allantois grows out from the 
posterior end of the embryo and makes contact with the chorion that has 
concomitantly been formed by extra-embryonic ectoderm underlying the EPC. The 
allantois gives rise to embryonic vessels which eventually form the umbilical chord. 
Chorionic trophoblasts differentiate into the various specialized trophoblast lineages 
that constitute the labyrinth layer of the placenta. Embryonic vessels invade the 
labyrinth layer which is also pervaded by maternal blood sinus. The labyrinth layer of 
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the placenta thus forms the direct interface for nutrient and waste exchange between 
fetal and maternal blood. Trophoblasts are important components of the placenta and 
defects in trophoblast development, stem cell maintenance and differentiation can 
result in embryonic lethality (59). Moreover, defects in chorioallantoic attachment as 
well as branching morphogenesis and vascularization of the labyrinth also 
compromise embryonic development (59, 89). These observations demonstrate that 
extra-embryonic membranes and tissues – trophoblast cells, yolk sac placenta and 
chorioallantoic placenta – make essential contributions to mammalian embryonic 
development. 
Figure 7. Placental development of the mouse. The origins of the extra embryonic lineages begin at embryonic day (E) 3.5 with
the formation of the blastocyst. At E8.0, chorioallantoic attachment occurs, followed by branching morphogenesis of the labyrinth
to form dense villi, within which nutrients are exchanged (E8.5–10.5). The mature placenta (E14.5) consists of three layers: the
labyrinth, the spongiotrophoblast, and the maternal decidua. Taken from (89) 
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Mammalian embryonic development is highly complex. During its course, a single cell 
gives rise to an entire organism with many different cell types and tissues. Numerous 
studies with mouse mutants have shown that despite its complexity, embryonic 
development can be broken down to several well defined milestones which the 
embryo has to meet (51, 52). The zygote has to undergo cell divisions to form the 
blastocyst which subsequently implants into the maternal uterine wall at E4.5. 
Development of the vascular and the hematopoietic system initiates in the yolk sac 
around E7.5, the primitive heart tube forms shortly afterwards and begins to beat at 
early E8. Development of the heart, vasculature and blood is highly interdependent. 
Contrary to other embryonic organs that develop slightly later, the cardiovascular 
system and the chorioallantoic placenta are the only systems that are essential for 
embryonic survival (51). Complete failure to establish cardiovascular circulation 
results in embryonic lethality by E10.5. The relevance of the enumerated 
developmental milestones is underlined by large numbers of mouse mutants whose 
phenotypes are characteristic of the milestone that they have failed to meet (53-56, 
58, 62, 63, 65, 66, 69-72, 76-87, 89).  
1.5 The first mouse model of Ndr deficiency reveals tumor 
suppressive functions of mammalian NDR kinases 
The first loss-of-function mouse model for mammalian NDR kinases has been 
reported recently (36). Mice that lack Ndr1 are viable, fertile and initially 
indistinguishable from wild type littermates. However, aged heterozygous and 
homozygous Ndr1 KO mice are highly susceptible to develop T-cell lymphoma. As 
described above, mammalian NDR is activated in response to apoptotic stimuli and 
loss of NDR results in increased resistance to apoptosis induction (27, 36). 
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Importantly, apoptotic cell numbers are decreased in tumors with low NDR protein 
levels (36). Resistance to apoptosis is a common theme in tumor development and 
could endow NDR with tumor suppressor function as postulated by Cornils et al. (36). 
Several reports describe deregulated Ndr transcript and protein levels in different 
human cancer types but their impact on tumor development remains unknown 
(summarized in (90)). The extended mammalian NDR kinase family comprises four 
members, NDR1/2 and LATS/2 (large antigen tumor suppressor). NDR and LATS 
kinases are highly conserved at the C-terminus which contains the catalytic domain 
but differ at the N-terminus where LATS kinases possess a long N-terminal sequence 
that is absent in NDR (Figure 1 and (13)). The lats/warts kinase was originally 
identified in Drosophila as a potent tumor suppressor (91). NDR and LATS kinases 
are positively regulated by the co-activator MOB1 (12, 21, 26, 27, 92, 93). Moreover, 
they share common up-stream kinases, namely MST1 and MST2 in mammals and 
the single MST kinase in fly which was termed hippo and subsequently lent its name 
to the pathway (reviewed in (13)). A schematic overview of the Hippo pathway in 
mammals is shown in Figure 8. Although both NDR and LATS are activated by 
MST1/2, only LATS has been shown to phosphorylate the transcriptional co-activator 
YAP in tissue cultured cells (94). YAP promotes growth via activating transcription 
factors of the TEAD family (95). YAP phosphorylation results in cytoplasmic 
sequestration and thus suppresses its transcriptional activity (96). In summary, the 
mammalian Hippo pathway negatively regulates growth via YAP phosphorylation 
(reviewed in (97-99)). Numerous studies in fly and mammalian tissue cultured cells 
have demonstrated that loss-of-function of Hippo pathway components – such as 
hippo/MST, mats/MOB1, lats/LATS1 and sav/WW45 – results in nuclear YAP 
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localization and unrestricted growth (reviewed in (99, 100)). Concurrently, several 
recent reports demonstrate that YAP over-expression leads to tissue-overgrowth and 
cancer (101-104).  At present, evidence for YAP phosphorylation by NDR kinases is 
limited to in vitro kinase assay data with recombinant protein while co-expression of 
NDR and YAP in Cos-7 cells did not result in YAP phosphorylation (94). However, a 
recent report describes YAP phosphorylation in the liver by a kinase distinct from 
LATS (105). Moreover, YAP phosphorylation in mouse embryos and MEFs is not 
affected by combined loss of Mst1 and Mst2 (106, 107), also suggesting that an 
additional kinase other than LATS can phosphorylate YAP. In summary, based on 
current evidence it cannot be excluded that NDR also phosphorylates YAP in vivo. 
 
Conversely, NDR kinases could also possess oncogenic properties as suggested by 
the observation that Ndr transcript levels are up-regulated in certain human cancers 
(summarized in (90)). Over-expression of human NDR in tissue-cultured cells leads 
MST1 MST3
LATS NDR
MOB1 MOB1
YAP
MOB2
P P
P
Apoptosis
Centrosome
duplication
?
proliferation
p21
P
p21 degradation:
proliferation
Apoptosis
Centrosome duplication
Proliferation
Figure 8. The mammalian Hippo pathway. The mammalian Hippo homolog MST1 phoshporylates and activates both LATS
and NDR kinases. The co-activator MOB1 stimulates both LATS and NDR kinase activity. MOB2 binds and negatively regulates
exclusively NDR. The only known down-stream targets of the mammalian Hippo pathway are YAP (yes-associated protein) for
LATS and p21 for NDR. Recombinant NDR phosphorylates YAP in vitro (dashed line), but has not been shown to do so in cells. 
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to centrosome over-duplication (37). A recent report shows that extra centrosomes 
alone promote chromosome missegregation during bipolar cell division (108). 
Chromosomal missegregation results in chromosomal instability, a hallmark of many 
tumors that correlates with the presence of extra centrosomes (109-112). Moreover, 
a recent study identifies mammalian NDR kinases as positive regulators of cell cycle 
progression (10), indicating that over-activation of NDR kinases could potentially 
drive excess proliferation. In summary, several lines of evidence suggest that NDR 
kinases might be linked to cancer development. However, additional over-expression 
and loss-of-function studies are needed to further elucidate the putative dual nature 
of mammalian NDR kinases as tumor suppressors and oncogenes in vivo. 
As mentioned above, mice with a targeted Ndr1 deletion do not show an 
obvious morphological phenotype until they come of age. However, NDR2 protein 
levels are up-regulated in Ndr1 KO tissues with high intrinsic NDR1 levels, namely 
thymus, spleen and lymph nodes. Therefore, the lack of an early developmental 
phenotype might be due to isoform compensation by NDR2. Interestingly, a similar 
situation has been reported for the up-stream kinases MST1 and MST2 (106, 107). 
Mice that lack Mst1 alone display a T-cell restricted phenotype but are otherwise 
normal (113). Mst2-null mice do not show an overt phenotype (106, 107). However, 
combined loss of Mst1 and Mst2 results in embryonic lethality between E9.5 and 
E11.5 (106, 107), indicating that MST1 and MST2 can mutually compensate for each 
other. Tissue-specific loss of Mst1 and Mst2 in the adult liver results in hepatocellular 
carcinoma (105, 107). Analogously, combined ablation of Ndr1 and Ndr2 in the 
mouse is warranted to confirm and expand initial insights into the in vivo functions of 
mammalian NDR kinases and their role(s) in tumorigenesis. 
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2. Aim and Scope of the Thesis 
The aim of the present study was to identify in vivo functions of mammalian NDR 
kinases. Studies in tissue cultured cell lines have demonstrated roles for mammalian 
NDR kinases in centrosome duplication, the alignment of mitotic chromosomes, 
proliferation and apoptosis. However, little is known about the in vivo roles of NDR 
kinases in mammals. When I joined the laboratory, the Ndr1 knock-out (KO) mouse 
had been generated. It does not display an overt morphological phenotype, but 
NDR2 protein levels are up-regulated in several tissues of Ndr1-null mice, suggesting 
that NDR2 might compensate for loss of NDR1. Moreover, aged Ndr1-null mice 
develop T-cell lymphoma, indicating a tumor suppressive function of NDR kinases. 
Several reports describe deregulated Ndr transcript levels in human cancers but the 
functional relevance of the expression changes has not been addressed.  
To study the physiological roles of mammalian NDR kinases in general and 
their impact on tumorigenesis in particular, I have generated a conditional Ndr1/2 
double KO mouse line. Complete loss of Ndr1/2 results in embryonic lethality and 
reveals essential roles for mammalian NDR kinases in proliferation, somitogenesis 
and cardiac development. As embryonic lethality precludes the analysis of in vivo 
roles of NDR kinases in the adult mouse, I have generated a mouse model where 
Ndr2 is specifically deleted in the intestinal epithelium of Ndr1-null mice. This model 
is used to study the role of NDR kinases in colon cancer. Initial data suggest that 
complete loss of NDR kinases in the intestinal epithelium predisposes mice to AOM-
induced colon carcinogenesis. 
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3. Results 
I have arranged the results section into two parts which are organized as separate 
manuscripts. Both parts contain a separate bibliography and numbering system for 
the figures, i.e. the first figure in each part is numbered as “1”. References from the 
general introduction and the general discussion are summarized in a common 
reference section situated after the general discussion.  
The first manuscript – “Mammalian NDR kinases are essential for cardiac looping 
and contribute to left / right symmetry in the embryo” will be submitted to the journal 
“Development” as soon as the final experiments are completed (Hand1, Hand2 and 
Nodal mRNA in situ hybridization and proliferation curve and beating kinetics of NDR 
pro- and deficient cardiomyocytes). 
The second part summarizes the work that has been done with the intestinal 
epithelium-specific Ndr double knock-out mouse line to address the role of NDR 
kinases in the context of colon carcinogenesis. This project is ongoing and will be 
continued in collaboration with Lei Zhang. 
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3.1 Mammalian NDR kinases are Essential for Cardiac Looping and 
Contribute to L/R Symmetry of the Embryo 
Debora Schmitz-Rohmer1, Simone Probst2, Alexander Hergovich1,4, Mario Stegert1, 
Zhong-Zhou Yang3, Michael Stadler1, Rolf Zeller2 and Brian A. Hemmings1 
 
1 Friedrich Miescher Institut for Biomedical Research, Maulbeerstrasse 66, CH-4058 Basel, Switzerland 
2 Department Biomedizin, Mattenstrasse 28, CH-4058 Basel, Switzerland 
3 Model Animal Research Center of NanJing University, 12 Xue-Fu Road, Pukou District, NanJing, P.R. 
China 210061 
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Contributions of Co-authors and FMI facilities to the work described in this 
manuscript 
 
Simone Probst taught me how to dissect mouse embryos at E8.5 and E9.5. We jointly 
dissected the embryos for the microarray analysis and for the mRNA in situ hybridization 
experiments. Certain mRNA in situ hybridization experiments were performed by her (Lnfg, 
Hes7), others were performed jointly. Results were discussed with her, leading to the design of 
subsequent experiments. Her critique helped to improve the manuscript. 
Alexander Hergovich taught me the practical basics of molecular cloning, gave advice on 
targeting vector design and performed one critical cloning step in the targeting vector generation. 
Mario Stegert generated the Ndr1 knock-out mouse line which I used to generate the Ndr1/2 
double knock-out mouse line. 
Zhong-Zhou Yang prompted me to consider the heart phenotype of Ndr-null mutants as a 
primary defect directly linked to the loss-of-function of NDR kinases. 
Michael Stadler implemented the mathematical model to approximate the effect of increased 
cell cycle duration on embryo size in the R program (Figure SXY, Supplementary Materials) 
Rolf Zeller facilitated the collaboration with Simone Probst and contributed scientific advice to 
the embryo work.  
 
The conditional Ndr2 knock-out mouse line was generated with the help of the Transgenic 
Facility. The labeling, hybridization and quality control of the microarray experiment was 
performed by the Genomics Facility. 
 
All other work was performed by me unless specifically indicated in the text.  
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3.1.1 Abstract 
The mammalian NDR kinases NDR1 and NDR2 are widely expressed and share a high 
degree of sequence identity (1-3). Human NDR kinases function in centriole duplication, 
proliferation, apoptosis and proper alignment of mitotic chromosomes (4-7). Mice lacking 
either Ndr isoform alone are phenotypically normal. Only aged Ndr1 knock-out (KO) mice 
frequently develop T-cell lymphoma (1). The remaining NDR isoform is up-regulated in 
distinct tissues of single KO mice, suggesting a compensatory link between both isoforms. 
To test this hypothesis in vivo, we generated the Ndr1/2 double KO line. Mice with a single 
allele of either Ndr1 or Ndr2 develop normally but we never obtained viable Ndr-null 
offspring. Ndr-null embryos are smaller and developmentally delayed at embryonic day (E) 
8 and die around E10. Transcript levels of the CDK inhibitors p21 and p27 are increased in 
mutant embryos, suggesting that NDR kinases positively regulate proliferation in vivo. 
Mutant embryos also display aberrant somite morphology. The somite-clock genes Lunatic 
Fringe and Hes7 are asymmetrically expressed in the presomitic mesoderm, indicating a 
role for NDR kinases in the control of L/R symmetry. However, aberrant somitogenesis is 
unlikely to cause embryonic death. Embryonic heart development of Ndr-null mutants 
arrests at the linear heart tube stage and does not proceed to cardiac looping. Importantly, 
proper establishment of the L/R axis is essential for rightward cardiac looping (8, 9). Mutant 
myocardium is thickened and the heart lumen partially obstructed. Cardiac malformation is 
most likely the primary cause for embryonic lethality of Ndr-null mutants. In summary, we 
demonstrate that mammalian NDR kinases are essential for embryonic development. They 
positively regulate growth, somitogenesis and heart development. Whether the defect in L/R 
symmetry control and the cardiac phenotype are causally connected remains to be 
addressed. 
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3.1.2 Introduction 
NDR kinases are highly conserved from yeast to man (3, 10, 11). Loss-of-function 
models for Ndr homologs in yeast and fly demonstrate essential functions of the 
respective kinases (reviewed in (11)). Cbk1, the Ndr homolog in S. cerevisiae, is 
indispensable for polarized growth and cell separation (12). NDR kinases in S.pombe 
and N.crassa play similar roles in controlling polarized cell growth (reviewed in (10)). 
Organismal loss of the Ndr homolog trc in D. melanogaster is lethal, and mosaic loss of 
function results in a sensory bristle defect with abnormally split and branched bristles 
(13). Importantly, trc and sax-1, the Ndr homolog in C.elegans, control dendritic tiling 
and branching of sensory neuron dendrites in fly and worm (14-16). The mammalian 
genome encodes two Ndr kinase isoforms – Ndr1 and Ndr2 (3) – which are expressed 
in a broad but distinct pattern in adult mouse tissues (1, 3). Mammalian NDR kinases 
positively regulate centrosome duplication (6) and proper alignment of mitotic 
chromosomes (4). Moreover, they function in apoptosis induction down-stream of 
RASSF1A (7). Decreased NDR levels confer partial resistance to apoptotic stimuli (1, 7). 
Lastly, NDR kinases control G1/S transition by directly regulating p21 and c-myc protein 
stability (5).  
The catalytic activity of mammalian NDR kinases is regulated by phosphorylation 
of a serine residue in the activation segment (AS) and a threonine residue in the 
hydrophobic motif (HM) (3, 17-20). While NDR kinases autophoshporylate at the 
activation loop (20), hydrophobic motif phosphorylation is catalyzed by the Ste-20-like 
kinase family members MST1, MST2 and MST3 (5, 7, 19, 21).  
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The first mammalian loss-of-function model for NDR kinases has been reported recently 
(1). Mice that lack Ndr1 are initially indistinguishable from wildtype littermates. However, 
aged heterozygous and homozygous Ndr1 KO mice develop T-cell lymphoma (1). 
Importantly, NDR2 protein levels are up-regulated in Ndr1 KO tissues. Therefore, 
isoform compensation by NDR2 might prevent an early developmental phenotype. 
Interestingly, a similar situation has been reported for the up-stream kinases MST1 and 
MST2 (22, 23). Mice that lack Mst1 display a T-cell restricted phenotype (24) but are 
otherwise normal. Mst2-null mice do not show an overt phenotype (22, 23). However, 
combined loss of Mst1 and Mst2 results in embryonic lethality by mid-gestation (22, 23), 
indicating that MST1 and MST2 can mutually compensate for each other. To address 
whether the restricted phenotype of Ndr1-null mice reflects isoform compensation and 
to further elucidate the in vivo roles of mammalian NDR kinases, we have generated a 
conditional targeted deletion of the Ndr2 gene and the Ndr1/Ndr2 double knock-out 
mouse line. 
We identify mammalian NDR kinases as essential positive regulators of growth, 
somitogenesis and heart development in vivo. Ndr2-null mice are phenotypically normal, 
but combined loss of Ndr1 and Ndr2 results in embryonic lethality by mid-gestation. This 
demonstrates that NDR1 and NDR2 can mutually compensate for each other. Ndr-null 
embryos are smaller, display aberrant somite morphology and fail to complete cardiac 
looping. Impaired cardiac function is the primary cause for embryonic death.   
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3.1.3 Results 
 Conditionally targeting the murine Ndr2 locus 
The mammalian homologs NDR1 and NDR2 are highly conserved and widely 
expressed (1, 19). Knock-out models for Ndr homologs in yeast and fly indicate 
essential functions of the respective kinases (13, 25-27). However, mice carrying a 
homozygous targeted deletion of Ndr1 are born in the expected mendelian ratio, viable 
and fertile (1). One potential explanation for this restricted phenotype is the 
compensatory up-regulation of NDR2 which the authors have observed in distinct 
tissues (1). To test this hypothesis and to further elucidate the in vivo functions of 
mammalian NDR, we have generated a conditional targeted deletion of the Ndr2 gene 
in the mouse.  
We isolated and sequenced 9080 base pairs (bp) of genomic DNA surrounding 
exon 2 of Ndr2 in Ola129 ES cells. In two regions, the obtained sequence differed 
significantly from the published sequence of the C57BL/6 strain: one deletion of 254 bp 
located downstream of exon 1 and one insertion of approximately 200 bp located 
upstream of exon 3. Additionally, we found numerous base pair exchanges spread out 
over the entire sequence analyzed, underlining the importance of sequence 
heterogeneity between the Ola129 and the C57BL/6 mouse strain. As detailed in 
Materials and Methods, we engineered a targeting vector to introduce loxP sites up- and 
downstream of exon 2. As shown in Figure 1A, Cre-mediated removal of exon 2 should 
lead to loss of functional NDR2 protein. Offspring with a conditionally targeted Ndr2 
locus was crossed with Meox2-Cre or FLP-deleter mice to generate the complete Ndr2 
knock-out (KO) or the clean conditional KO, respectively. Genotyping and Western blot 
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analysis confirmed successful targeting (Figure 1B, C). A clear decrease of NDR2 
protein levels was already apparent in the heterozygous situation (Figure 1C). This 
gene-dosage effect was also observed in the Ndr1 single KO (1). Mice lacking NDR2 
protein were viable, born in the expected mendelian ratio (Figure 1D) and fertile, 
indicating that NDR2 is dispensable for normal development in the Ndr1 wild type 
background. 
 
 
  
loxP site
frt site
1 3 4
2
A
wildtype allele
targeting vector
E E1 3
2
4
E
Neo
E
: internal southern probe
conditional allele
knock-out allele
5‘ ex wt
3‘ ex wt
5‘ int wt
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3‘ Hrec
5‘ Hrec
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+/- -/-+/+ Ndr2 genotype
B
NDR2
actin
+/- -/-+/+ 
C D Ndr2
Genotype +/+ +/- -/-
Number of 
animals
49 113 52
Obtained 23% 53% 24%
Expected 25% 50% 25%
Figure 1 Targeting scheme and validation of the conditional Ndr2 knock-out in the mouse.  A Genomic structure of the Ndr2
locus in the mouse and targeting vector for conditional Ndr2 knock-out. Primer binding sites for ES cell screening are indicated (Ex
com 5‘/3‘– common external 5‘/3‘ pimer; wt 5‘/3‘ – wild type internal primers; H rec 5‘/3‘ – homologous recombination primers in Neo
cassette). E: EcoRl restriction sites used for Southern blot validation of single integration. See Materials and Methods section for
detailed description of the targeting strategy. B Genotyping PCR of wild type, heterozygous and homozygous Ndr2 knock-out ear
notch samples. C Westernblot analysis confirms loss of NDR2 protein in Ndr2 knock-out . D Ndr2 heterozygous and homozygous
offspring from Ndr2 heterozygous intercrosses are born in the expected Mendelian ratio. Genotypes were determined at weaning 
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NDR1 protein and phosphorylation levels are up-regulated in distinct Ndr2 knock-
out tissues  
NDR2 levels are up-regulated upon ablation of NDR1, suggesting a compensatory link 
between the two isoforms (1). More precisely, up-regulation of NDR2 occurs particularly 
in tissues with high Ndr1 expression in the wild type situation, notably thymus, spleen 
and lymph nodes (1). In general, Ndr1 and Ndr2 expression patterns partially overlap. 
So far, all mouse tissues examined expressed at least one of the two Ndr isoforms. 
While NDR1 protein levels are highest in organs of the immune system – thymus, 
spleen and lymph nodes – NDR2 protein levels peak in the colon and the brain (1-3).  
To address whether loss of NDR2 protein conversely results in the up-regulation 
of NDR1 protein, we analyzed tissues of Ndr2 wild type, heterozygous and knock-out 
littermate adult mice (Figure 2A).  
 
Our results mirrored the findings from the Ndr1 KO (1), namely that loss of Ndr2 
resulted in an up-regulation of NDR1 in tissues with high intrinsic NDR2 levels – such as 
colon and lung. Moreover, we also found that mRNA levels of Ndr1 remained constant 
in Ndr2 KO colon (Figure S1, Supplementary Material), indicating that NDR1 protein 
NDR1
actin
thymuslung colon stomach brain
Genotype
Ndr2
NDR2
+/+ +/- -/- +/+ +/- -/- +/+ +/- -/- +/+ +/- -/- +/+ +/- -/-
A
Figure 2A NDR1 protein levels are up-regulated in distinct Ndr2 knock-out tissues. Westernblot analysis of NDR1 and NDR2
levels in wild type, heterozygous and homozygous Ndr2 knock-out tissues of indicated organs. NDR2 levels are clearly gene-dose
dependent. They are decreased in Ndr2 heterozygous tissues and absent in all Ndr2 knock-out tissues as expected. Conversely,
NDR1 levels are up-regulated in lung and colon of Ndr2 heterozygous and knock-out mice. Although NDR2 levels are intrinsically
high in the brain, NDR1 levels are not up-regulated in Ndr2 knock-out brain. Actin serves as loading control.  
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levels are increased by a post-transcriptional mechanism. The brain, however, differed 
from this pattern. In the wild type brain NDR2 levels were high, but we did not detect 
any NDR1. Even when we completely abolished Ndr2 expression, total NDR1 protein 
did not come up to detectable levels. The adult brain was thus the only tissue analyzed 
which did not counter-act loss of endogenous NDR by the up-regulation of the 
remaining isoform.   
 
Human NDR was recently shown to play a role in centrosome duplication (6), apoptosis 
(7) and c-myc stabilization in the context of cell cycle progression (5). In all three 
processes, hydrophobic motif phosphorylation is essential as rescue-experiments with 
T444A mutants do not restore the wild type situation. Therefore, we asked whether the 
up-regulation of NDR protein was paralleled with an increase in hydrophobic motif (HM) 
phosphorylation, also indicative of catalytically active NDR. We found prominent 
increases in HM phosphorylation of NDR2 in thymus, spleen and lymph nodes of Ndr1 
deficient mice, where it is almost absent in the wild type and strongly up-regulated in 
P444/2
NDR1
NDR2
HSC70
brain
Ndr1
Ndr2 ++ ++ ++ ++ ++ ++
+ + + + + + + + + + + +
colon heart thymus spleen LN
B
Figure 2B. The up-regulation of the remaining NDR isoform in Ndr single knock-out tissues is accompanied by
hydrophobic motif phosphorylation. In colon, thymus, spleen and LN of Ndr1 knock-out mice both total and phospho-NDR2
levels are strongly increased, suggesting that the kinase is catalytically active.  Similarly, total and phosho-NDR1levels rise in the
colon of Ndr2 knock-out mice. Hydrophobic motif phosphorylation in wildtype, Ndr1 and Ndr2 single knock-out tissues was detected
by the phospho-444/2 antibody. Upper band in 444/2 panel: NDR2; lower band: NDR1 phosophorylated at the hydrophobic motif.
HSC-70 serves as loading control. LN: lymph nodes. Amount of protein loaded per lane: 1 mg. 
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Ndr1 knock-out tissue (Figure 2B). Similarly, phospho-HM levels of NDR1 rose – albeit 
to a lesser extent – in the colon when Ndr2 was lost.  On the contrary, we barely 
detected phospho-HM of either NDR1 or NDR2 in the brain although total NDR2 levels 
were high in wild type mice. The complete absence of NDR in Ndr2 KO brain is 
exceptional and warrants in depth analysis of Ndr2-/- brains, especially in light of the 
finding that Pax6 was down-regulated 1.5 fold in Ndr1/2 double KO mouse embryos at 
E8.5 (data not shown, available upon request). Pax6 KO mice display an axonal wiring 
defect (28). In summary, we show that the increase in protein levels of the remaining 
NDR isoform was paralleled by an increase in HM phosphorylation, suggesting that it is 
catalytically active. Taking into account that HM phosphorylation was shown to be 
essential for the three biological functions of the kinase described so far, our findings 
support the hypothesis that mammalian NDR1 and NDR2 can compensate for each 
other.  
The compound Ndr1/Ndr2 double knock-out is embryonic lethal 
To address whether NDR kinases play an essential in vivo role in mammalian biology, 
we generated the compound Ndr1/Ndr2 double knock-out by crossing the respective 
Ndr single KOs. When we intercrossed ndr1+/-ndr2+/- mice, we did not obtain any double 
knock-out offspring (Table 1). All other genotypes were represented in approximately 
the expected mendelian ratio. Moreover, they were fertile and did not present any overt 
phenotype. This indicates that complete absence of NDR results in embryonic lethality 
while a single remaining Ndr allele is sufficient for normal development and reproduction. 
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To elucidate how lack of NDR results in embryonic lethality, we intercrossed Ndr single 
allele mice. We collected embryos at different stages of development to determine the 
time window of embryonic lethality and did not detect Ndr-null embryos after embryonic 
day (E) 10.5. At E10.5, we recovered Ndr1/2 double KO embryos which were severely 
growth retarded and had already started to undergo the resorption process (data not 
shown), indicating that NDR is essential for normal embryonic development prior to this 
time-point. Therefore, we analyzed embryos at earlier time-points, namely E8.5 and 
E9.5. At these stages, double KO embryos were detected at the expected Mendelian 
ratio (Table 2).  
 
Ndr1-Ndr2 GT wt-wt wt-ko ko-ko ko-wt wt-het het-ko ko-het het-wt het-het
offsrping numbers 37 23 0 28 44 54 42 53 134
theoretical (%) 6.25 6.25 6.25 6.25 12.5 12.5 12.5 12.5 25
actual (%) 8.92 5.54 0.00 6.75 10.60 13.01 10.12 12.77 32.29
n = 415
Table 1 The Ndr1/2 double knock-out is embryonic lethal but a single Ndr-allele is sufficient for normal development.
Genotype distribution of offspring from Ndr1/2 double-heterozygous intercrossings at weaning. No Ndr1/2 double KO embryos
were detected. All other genotypes were obtained at approximately the expected Mendelian ratio. Total numbers and expected
and obtained ratios are indicated.  
a: all embryos recovered at E10.5 were dead and had started to disintegrate
stage het-het het-ko ko-het ko-ko unknown total
E8.5 - E9.5 53 54 56 56 7 226
E10.5 4 6 5 5a 1 21
postnatal 69 65 59 0 0 193
Ndr1-Ndr2 genotype
Table 2 Complete loss of Ndr1/2 is embryonic lethal around E10. Genotype distribution of offspring from Ndr-single allele 
matings at indicated time-points. Between E8.5 and E9.5 Ndr-null embryos were recovered in the expected Mendelian ratios. All 
mutant embryos that were recovered at E10.5 were dead and had started to undergo the resorption process, indicating that 
mammalian NDR kinases are essential for survival beyond E9.5.
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Gross analysis revealed that at E8.5 mutant embryos were slightly smaller and 
developmentally delayed as judged by somite numbers (3A, B). While normal 
littermates had developed an average of ten somites, mutant embryos had only 
between six and seven (Figure 3C). Significantly, mutant somites appeared smaller and 
less well defined. The notochord, a rod-like structure underlying the neural tube (29), 
patterns the surrounding tissues, including somites, by secreting the morphogen Sonic 
Hedgehog (30-34). While Shh is essential for notochord maintenance (30), notochord 
formation critically depends on the T-box transcription factor T/Brachyury (35-39). To 
address whether altered somite morphology in Ndr-null embryos was a result of 
compromised notochord function, we analyzed the expression patterns of Brachyury 
and Sonic hedgehog (Shh) (Figure S2, Supplementary Material). Expression of both 
genes was normal in Ndr-null embryos at E8.5, indicating that NDR is dispensable for 
the formation of a continuous notochord and Shh expression. 
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Figure 3. Ndr1/2-null embryos are smaller and developmentally delayed from E8.5. Brightfield image of A normal and B Ndr-null
(mutant) littermate at E8.5, both embryos are at the 6-somite stage. Mutant somites are small and irregular. C Average somite
numbers of normal and mutant littermates at E8.5. Mutant embryos are developmentally delayed by approximately 4 somites Average
somite number normal embryos: 10.2, mutant embryos: 6.4.  n = 15 litters. Scale bar in A, B: 0.5 mm 
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At E9.5, the size difference between mutant and normal littermates had approximately 
doubled (Figure 4) and about half of the mutant embryos were still unturned. In normal 
embryos, the turning process is initiated at the six to eight somite stage (40). Moreover, 
about half of the mutants had developed pericardial edema (Figure 4C), indicative of 
pathologic fluid accumulation in the heart region due to cardiac malfunction. However, 
we did observe cardiac contractions in several mutants at E9.5. Mutant yolks sacs also 
differed strikingly from their normal counterparts. While the vascular plexus of normal 
yolk sacs had undergone extensive remodeling and macroscopic vessel structures filled 
with red blood cells were readily detectable, large remodeled vessels were absent in 
mutant yolk sacs (Figure 4E,F). We did observe a faint mesh of red lines in certain 
areas of mutant yolk sacs, indicating that primitive hematopoiesis had taken place to 
some extent. Moreover, mutant yolk sacs had a distinct “ruffled” appearance. The 
A B C
D FE
Figure 4. Ndr-null embryos fail to remodel yolk sac vasculature and develop pericardial edema by E9.5 A normal littermate 
(A) and its yolk sac (D) and two mutants (B,C) and their yolk sacs (E,F) are shown. Mutant embryos (B, C) are significantly smaller, 
not all mutants have completed embryonic turning (B), yolk sac vasculature has not been remodeled (E,F). Distinct remodeled 
vessels are apparent in the normal yolk sac (D). Significantly, several mutants have developed pericardial edema (C, arrow), 
indicative of cardiac insufficiency. Heartbeat was detected in mutant embryos until E9.5. Scale bars = 0.5 mm.  
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allantois of mutant embryos, however, appeared always well developed and had 
attached to the chorion. The allantois is primarily of mesodermal origin (41), indicating 
that loss of NDR did not negatively affect mesoderm formation in general. In summary, 
we show that NDR kinases are essential for embryonic development and survival 
beyond E10.5. From early somite stages onwards, the size of Ndr-null embryos was 
reduced compared to normal littermates. Secondly, mutant somites were smaller and 
irregularly shaped. Thirdly, mutant heart function appeared compromised and vessel 
remodeling in the yolk sac had not taken place by E9.5. Our findings thus confirm that 
the up-regulation observed in the respective Ndr single knock-outs represents functional 
compensation by the remaining isoform. 
 
The cyclin dependent kinase inhibitors p21 and p27 are up-regulated in Ndr-null 
embryos  
To pursue our search for a molecular explanation of the observed embryonic lethality, 
we performed microarray analysis of Ndr-null versus normal embryos. Although the 
phenotype was more severe in E9.5 mutant embryos, we focused our analyses on E8.5 
embryos to address the primary defect caused by loss of NDR. Both Ndr1 and Ndr2 are 
broadly expressed at E8.5 as assessed by RNA in situ hybridization (Figure S3, 
Supplementary Material). At this stage, embryonic development proceeds extremely 
fast reflecting rapid gene expression changes. Therefore, we set our experimental 
window to include only embryos with seven to nine somites. The complete lists of up- 
and down-regulated genes is available upon request and will be deposited in the Gene 
Expression Omnibus (GEO) of the NCBI (National Center for Biotechnology 
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Information) at the time of publication. Microarray analysis revealed that cdkn1a and 
cdkn1b transcripts, encoding the cyclin-dependent kinase (CDK) inhibitors p21 and p27, 
respectively, were each up-regulated about 1.5 fold in NDR-deficient embryos (Table 
3A).  
 
Moreover, klf6 transcript levels were also up-regulated 1.45 fold. The Klf6 gene encodes 
the transcription factor Krüppel-like 6 which directly activates transcription of Cdkn1A 
both in vitro and in vivo (42, 43). The up-regulation of cell cycle inhibitors could 
negatively affect proliferation and thus provide a straightforward explanation for the 
reduced size of Ndr-null embryos. Although the list of differentially-regulated genes did 
not contain an apoptotic signature, we performed TUNEL analysis on embryo sections 
to exclude that the observed size reduction of Ndr-null embryos was due to an 
Table 3. CDK inhibitors and somitogenesis-related genes are deregulated in Ndr-null embryos at E8.5. mRNA of Ndr-null and 
Ndr double heterozygous male embryos was subjected to microarray analysis as described in Materials and Methods. A Transcripts 
of Cdkn1A and Cdkn1B – encoding the CDK inhibitors p21 and p27 – are up-regulated in Ndr-null embryos. B Somitogenesis-
related genes are down-regulated in Ndr-null embryos. For each gene, p-value and linear fold change are indicated. N = 3 embryos
linear FC Gene symbol Description p-Value
+1.50 Cdkn1a cyclin-dependent kinase inhibitor 1A (P21) 0.0011
+1.48 Cdkn1b cyclin-dependent kinase inhibitor 1B (p27) 0.0193
+1.45 Klf6 Kruppel-like factor 6 0.0013
linear FC Gene symbol Description p-Value
-1.61 Meox1 mesenchyme homeobox 1 0.0005
-1.33 Tbx6 T-box 6 0.0011
-1.33 Aldh1a2 = Raldh2 aldehyde dehydrogenase family 1, subfamily A2 0.0224
-1.30 Dll1 delta-like 1 (Drosophila) 0.0018
-1.30 Sfrp1 secreted frizzled-related protein 1 0.0076
-1.29 Dll3 delta-like 3 (Drosophila) 0.0422
-1.28 Msgn1 mesogenin 1 0.0105
-1.27 Meox2 mesenchyme homeobox 2 0.0193
-1.21 Lfng lunatic fringe 0.0207
A
B
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increased rate of apoptosis. As expected, we detected only very few apoptotic cells in 
both normal and mutant embryos (S4, Supplementary Material). In summary, we 
present initial evidence that the size reduction of Ndr-null embryos might be due to the 
concurrent up-regulation of the two CDK inhibitors p21 and p27. 
 To address whether the up-regulation of p21 and p27 resulted in a decreased 
proliferation rate, we tested three different cellular markers for proliferation, namely Ki67, 
BrdU incorporation and histone 3 phosphorylation (poshpo-H3). We dismissed Ki67 
because almost every cell both in wild type and mutant embryo sections stained positive. 
BrdU labeling of cells in the embryo was more restricted but introduces additional 
variables into the analysis. In particular, BrdU is injected into the mother and reaches 
the embryo via its yolk sac. As described above (Figure 4E,F), Ndr-null yolk sacs were 
clearly affected and might thus influence the final incorporation rate into dividing cells in 
the embryo. Therefore, we determined the proliferation index of wild type and mutant 
embryos based on the fraction of phospho-H3-positive cells. Serine 10 of histone 3 is 
strongly phosphorylated in mitotic cells (44). Representative embryo sections stained 
with an anti-phospho-H3 antibody are shown in Figure 5. Unexpectedly, we found the 
proliferation index – defined as the percentage of phospho H3 positive cells over total 
cells – to be almost identical in both groups (Figure 5C). In conclusion, the immuno-
histochemical approximation of the mitotic cell fraction did not confirm a decreased 
proliferation rate in Ndr-null embryos at E8.5. However, this does not exclude the 
possibility that complete loss of NDR did result in a proliferation defect which might have 
been too small to be picked up by this method. Only FACS analysis of total embryos 
could provide a definitive evaluation of these hypotheses. 
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Abnormal somite morphology in NDR deficient embryos 
As described earlier, Ndr-null mutants also displayed smaller and irregularly shaped 
somites. Significantly, our microarray data also contained a set of down-regulated 
genes that are predominantly expressed in somites or implicated in somitogenesis 
(Table 3B). The most prominently down-regulated gene, Meox1, is a transcription factor 
commonly used as a somite marker (45). The second member of the Meox family, 
Meox2, is also down-regulated in Ndr-null embryos. Concerted action of MEOX1 and 
MEOX2 is required upstream of genetic pathways essential for the formation, patterning 
and differentiation of somites (46).The transcription factor Tbx6 is expressed in the 
presomitic mesoderm (PSM) (47) and was reduced in Ndr-null embryos as well. 
Reduced levels of Tbx6 result in defective somite patterning (48, 49). Tbx6 and WNT 
signaling synergistically controls the expression of Mesogenin1, a transcription factor 
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Figure 5. The mitotic index of wildtype and Ndr-null embryos is comparable at E8.5. Mitotic cells in A wildtype and B Ndr-null
embryos were labeled on paraffin sections with an anti-phospho Histone 3 antibody, nuclei were counterstained by DAPI. The
mitotic index was defined as the percentage of phospho-H3 positive cells per embryo. C Quantitative approximation of the mitotic
index of wildtype and Ndr-null embryos. Four embryos per genotype and five sections per embryo were quantified, amounting to a
total of > 40 000 cells counted per genotype. Error bars indicate the standard error of the mean (SEM).  
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that is essential for maturation of the PSM and that was also down-regulated in Ndr-null 
embryos (50). Expression of Sfrp1 (secreted frizzled-related protein 1) was also 
decreased in mutant embryos. Members of the Sfrp family bind directly to WNT proteins 
and thus antagonize WNT signaling (51, 52). Sfrp1 was shown to regulate anterior-
posterior axis elongation and somite segmentation in conjunction with Sfrp2 in the 
mouse embryo (53). Lastly, three components of the Notch pathway were down-
regulated in NDR deficient embryos, namely Lunatic fringe (Lnfg) and the Notch 
ligands Dll1 and Dll3. LNFG negatively regulates Notch signaling and Lnfg-null mice 
present somitogenesis defects (54). Dll1 and Dll3 play each essential roles in somite 
formation (55, 56) and cooperate to establish inter-somitic boundaries (57). In summary, 
all genes described above are tightly linked to somitogenesis and their down-regulation 
reflects the somite defect detected in NDR deficient embryos. Loss of NDR negatively 
affected three components of the Notch pathway, indicating that NDR might interact 
with it. 
To validate and expand our microarray data on the somite phenotype, we 
performed RNA in situ hybridization and histological analyses. In situ hybridization 
confirmed that Tbx6 levels were significantly down-regulated in Ndr-null embryos 
(Supplementary Materials, Figure S5). In wild-type embryos, Meox1 was uniformly and 
strongly expressed in all somites and clearly demarcated somite borders from the 
surrounding tissue. Distances along the anterior – posterior (A-P) axis between 
neighboring somite pairs were evenly spaced (Figure 6A, left embryo). This was not the 
case in the Ndr-null embryo, where meox1 levels were generally decreased, somite 
borders were fuzzy and distances between somites on the AP axis tended to vary 
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between the left and the right somite (Figure 6A, right embryo). Moreover, the location 
of the most recently formed somite was unclear. These findings confirmed a decrease in 
Meox1 levels and further highlighted the altered somite morphology in Ndr-null embryos. 
Next, we analyzed the polarity of mutant and normal somites. Within the newly formed 
somite, expression of Uncx4, a member of the paired-related class of homeodomain 
transcription factors, is restricted to the caudal half (58). This caudal restriction was 
maintained in Ndr-null embryos at the six and eight somite stage (Figure 5B, C and data 
not shown, respectively), indicating that cranio-caudal polarity was established. 
However, as already observed with the Meox1 expression domains, Uncx4 levels were 
heterogeneous and not contained within clear borders. Distances between A-P neighbor 
somite pairs were symmetrical in the wild type, but again unevenly spaced in the 
mutants.  
 
We subsequently performed H&E stainings on paraffin sections to further analyze 
somite morphology at the cellular level. Transversal and parasagittal sections of wild 
type and Ndr-null somites at the six somite stage revealed that size and cell number of 
mutant somites were significantly reduced (Figure 7A-D). In summary, we show that the 
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Figure 6 Altered somite morphology in Ndr-null embryos at E8.5. A Meox1 mRNA in situ hybridization demarcates small and
irregularly shaped somites in mutant embryos (right) compared to normal littermate (left) B,C Uncx4 in situ hybridization of wildtype
(B) and mutant (C) embryos reveals that rostro-caudal identity is correctly established in mutant embryos. 
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absence of NDR lead to a down-regulation of somite markers and genes implicated in 
somitogenesis by E8.5. Three of these genes belong to the Notch pathway. Mutant 
somites retained their internal A-P polarity but were irregularly shaped and spaced over 
the embryonic A-P axis. Moreover, they were smaller due to a decrease in cell number. 
We conclude that NDR is essential for proper somite formation and spacing along the 
A-P axis and might exert this effect via interacting with the Notch pathway.  
Asymmetric expression patterns of Notch pathway components in the presomitic 
mesoderm of NDR deficient embryos 
Somitogenesis is a highly symmetrical process. Pairs of somites periodically pinch off 
from the anterior tip of the PSM until a species-specific number of somite pairs has 
been generated. The so-called segmentation clock interacts with the wave front, an 
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Figure 7.  Somites of Ndr-null embryos are smaller and contain less cells than wildtype somites. Hematoxylin/Eosin
staining of transversal (A,C) and parasagital (B,D) sections of wildtype (A,B) and mutant (C,D) embryos at the 6-somite stage
show that mutant somites (C, white asteriks) are significantly smaller and contain less cells than their wildtype counterparts (A,
white asteriks). PSM: presomitic mesoderm; SI, SII, SIII: first, second and third somite. Scale bars = 50 µm 
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anterior - posterior gradient of specific factors, to coordinate the reiterative process of 
somite formation (reviewed in (59)). The wave front was found to be an opposing 
gradient of retinoic acid (RA) and FGF8 (60). RALDH2 is the main enzyme responsible 
for RA synthesis in the embryo (61-63). At E8.5, Raldh2 is expressed in the somites, the 
trunk mesoderm and the anterior PSM (62, 64), while Fgf8 is expressed in the posterior 
PSM and certain regions of the developing brain (65). To address whether loss of NDR 
disturbs this gradient, we determined the expression patterns of Raldh2 and Fgf8 
(Figure 8). We found that Raldh2 was expressed in comparable levels in wild type and 
mutant embryos. Fgf8 expression in the PSM, however, was significantly weaker in the 
Ndr-null embryo while Fgf8 levels in anterior expression areas – such as the 
prospective forebrain and the midbrain-hindbrain barrier – were comparable in wild type 
and mutant embryos. This shows that NDR is required for high Fgf8 expression levels in 
the PSM but dispensable for Raldh2 expression.  
Raldh2 - wt Raldh2 - mut Fgf8
wt mutA CB
Figure 8. Fgf8 levels in the presomitic mesoderm are decreased in Ndr-null embryos at E8.5. Raldh2 mRNA in situ hybridization
in wildtype (A) and mutant (B) embryos indicates similar expression patterns. C Fgf8 levels are decreased in the presomitic mesoderm
of mutant embryos (wildtype: left, mutant: right) but similar in anterior expression domains. 
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As delineated by Dequeant et al. (66), the segmentation clock is implemented through 
cyclic expression of distinct genes belonging to the FGF, Wnt and Notch pathways. 
Cyclic FGF and Notch pathway members oscillate in phase, opposite to cyclic Wnt 
genes. Therefore, we analyzed the expression patterns of representative cycling 
members of the respective pathways by in situ hybridization. Axin2, a central cycling 
component of the Wnt pathway, was normally expressed in Ndr-null embryos (data not 
shown).  
 
However, Lunatic fringe (Lnfg), a negative regulator of the Notch pathway, was 
asymmetrically expressed in approximately half of the Ndr-null embryos, while it was 
always symmetrically expressed in wild-type embryos (Figure 9 A,B). Moreover, the size 
of the prominent posterior expression stripe was significantly reduced in all mutants. A 
second oscillating member of the Notch pathway, Hairy and enhancer of Split 7 (Hes7), 
was also asymmetrically expressed, albeit to a less striking degree, in mutant embryos 
only (Figure 9 C,D). Furthermore, Hes7 levels were decreased in NDR-deficient 
embryos. Of note, asymmetric loss of expression of both Lnfg and Hes7 was always 
observed on the right side of the mutant PSM, although additional embryos have to be 
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Figure 9. The Notch pathway components Lnfg and Hes7 are asymmetrically expressed in Ndr-null embryos at E8.5. A,B 
Lnfg expression is lost in the posterior expression domain (arrow) on the right side in mutant embryos (A: wildtype, B: mutant). In 
general, Lnfg expression is reduced, confirming the microarray data. C,D Hes7 expression is lost in the anterior expression domain 
on the right side (arrow) in mutant embryos (C: wildtype,D: mutant).  
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analyzed to establish whether this finding is statistically significant. In summary, our 
findings show that loss of NDR negatively regulates Fgf8 levels in the PSM while 
Raldh2 expression is unaffected. Moreover, they indicate that NDR positively regulates 
both expression levels and symmetry of Notch pathway genes in the PSM, further 
supporting the hypothesis that NDR might interact with the Notch pathway.  
 
NDR is essential for cardiac looping  
Aberrant somitogenesis is unlikely to account for embryonic lethality. Meox1/2 double 
KO mice show severely disrupted somite morphology and do not develop an axial 
skeleton, however, they survive until birth (46). The first organ that is essential for 
survival of the developing embryo is the heart (67). The primitive linear heart tube is 
established around E8.0 (68, 69). Consistent heart beat is detectable at the 3-somite 
stage followed by the onset of blood flow between the 4- to 6-somite stage (70, 71). The 
transition from the linear heat tube to the four-chambered adult heart proceeds via a 
process termed “cardiac looping” and represents the first symmetry-breaking event in 
the embryo. The initial steps of cardiac looping occur between E8.0 and E8.5 (8) and 
are categorized as looping stage (LS) 0 to III (72). When we analyzed the hearts of Ndr-
null embryos at E8.5, we found that they were in LS-II (Figure 10C), while hearts of 
normal littermates had proceeded to LS-III with prominent rightward looping (Figure 10 
A). Additionally, mutant hearts had adopted a bulbous character and appeared less 
transparent than wild type controls (Figure 10 C,D), suggesting a thickened myocardium 
and reduced heart lumen. To determine whether this phenotype resulted from a 
developmental delay or a developmental arrest, we analyzed embryos at E9.5. As 
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shown in Figure 10 G,H,  hearts of mutant embryos at E9.5 where still in LS-II, 
indicating that heart development had arrested at this stage. Consequently, we never 
observed rightward looping of Ndr-null hearts. Importantly, the remainder of the mutant 
embryo had continued to develop – although slower than normal littermates (see also 
Figures 3 and 4) – indicating that only cardiac development had come to a complete 
arrest. The occurrence of pericardial edema in several mutant embryos at E9.5 (Figure 
4C) is also indicative of defective heart development.  
 
To analyze altered heart morphology in Ndr-null embryos on the cellular level, we 
performed H&E stainings on paraffin sections of mutant and wild type embryos at the 6-
somite stage (Figure 11). We found the myocardium to be thickened (Figure 11F-G) and 
the heart lumen to be filled with abnormal cell masses, resulting in the opacity of mutant 
hearts described above. Both partial constriction and obstruction reduce the flow of 
A B E F
C D G Hmut mut
wtwt
Figure 10. Cardiac looping arrest and bulbous heart tubes in Ndr-null embryos at E8.5. By E8.5, the heart tube of wildtype 
embryos has undergone rightward cardiac looping (A) and appears transparent in the lateral view (B). Heart tubes of Ndr-null
embryos have not initiated looping (C) and display a bulbous and opaque heart tube (C,D). At E9.5, wildtype hearts have 
continued the looping process (E,F) while mutant hearts have remained arrested at the onset of cardiac looping (G,H). Images A-D 
were taken at 115x magnification. Scale bars in E-H: 100 nm. A,B: ventral and lateral view of wildtype embryo at E8.5; C,D: ventral 
and lateral view of mutant embryo at E8.5; E,F: ventral and lateral view of wildtype embryo at E9.5; G,H: ventral and lateral view of 
mutant embryo at E9.5 
52 
 
plasma and blood even in the presence of normal cardiac contraction. Plasma and 
blood flow are critical to sustain and promote embryonic development on different levels. 
In particular, remodeling of the yolk sac vasculature was shown to depend on 
hemodynamic forces exerted by plasma and blood flow (71). The reduction of flow could 
thus explain the yolk sac vasculature remodeling defect observed in NDR deficient 
embryos (Figure 4E,F). On these grounds, we conclude that cardiac malformation is the 
primary cause for embryonic lethality of Ndr-null embryos.  
 
Interestingly, we did detect heart beat in both E8.5 and E9.5 mutant embryos and 
obtained comparable numbers of beating foci when we differentiated NDR pro- and 
deficient ES cells into cardiomyocytes (Supplementary Materials, Figure S6), indicating 
that NDR is dispensable for cardiac contraction. In this regard, the cardiac phenotype of 
Ndr-null embryos was almost identical to the one observed in knock-out embryos of the 
important cardiogenic regulator Nkx2.5 (73). NKX2.5 holds a pivotal position in the 
cardiac regulatory hierarchy and controls the expression of numerous other cardiac 
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Figure 11.Thickened myocardium and abnormal endocardium in Ndr-null hearts at E8.5. Transversal sections of a wildtype
(A-D) and a mutant (F-I) heart at the 6-somite stage. Thickened myocardium and abnormally expanded endocardium are most likely
the cause for cardiac insufficiency and embryonic lethality of Ndr-null embryos. E: schematic representation of the localization of the
sections within the embryo. Myocardium (my), endocardium (en) and headfolds (HF) are indicated in B and G. Distance between the
sections ~ 30 µm 
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transcription factors (74, 75). Of note, Nkx2.5 transactivates the Xin promoter and 
knock-down of Xin in the chick results in cardiac looping defects and thickened 
myocardium (76). The striking resemblance of the Ndr and Nkx2.5 knock-out heart 
phenotypes suggests that NDR might function in the same pathway as the cardiac 
master regulator Nkx2.5.   
 
3.1.4 Discussion 
NDR kinases are highly conserved within the eukaryote domain and play essential roles 
in yeast and fly (reviewed in (11)). Although loss of NDR kinases in lower eukaryotes 
results in embryonic lethality (13, 25-27), Ndr1 KO mice develop normally (1). Similarly, 
we find that Ndr2 KO mice are viable, fertile born in the expected mendelian ratio and 
do not display an overt phenotype (Figure 1). However, protein levels of the remaining 
NDR isoform are up-regulated in both Ndr1 and Ndr2 single KO mice, suggesting that 
they may compensate for each other ((1), Figure 2A).  Moreover, we show that the up-
regulation in Ndr1 and Ndr2 single KO tissues is paralleled by an increase in 
hydrophobic motif phosphorylation (Figure 2B). Given that hydrophobic motif 
phosphorylation is essential for NDR to exert its role in centrosome duplication and 
apoptosis (6, 7), this finding further supports the hypothesis that NDR1 and NDR2 
compensate for each other in the respective single KOs. Combined loss of NDR1 and 
NDR2 results in embryonic lethality around E10 (Table 2), demonstrating that 
mammalian NDR kinases indeed compensate for each other and are essential for 
embryonic development. Interestingly, the up-stream kinases of NDR, MST1 and MST2 
also exhibit mutual compensation as only the Mst1/2 double KO is embryonic lethal (22). 
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This may indicate that isoform compensation is a general theme in the NDR pathway in 
mammals. In summary, we show that mammalian NDR kinases can compensate for 
each other and are essential for embryonic development.  
Ndr1/2 double KO embryos display multiple phenotypes. They are 
developmentally delayed and smaller from E8.5 (Figure 3) and their somites are small 
and abnormally shaped (Figure 6 and 7). Importantly, Ndr-null embryos arrest cardiac 
development at the onset of cardiac looping (Figure 10). To investigate the defects 
caused by loss of NDR on the molecular level, we have performed microarray analysis 
of mutant and control embryos at E8.5. Although mammalian NDR plays a role in 
apoptosis (1, 7), we do not observe expression changes in genes implicated in 
apoptosis. TUNEL analysis further confirms low and similar apoptotic cell numbers in 
mutant and wild type embryos (Figure S4) indicating that the reduced size of mutant 
embryos at E8.5 is not due to increased apoptosis. However, cdkn1A and cdkn1B 
transcript levels are up-regulated in mutant embryos (Table 3A). Cdkn1A and Cdkn1B 
encode the cyclin dependent kinase (CDK) inhibitors p21 and p27 which negatively 
regulate cell cycle progression by inhibiting the activity of CDKs (77-80). Therefore, 
increased p21 and p27 levels might result in reduced proliferation which could account 
for the smaller size of Ndr-null embryos. Indeed, a recent report shows that 
simultaneous knock-down of Ndr1 and Ndr2 in HeLa cells leads to increased p21 and 
p27 levels and G1-cell cycle arrest (5). A block in G1 would be expected to translate 
into a decrease of the mitotic fraction in the embryo. Surprisingly, the mitotic index of 
NDR-deficient and wild type embryos based on the ratio of phospho-H3 positive cells is 
comparable at E8.5 (Figure 5). However, in a rapidly growing embryo, even minor 
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increases in cell cycle duration could account for significant size differences. We have 
established a simple model to mathematically approximate the effect of increases in cell 
cycle duration from E7.5 to E8.5 in mouse development. Thereby we find that a 20% 
increase in mean cell cycle duration during this period would suffice to generate the 1.5 
fold size difference that we observe between normal and Ndr-null littermates at E8.5 
(Supplementary Material, Figure S7). Even smaller increases would translate into 
significant developmental differences if they occurred for longer time periods. 
Alternatively, loss of NDR could potentially affect cell size. Although we do not detect 
gross cell size difference by visual examination of the embryo sections, further analyses 
are required to exclude that loss of NDR negatively affects cell growth. Conditional 
primary Ndr double KO mouse embryonic fibroblasts will provide a complementary and 
homogeneous system to further characterize the function of NDR kinases in cell cycle 
progression in a non-transformed setting. Additional analyses, such as whole embryo 
FACS, are warranted to determine on which level loss of NDR negatively affects 
embryo growth prior to the onset of cardiac function. In summary, complete loss of NDR 
leads to increased p21 and p27 levels in the embryo. Increased p21 and 27 levels could 
result in a partial block in cell cycle progression and reduced proliferation, indicating a 
potential mechanism that could account for the growth defect observed in NDR kinase-
deficient embryos at E8.5. 
In addition to a general size reduction, NDR-deficient embryos also display small 
and irregularly shaped somites (Figure 6 and 7). Indeed, somite markers and genes 
linked to somitogenesis are down-regulated in NDR-deficient embryos at E8.5 (Table 
3B), reflecting the morphological somite phenotype. Somites derive from the presomitic 
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mesoderm (PSM). Therefore, decreased expression levels of genes that are important 
for PSM maturation – such as Tbx6 and Mesogenin (48-50) – or somite formation and 
patterning (Meox1/2, Sfrp1, Lnfg, Hes7 and Dll1/3 (46, 53-56, 81)) are expected to 
result in aberrant somitogenesis. Meox1 and Uncx4 in situ hybridization as well as 
histological analysis further illustrate small and irregularly shaped somites in Ndr-null 
embryos at E8.5 (Figure 6, 7 and 9). Interestingly, several of the affected genes belong 
to the Notch pathway, namely the ligands Dll1 and Dll3, the negative regulator Lunatic 
Fringe and the target gene Hes7. Loss-of-function mouse models of all four genes 
display strong segmentation defects with disrupted somite patterning (54-56). The 
reported somite defects in these mutants are stronger than in Ndr-null embryos but 
were always analyzed after E9.5. Somite defects in NDR-deficient mutants might be 
also more pronounced at later stages, but general deterioration of NDR-deficient 
embryos precludes meaningful somite analysis after E8.5. Interestingly, at E8.5, Lnfg 
and Hes7 transcripts are not only reduced but also asymmetrically expressed in several 
Ndr-null embryos (Figure 9), indicating that NDR kinases also contribute to symmetry 
decisions in the embryo. Intriguingly, Dll1-mediated Notch signaling is essential for left-
sided Nodal expression in mice and Dll1-null mice display randomized laterality (82). 
Taken together, these observations point towards a potential role of NDR in 
(a)symmetry implementation, possibly in the context of Notch signaling. So far, NDR 
kinases have not been linked to Notch signaling. Interestingly, the Notch ICD bears two 
putative phosphorylation sites for NDR (R. Tamaskovic, unpublished observation). 
Therefore, it would be interesting to address a potential connection of NDR kinases and 
Notch signaling in the future. Its role in centriole duplication (6) could also provide a link 
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between NDR and symmetry. Modified centrioles, so-called basal bodies, are core 
components of primary cilia (83). Therefore, loss of NDR might result in defective 
primary cilia. Primary cilia in the node generate leftward flow of extra-embryonic fluid 
which induces left-restricted expression of Nodal and thus breaks the initially bilateral 
symmetry of the embryo (84-90). Importantly, impaired primary cilia function results in 
laterality defects in mice (91-96) and humans (summarized in (97)). Analysis of Nodal 
expression and other left-restricted factors (such as Lefty2 and Pitx2) in Ndr-null 
embryos at early somite stages will show whether NDR participates in the initial 
breaking of bilateral symmetry in the embryo. In summary, NDR is required for proper 
somitogenesis and symmetrical expression of Notch pathway components in the 
presomitic mesoderm. Further studies addressing the potential link of NDR kinases and 
the Notch pathway and the role of NDR in cilia biogenesis and function in the context or 
L/R axis establishment are warranted.  
A properly established L/R axis is essential for cardiac rightward looping. NDR-
deficient hearts arrest at the onset of cardiac looping and present a thickened 
myocardium and abnormal cell masses in the heart tube lumen at E8.5 (Figure 10 and 
11). Mutant embryos subsequently develop pericardial edema and fail to remodel their 
yolk sac vasculature, indicative of cardiac insufficiency and most likely the primary 
cause for embryonic death of around E10. Although loss of NDR increases resistance to 
apoptotic stimuli (1, 7), it seems unlikely that the thickened myocardium in Ndr-null mice 
is due to defective apoptosis because developmental apoptosis occurs primarily in the 
non-myocardial compartments and at later stages of heart development (98, 99). 
58 
 
Nevertheless, only quantitative TUNEL analysis of NDR-deficient heart tubes could 
formally exclude this hypothesis. 
We do not observe expression changes of cardiac regulatory genes in our 
microarray analysis of whole embryos at E8.5 (microarray data available upon request; 
will be deposited in Gene Expression Omnibus (GEO) at NCBI at the time of 
publication). However, by E8.5 the developing embryo contains a variety of different cell 
types which compromises the detection of gene expression changes restricted to small 
cell populations such as the developing heart. Although overall transcript levels of the 
cardiac transcription factor Nkx2.5 are not altered in Ndr-null embryos the cardiac 
phenotypes of Ndr-null and Nkx2.5-null embryos are strikingly similar (73). Loss of both 
NDR and Nkx2.5 leads to the arrest of heart development at the onset of cardiac 
looping (Figure 10, (73)). Moreover, as observed in Ndr-null embryos (Figure 4), 
Nkx2.5-deficient yolk sacs fail to undergo remodeling of yolk sac vasculature and have 
a distinct “ruffled” appearance (100). In the absence of Nkx2.5 or NDR, cardiac 
contractions are still observed both in the heart and in in vitro differentiated 
cardiomyocytes (Supplementary Material, Figure S6 and (73)). This indicates that loss 
of both Nkx2.5 and NDR affects cardiac looping rather than cardiomyocyte 
differentiation. Taken together, the phenotypical similarities suggest that NDR and 
Nkx2.5 act in the same pathway in the context or cardiac development. Phosphorylation 
of Nkx2.5 has been reported (101), but whether this modification is functionally relevant 
in vivo and whether NDR can function as an up-stream kinase of Nkx2.5 remains to be 
addressed. Although much progress has been made in deciphering the transcriptional 
networks that govern the patterning of the vertebrate heart (reviewed in (102-104)), the 
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cellular and biophysical bases of cardiac looping are less well defined (72, 105). One 
line of evidence proposes differential proliferation in the cardiac mesoderm (106) and 
the dorsal mesocardium (107) as a morphogenic driving force for cardiac looping 
whereby increased proliferation on the right side results in right-ward looping. This 
differential proliferation could be lost in the heart tube of NDR-deficient embryos. Equal 
proliferation rates on both sides could result in an elongation of the heart tube which 
might subsequently be compressed due to space constraints in the pericardial cavity 
leading to the thickened and bulbous character of Ndr-null hearts. Other lines of 
evidence suggest changes in myocardial cell shape, re-arrangements of intracellular 
actin bundles and extra-cellular matrix (ECM) remodeling as key effectors of cardiac 
looping (76, 107-115). Importantly, all of the proposed mechanisms implement cardiac 
looping based on previously established L/R identity. The knock-down phenotype of the 
actin bundling protein Xin (Chinese for “heart”) in chick embryos exemplifies the 
importance of the actin cytoskeleton in cardiac looping (76, 112, 116). Xin-depleted 
hearts display arrested or abnormal leftward cardiac looping (76). Importantly, their 
myocardium is thickened and forms invaginations into the heart cavity (76) as observed 
in Ndr-null hearts (Figure 11). The murine Xin promoter is activated by Nkx2.5 (76), 
indicating that the cardiac looping arrest in Nkx2.5-null hearts (73) could at least in part 
be due to concurrent loss of Xin protein. Interestingly, over-expressed human NDR2 
also co-localizes and interacts with actin and might be involved in controlling cell 
morphology (117). Moreover, the Ndr homolog Cbk1 in yeast closely interacts with the 
cytoskeleton and is essential for polarized growth (12, 118, 119). Taken together, these 
parallels indicate that mammalian NDR might function in the re-arrangement of the 
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cytoskeleton during cardiac looping. In summary, our current data clearly demonstrate 
that NDR is essential for cardiac looping. However, whether NDR is essential to initially 
establish the L/R axis or whether it functions in the morphogenetic processes that 
interpret L/R identity to direct rightward cardiac looping remains an open question. 
While the cardiac phenotypes of Nkx2.5 and Ndr-null embryos are very similar, only 
Ndr-null embryos are smaller than their normal littermates and developmentally delayed 
from early E8 (Figure 3). Nkx2.5-null embryos only deviate from the normal 
developmental rate at the 15-Somite stage, (73)). This demonstrates that loss of NDR 
causes developmental defects prior to the onset of cardiac function, possibly via the up-
regulation of p21 and p27 which might result in slowed embryo growth. Therefore, 
tissue-specific ablation of Ndr in the heart is warranted to specifically study the role of 
NDR in heart development. Embryonic lethality of the whole body Ndr1/2 double KO 
precludes the identification of additional roles of NDR. Therefore, conditional ablation of 
Ndr in specific tissues and cellular systems has been initiated and will represent 
valuable tools to define additional in vivo functions of NDR kinases. 
In summary, we demonstrate that mammalian NDR kinases are essential for 
embryonic development. Both NDR kinase isoforms compensate for each other with 
high efficiency, explaining the absence of a developmental phenotype in Ndr1 and Ndr2 
single KO mice. We identify NDR kinases as positive regulators of growth, 
somitogenesis and heart development. Our data suggest that NDR kinases could 
promote growth by negatively regulating expression levels of the CDK inhibitors p21 
and p27 in the embryo. Moreover, NDR kinases are essential for the symmetrical 
expression of the somite-clock genes Lnfg and Hes7 in the presomitic mesoderm. The 
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most vital function of NDR kinases during embryonic organogenesis appears to be in 
cardiac looping. Proper establishment of the embryonic L/R axis is indispensable for 
cardiac rightward looping. Therefore, the symmetry defects in somite-clock gene 
expression and the cardiac looping arrest might reflect a general symmetry defect in 
Ndr-null embryos, suggesting that NDR kinases contribute to L/R symmetry decisions in 
the embryo. 
 
3.1.5 Materials and Methods 
Conditional targeting of the murine Ndr2 locus 
Genomic DNA from 129Ola (E14) ES cells served as a PCR template to generate the 
homology arms for the targeting vector. We used the following three primer pairs to 
amplify a region spanning 9080 bp of the ndr2 locus:  
 
F1fwd-gagcaagcttccagaaaccatgatgagacctg,  F1rev-gcagatggaaatgaggactgtg;  
F2fwd-gctgggataggtggataaatgg,    F2rev-gcacagggcctaacaataaacac;  
F3fwd-ggtttcttgggagtcaggaactgtc,   F3rev-ctcacagactagctcaggtgac  
The region encompasses exon 1 and exon 2. We introduced loxP sites up- and 
downstream of exon 2 using an over-lap PCR strategy as there are no suitable 
endogenous restriction sites in the vicinity of exon 2. Excision of exon 2 should result in 
the loss of functional NDR2 kinase because putative alternative splicing joining exon 1 
and 3 or exon 1 and 4 results in a +1 frameshift which changes the catalytic lysine and 
thus abolishes kinase activity.  We flanked the tk-neo sequence from pMC1 neo polyA 
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with frt sites to allow for later removal of the selection marker and inserted the cassette 
into the endogenous XbaI site downstream of exon 1. An additional loxP site was 
introduced upstream of the tk promoter to remove the neo gene and exon 2 at the same 
time when generating the complete full body Ndr2 knock-out. The targeting vector was 
linearized with Spel and electroporated into 129Ola cells which were subsequently 
grown in the presence of G418. Resistant clones were screened for the desired 
homologous recombination event using PCR reactions at the 5’ and the 3’ integration 
site (Primer binding sites are indicated in Figure 1A, PCR results are shown in 
Supplementary Materials, Figure S8). Each primer set contained one primer that bound 
outside of the targeting vector region in the endogenous locus sequence. Positive 
clones were screened for single targeting vector integration by southern blot analysis of 
EcoRI digested DNA with an internal probe hybridizing immediately up-stream of the 
neo cassette (Supplementary Materials, Figure S9). Finally, we sequenced all exons, 
intron-exon borders, loxP sites and frt sites to validate their integrity. Two independent 
validated clones were expanded and aggregated with d2.5 morulas followed by 
implantation into foster mothers. The resulting chimeric offspring was crossed with 
either the Meox2-Cre deleter (B6.129S4-Meox2tm1(cre)Sor/J) to obtain complete ndr2 
knock-out animals or the Rosa-FLP deleter strain (129S4/SvJaeSor-
Gt(ROSA)26Sortm1(FLP1)Dym/J) to remove the neo marker to establish the conditionally 
targeted ndr2 mouse line. Both the Meox2-Cre and the Rosa-FLP deleter strain were 
obtained from the Jackson Laboratory, Main, USA. 
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Genotyping and gendertyping 
Genotyping reactions to distinguish between wild type (wt), full KO (fKO), floxed (fx) and 
conditional KO (cKO) ndr2 alleles share a common forward primer 
5’gctgggataggtggataaatgg3’ and the following reverse primers: 5’gcttaagtcttaagctcaacctc3’ 
for wt and fx, yielding PCR products of 424 bp (wt) and 513 bp (fx); 
5’gcctgcattgcagtccttagc3’ for the fKO allele yielding a PCR product of 843 bp and 
5’gacagtcattcatcagtgagg3’ for the cKO allele with a product of 665 bp. PCR reactions 
were performed on a Thermal Peltier Cycler (Biorad), the cycling protocol is described 
in Supplementary Materials (Figure S10A). Genotyping of Ndr1 alleles was performed 
according to the protocol published by Cornils et al. (1). Embryo genders for the 
microarray experiment and ES cell genders for cardiomyocyte differentiation were 
determined using the smcx-1 primer (5’tgacagggaaaccgctgccaaattctttgg3’) and the 
smc4-1 primer (5’ctgaagcttttggctttgagcaggctac3’) yielding a single band around 300 bp 
for females and a double band for males. The cycling protocol is described in 
Supplementary Materials (Figure S10B). 
 
Western blotting 
For tissue protein extracts, flash frozen tissues were homogenized in 6 l ice cold lysis 
buffer per mg tissue using  a tissue homogenizer. Lysis buffer contained 50mM Tris-HCl 
(pH 7.5), 120 mM NaCl, 40 mM -glycerophosphate and was supplemented with the 
following phosphatase and protease inhibitors: 1 mM NaF, 1 mM sodium pyrophosphate, 
2 M Microcystein, 1 mM PMSF and 1 mM Benzamidine. Homogenized extracts were 
incubated on ice for 30 minutes prior to two consecutive centrifugation steps at 14000 g 
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to obtain clear lysates.  For detection of NDR, samples were resolved on a 10% SDS 
PAGE gel, a 12% gel was used to detect MOB proteins. Total MOB1, MOB2, NDR1 and 
NDR2 protein as well as NDR phosphorylated at the hydrophobic motif were detected 
by polyconal rabbit antibodies as described (MOB1: Hergovich et al., 2009; MOB2: 
Kohler et al., 2010; total NDR1 and NDR2: Cornils et al., 2010; phospho-444/2: 
Tamaskovic et al., 2003). The HSC-70 protein detected by a rat-monoclonal antibody 
(Clone 1B5, Stressgen) served as loading control. Fluorescence-labeled secondary 
antibodies (goat α-rabbit IRDey®800CW, LI-COR Biosciences; goat α-rat Alexa Fluor 
680, Invitrogen) in conjunction with the Odyssey scanner (LI-COR Biosciences) were 
used to visualize protein bands. 
 
In situ probe synthesis 
The following probes were used: Axin2 – Aulehla et al. (120); Fgf8 – Crossley et al. 
(65); Hes7 – Bessho et al. (81); Lunatic Fringe – Evrard et al. (121); 1993 #851}; Meox1 
– Mankoo et at. (122); Raldh2 – Niederreither et al. (62); Sonic hedgehog – Echelard et 
al. (31); T/brachyury – Herrmann (123); Tbx6 – Chapman et al. (47); Uncx4 – Dequeant 
et al. (66). 20 µg of each vector were linearized with the appropriate restriction enzyme. 
DNA was extracted by Phenol/Chloroform/Isoamylalcohol (25:24:1), precipitated with 
sodium acetate and taken up in 20 µl of TE. Probe synthesis was performed by the sp6, 
T3 or T7 RNA polymerase at 37°C for 120 min in the presence of Placental 
Ribonuclease Inhibitor. Newly synthesized probes were purified by two consecutive 
precipitations with LPA (Linear Polyacrylamide), dissolved in TE and stored at -20°C. 
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Whole-mount in situ hybridization 
Whole-mount in situ hybridization was performed according to Haramis et al. (124). In 
brief, pregnant females were sacrificed on E8.5. Uteri were removed, embryos 
dissected in ice cold PBS and fixed in 4% PFA over night. They were dehydrated 
through a graded series of MetOH and PBT (25% - 50% - 75% - 100%) and stored in 
100% MetOH at -20°C until further use. At the beginning of the experiment, embryos 
were re-hydrated through the same graded MetOH / PBT series. All subsequent steps 
were performed in 2 ml Eppendorf tubes. Unless otherwise specified, each washing 
step was done for 5 min at room temperature. Embryos were treated with Proteinase K 
for 15 min which was subsequently inactivated by 2 mg / ml Glycine in PBT, followed by 
two washes in PBT. They were re-fixed with 4%PFA/0.2%Glutaraldehyde for 20 min 
and incubated in prehybridisation solution at 70°C for 1h. The prehybridisation solution 
(prehyb) contained: 50% formamide, 5x SSC pH 4.5, 2% blocking powder (Boehringer), 
0.1%Tween, 0.5%CHAPS (Sigma), 50 µg/ml yeast RNA, 5  mM EDTA and 50 µg/ml 
Heparin (Sigma). 20xSSC stock solution contained 3 M NaCl, 0.3 M 
Sodiumcitrate:H2O2Probes and was adjusted to pH 4.5 with 1M HCl. Probes were 
heated to 85°C for 5 min, then added to embryos at a final concentration of 1 µg/ml and 
incubated at 70°C over night. Subsequently, embryos were washed with prehyb alone, 
followed by a graded series of 2x SSC / prehyb solutions (1/4, ½, ¾). All washes were 
carried out at 70°C. Next, embryos were washed twice for 30 min with 2x SSC / 0.1% 
CHAPS at 70°C, then twice for 10 min with 100 mM maleic acid, 150 mM NaCl at pH7.5 
at room temperature, followed by two additional washes with 100 mM maleic acid, 150 
mM NaCl at pH7.5 at 70°C. Embryos were then washed three times with fresh TBST. 
Prior to antibody addition, embryos were blocked in 10% sheep serum in TBST for 60 
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min, then incubated in a 1:5000 dilution of anti-DIG-AP antibody (Boehringer 
Mannheim) in 1% sheep serum in TBST at 4°C over night. Next, embryos were washed 
3 times with TBST, then five times with TBST changes every 90 min, followed by a final 
wash step at 4°C over night. Probe detection was performed in NTMT which contained 
100 mM NaCl, 100 mM Tris pH 9.5, 50 mM MgCl2 and 1% Tween-20. Embryos were 
washed three times in NTMT for 10 min, then incubated with 1 ml of BM purple (Roche) 
and protected from light. Progress of staining reaction was monitored regularly and 
eventually stopped with several washes in PBT, then PBS. Embryos were 
photographed under a Leica MZ16FA microscope (Leica), for long term storage 0.05% 
Azide were added to the PBS. 
 
Phospho-histone 3 detection and hematoxylin / eosin stainings on embryo 
paraffin sections 
Pregnant females were sacrificed on E8.5. Uteri were removed, embryos dissected in 
ice cold PBS and fixed in 4% PFA over night. Next, embryos were dehydrated through a 
graded EtOH / H20 series (30% - 50% - 70%). All following steps were performed in 
glass vials. Embryos were washed three times for 10 min with 100% EtOH, then three 
times for 10 min with Ultraoclear (Medite) at room temperature. Next, embryos were 
incubated in a 1:1 solution of Histoclear and paraffin at 60°C for 30 min. After three 
changes of paraffin for 20 min each, embryos were embedded on a Medite embedding 
station. Embedded embryos were sectioned at 2.5 µm and mounted on poly-lysine 
coated slides. Sections were stained for phosphorylated histone 3 on the Discovery XT 
system (Ventana) with antibody m14955 (Abcam) at a 1:1000 dilution. Alexa Fluor® 568 
goat anti-mouse IgG (Invitrogen) was used for detection at a 1:100 dilution. The FLUO 
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FMI staining protocol (Ventana) with slide pre-treatment by buffer CC1 (Ventana) for 30 
minutes was used. Sections were mounted in Dapi-containing VectaShield mounting 
medium (Vector Laboratories). H&E stainings were performed with the Programmable 
Slide Stainer TST (Medite). 
 
Image analysis and quantification 
Phospho-H3 stained sections were analyzed by the Zeiss Z1 Widefield microscope. 
Images for quantification were acquired by the AxioCam MRm (Zeiss) in conjunction 
with the Axiovision software (Zeiss). Phospho-H3 cells and total cells were counted 
using the Imaris program (Bitplane Scientific Software). H&E stained sections were 
analyzed on the Nikon Eclipse E600 microscope, images were acquired with the Nikon 
DX1200 camera in conjunction with the Image Access software (Imagic). 
 
 Microarray analysis of embryos 
Matings of single allele ndr1 and single allele ndr2 mice were setup. Pregnant females 
were sacrificed on day 8 after fertilization (E8.5). The uterus was dissected out and 
placed in PBS on ice. Embryos were dissected out with their yolk sacs. Only embryos 
with seven to nine somites were kept and placed into separate Eppendorf tubes filled 
with 200 ul of RNA later (and stored on ice until the entire litter had been processed.  
Next, total RNA was isolated on the same day using the Qiagen RNeasy Micro Kit. 
Embryos were homogenized using 1ml syringes with 26 Gauge needles. The remaining 
isolation procedure was carried out according to the protocol provided by the 
manufacturer. Genomic DNA for consecutive genotyping and gendertyping of the 
embryos was isolated from the flow-through of the RNeasy Micro column. To that end, 
68 
 
the DNeasy Blood and Tissue kit from Qiagen was used. Elution of genomic DNA was 
performed in a single step with 100 ul of bidest water to maximize DNA concentration. 
RNA concentration and purity were measured on the nanodrop apparatus (nd-1000 
Spectrometer, Thermo Scientific). The ndr1 and ndr2 gentoype were determined as 
detailed above. Only male embryos were used in the experiment. Embryos 
heterozygous for both Ndr1 and Ndr2 served as control for mutant embryos. All three 
embryos within each group – mutants and controls, respectively – originated from 
different litters to avoid litter-specific bias. RNA samples were stored at -80°C until all 
samples had been collected.  
RNA was processed with the WT cDNA Synthesis & Amplification kit and labeling 
was performed with the WT Terminal Labeling kit from Affymetrix (Affymetrix, Santa 
Clara, CA) according to the manufacturer's instructions. GeneChip Mouse Gene 1.0 ST 
arrays were hybridized following the "GeneChip Whole Transcript (WT) Sense Target 
Labeling Assay Manual" (Affymetrix, Santa Clara, CA) with a hybridization time of 16h. 
The Affymetrix Fluidics protocol FS450_0007 was used for washing. Scanning was 
performed with Affymetrix GCC Scan Control v. 3.0.1 on a GeneChip® Scanner 3000 
with autoloader (Affymetrix). Probesets were summarized and probeset-level values 
normalized with justRMA() function from R (version 2.10.0) / Bioconductor (version 2.5) 
package affy using the CDF environment MoGene-1_0-st-v1.r3.cdf (as provided by 
Bioconductor) and annotation from Netaffx (www.netaffx.com). Differentially expressed 
genes were identified using the empirical Bayes method (F test) implemented in the 
LIMMA package and adjusted with the false discovery rate method (Wettenhall JM 
Smyth GK. limmaGUI: a graphical user interface for linear modeling of microarray data. 
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Bioinformatics (Oxford, England, 2004). Hierarchical clustering and visualization were 
done in R. Probe sets with a log 2 average contrast signal of at least 5, a P value of 
<0.05, and an absolute log 2 fold-change of >0.263 (1.2-fold in linear space) were 
selected leading to the identification of 701 genes that were up-regulated and 183 
genes that were down-regulated in Ndr-null embryos. The complete microarray data will 
be available in the Gene Expression Omnibus once the manuscript has been submitted 
for publication.  Paragraph provided by Tim Roloff. 
 
ES cell isolation and cardiomyocyte differentiation 
Super-ovulated females were mated with males and sacrificed 2.5 days after plugging. 
Uteri were removed and flushed to obtain morulae. The zona pelucida was removed 
and naked morulae plated onto feeder layers of inactivated mouse embryonic 
fibroblasts. Upon confluency, aliquots were frozen until further use. Aliquots for genomic 
DNA extraction for geno- and gendertyping were plated without feeder cells. Geno- and 
gendertyping was performed as described above. Prior to cardiomyocyte differentiation, 
ES cells were passaged twice in the absence of feeder cells. Embryoid bodies were 
generated according to the screw cap method described by Kurosawa et al. (125). In 
brief, 20 000 ES cells were incubated in 1ml of ES cell medium in 1.5 ml screw cap 
tubes (Sarstedt). After 5 days, embryoid bodies had formed and were plated in 24-well 
plates in the presence of 10 µM PP2 to enhance the differentiation into cardiomyocytes 
as described by Hakuno et al. (126). Four days after plating, the total number of beating 
foci per well was counted under the light microscope. 
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Figure S1. mRNA levels of Ndr1 remain unchanged in Ndr2 knock-out colon. A NDR1 and NDR2 protein levels in colon
extracts of indicated genotype; HSC-70 served as loading control. Amount of protein loaded per lane: 1 mg. B Quantification of
protein levels in A) by the LICOR system. C Corresponding Ndr1 mRNA levels of tissues analyzed in A, determined by quantitative
real-time PCR, normalized to GAPDH.  
Tissue mRNA was extracted with Trizol (Invitrogen) according to the manual provided by the manufacturer and further purifier via
the Qiagen RNAesy columns (Qiagen). mRNA concentration and purity were determined on the nanodrop spectrometer (nd-1000,
Thermo Scientific). cDNA synthesis was performed with the M-MuLV reverse transcriptase (NEB). Quantitative real time PCR was
performed with the SYBR green PCR Master Mix (Applied Biosciences) on the ABI Prism 7000 (Applied Biosciences). Ndr1
transcripts were detected using the following primers: fwd-5’cagacagtttgtgggttgtg3’ and rev-5’tcctcttctgtcagagtatc3’. Signals obtained
for Ndr1 were normalized to Gapdh transcript levels. 
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Figure S2 . The notochord of Ndr-null embryos at E8.5 is intact. Expression pattern of Sonic hedgehog (left) and T/brachyury
(right) determined by mRNA in situ hybridization demonstrate that the notochord is continuous, indicating that loss of NDR does not
negatively affect notochord development. Control embryos (con) are shown on the left, mutant embryos (mut) on the right. 
Figure S3. Ndr1 and Ndr2 are broadly expressed in the mouse embryo at E8.5. mRNA in situ hybridization with Ndr1 and Ndr2
probes. Both probes were designed to hybridize to the 3’UTR (sequences available upon request).    
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Figure S4. Wildtype and Ndr-null embryos show low and comparable levels of apoptosis at E8.5. This indicates that the small
size of Ndr-null embryos is not due to increased levels of apoptosis. Apoptotic cells in wildtype (left) and Ndr-null (right) embryo labeled
by the TUNEL method with FITC-labeled nucleotides. TUNEL analysis was performed on paraffin sections with the ApoAlert DNA
Fragmentation Assay Kit. The protocol from the manufacturer was adapted for the Venata Biobench machine (S. Schultze), final
washing steps were performed manually according to the protocol provided by the manufacturer. 
Tbx6
con
mut
Figure S5. Tbx6 expression is decreased in Ndr-null embryos at E8.5. Expression pattern of Tbx6 in control (top) and Ndr-null
embryos (bottom) determined by mRNA in situ hybridization. These data confirm the down-regulation of Tbx6 observed in the microarray
analysis  
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Figure S6. NDR-deficient ES cells differentiate into cardiomyocytes. These data show that NDR is dispensable for the formation
of beating cardiomyocytes. ES cells pro- or deficient for NDR were differentiated into cardiomyocytes (see Materials and Methods for
detailed protocol). Beating foci were counted four days after EB plating (15 wells of a 24-well plate per genotype)   
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Figure S7 Moderate increases of cell cycle duration over a short time period result in significant growth retardation of the
mouse embryo at E8.5. We generated a mathematical model to approximate the effect of an increase in cell cycle duration on embryo
growth at E8.5. The model is based on the simplifying assumption that all cells in the embryo divide at the same, constant rate wt from
E7.5 to E8.5.  This leads to an exponential equation where Xt = X0 * 2t/. X0 is the total cell number of the embryo at t0,  is the cell cycle
duration in hours and Xt the number of cells after t hours. We subsequently introduce the ratio “Q” of Xt, wild type over Xt, mutant to describe
relative growth retardation as a function of the increase in  in the mutant. Q is plotted as a function of increasing cell cycle duration in the
mutant after a period of 24 hours (t = 24). We observed earlier that wildtype embryos were approximately 1.5 fold bigger than Ndr double-
KO littermates at E8.5 (Figure 3). According to our model, an increase of cell cycle duration from 6.7h* to 8h (intersection of dashed and
solid red line) over 24 hours would suffice to generate a 1.5 fold difference at E8.5. *approximate cell cycle duration at E7-7.5, taken from
Snow, J. Embryol. Exp. Morphol 1977 
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Figure S8 ES cell screenig by PCR. G418-resistant ES cell clones were screened by two different PCR reactions for homologous
recombination at the Ndr2 locus. The over-all targeting strategy is described in Figure 1A and in Materials and Methods.  All primer binding
sites are indicated in Figure 1A. To identify clones that had correctly integrated the targeting vector at the 5‘end of the locus, a PCR 
reaction with one forward primer (5‘wt)  that bound up-stream of the targeting vector homology region  and two different reverse primers
was set-up. The first reverse primer (3‘Hrec) bound to a sequence in the Neo cassette of the targeting vector. Therefore, this PCR would 
only generate a product if the clone had integrated the targeting vector in the Ndr2 locus. To control for the quality of genomic DNA and the 
PCR reaction, a second reverse primer (3‘wt) was introduced that bound to an endogenous region in the Ndr2 locus and was thus 
expected to yield a PCR product in the absence of target vector integration. Results of a 5‘ screening PCR are shown in A. The bands 
(5‘Hrec) in the upper panel denote three clones (marked by asteriks)  that have correctly integrated the targeting vector at the 5‘ end. The 
lower panel shows that the PCR reaction for the control fragment works in most clones, indicating that the risk of false negatives was rather
low. Clones that were positive for the 5‘Hrec fragment were tested with an analogous PCR on the 3‘ end of the vector integration site. The
3‘Hrec fragment contained a SpeI restriction site that had been introduced adjacent to the loxP site that was farthest away from the Neo 
selection cassette. Therefore, 3‘Hrec fragments were subjected to SpeI restriction digest to identify clones that had successfully integrated 
the loxP site, indicative of correct target vector integration. The result of a 3‘ PCR screen is shown in B. Three of the five clones (marked by 
an asteriks) that yielded a 3‘Hrec fragment contained the SpeI site, suggesting that they had correctly integrated the most external loxP 
site. 
* * m I n I
wt
Hrec
Figure S9, Validation of single targeting vector integration. 5‘ and 3‘ PCR reactions described in Figure S8 identified clones that had
correctly integrated the targeting vector in the Ndr2 locus. To exclude clones with multiple targeting vector integration events, Southern blot
experiments were performed with an internal probe that bound immediately up-stream of the Neo cassette. The Figure shows the Southern 
blot result of two clones with unique targeting vector integration (denoted by an asteriks), one clone with multiple integration (m I) and one 
clone which did not integrate the targeting vector (n I). 
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Ndr2 temp (C°) duration (sec)
initial denaturing 94 120
denaturing 94 45
annealing initial 63  -0.5/cycle 30 10 cycles
elongation 72 60
denaturing 94 45
annealing 58 30 25 cycles
elongation 72 60
final elongation 72 300
Gender
initial denaturing 94 180
denaturing 94 45
annealing 65 30 35 cycles
elongation 72 30
final elongation 72 420
Figure S10. PCR cycling protocols for genotyping of the Ndr2 locus (as described in Materials and Methods) and gender 
determination (used for selection of embryos for microarray analysis as described in Materials and Methods) 
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3.2 Complete Loss of NDR Kinases in the Intestinal Epithelium 
Induces Rectal Prolapse and Increases Susceptibility to 
Azoxymethane-induced Colon Carcinogenesis 
This part summarizes the work that has been done with the intestinal epithelium-specific 
Ndr double knock-out mouse line to address the role of NDR kinases in the context of 
colon carcinogenesis.  
 
Contributions  
 
Deborah Hynx performed the AOM injections and the weekly monitoring of 
experimental mice during the carcinogen studies. She also assisted with necropsies and 
dissections.  
David Restuccia assisted with dissections and tissue embedding. 
Michael Stadler performed Fisher’s exact test to evaluate the statistical significance of 
colonic nodule development in NDR proficient versus NDR deficient mice (Figure 4). 
 
All other work was performed by me. 
 
 
The project is ongoing and will be continued in collaboration with Lei Zhang. 
 
  
93 
 
3.2.1 Introduction 
Mammalian NDR kinases NDR1 and NDR2 are widely expressed and highly conserved 
(1-4). They positively regulate centrosome duplication, alignment of mitotic 
chromosomes, apoptosis and proliferation (1, 5-8). Several reports describe 
deregulated NDR levels in human malignancies (summarized in (9)). Importantly, aged 
mice with a targeted deletion of Ndr1 develop T-cell lymphoma and tumors with low total 
NDR kinase levels display decreased levels of apoptosis, further supporting a positive 
role for NDR kinases in apoptosis induction (1). Moreover, these findings indicate that 
mammalian NDR has tumor suppressive properties.  
We have recently generated a conditional targeted deletion of the Ndr2 gene in 
the mouse (see section 3.1). Mice that completely lack functional NDR2 protein are 
phenotypically normal and do not display increased susceptibility to tumor development. 
However, similar to the Ndr1 knock-out (KO) mouse, protein levels of NDR1 are 
increased in tissues with high endogenous NDR2 levels which might mask the tumor 
suppressive function of NDR kinases. To exclude potential compensation by the 
remaining NDR isoform, we generated the Ndr1/Ndr2 double KO mouse line.  Complete 
loss of Ndr1 and Ndr2 results in embryonic lethality at mid-gestation (section 3.1), 
precluding the evaluation of the tumor suppressive function of NDR in the systemic 
Ndr1/2 double KO. Therefore, we decided to make use of the conditionally targeted 
Ndr2 gene to study the tumor suppressive function of NDR kinases in a tissue-specific 
Ndr-null mouse line. 
NDR2 protein levels are particularly high in the murine colon ((1), section 3.1). 
The turn-over of cells in the intestinal epithelium ranges among the fastest in the human 
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body (10). Colorectal cancer (CRC) originates in this tissue. NDR1 protein levels are 
particularly high in organs of the immune system and loss of Ndr1 results in T-cell 
lymphoma (1). Conversely, NDR2 levels are highest in the colon. Therefore, we 
hypothesized that ablation of Ndr2 in the colon could contribute to CRC formation. To 
eliminate isoform compensation by NDR1, we specifically ablated Ndr2 in the intestinal 
epithelium of Ndr1-null mice. Spontaneous colon cancer in rodents is very rare. In 
addition to genetic models such as the APCmin mouse (11), carcinogen models have 
been established to study factors thought to play a role in tumor initiation and / or tumor 
progression in the colon (12). Azoxymethane (AOM)-induced tumors in mice resemble 
human CRC. They are characterized by aberrant APC expression, altered -catenin 
localization and K-ras mutations (13). Therefore, we treated conditional Ndr1/2 double 
KO mice with AOM to study the potential tumor-suppressive function of NDR kinases in 
the colon.  
We find that NDR2 protein is highly expressed in the colonic epithelium. Mice 
that lack both Ndr1 and Ndr2 (Ndr1-/-Ndr2Δ/ΔVilCre) in the intestinal epithelium are viable 
and fertile. However, homozygous Ndr1-/-Ndr2Δ/ΔVilCre mice develop rectal prolapse, a 
symptom of chronic colonic inflammation. We do not observe spontaneous colon cancer 
development, but Ndr1-/-Ndr2Δ/ΔVilCre mice seem to be more susceptible to AOM-induced 
colon carcinogenesis. Therefore, Ndr1-/-Ndr2Δ/ΔVilCre mice could represent a new model 
to study CRC development in the context of chronic inflammation. 
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3.2.2 Results 
NDR2 is expressed in the colonic epithelium 
Initial lesions that develop into colorectal cancer (CRC) arise in the colonic epithelium 
(reviewed in (14)). The colon is constituted of four tissue layers, namely the serosa, the 
muscularis externa, the submucosa and the mucosa which comprises the lamina 
muscularis mucosae, the lamina propria and the epithelium (15). Although Westernblot 
data show high NDR2 protein levels in whole colon tissue extracts (section 3.1, Figure 
2), they do not indicate where the protein is localized. Therefore, we determined NDR2 
localization in the murine colon by immuno-histochemistry using an NDR2 specific 
antibody (1). Colon from a Ndr2-null littermate served as negative control. NDR2 protein 
was detected in all layers of the murine colon with highest expression in the epithelium 
(Figure 1), consistent with a putative role as a tumor suppressor in CRC. 
Ndr2 wild-type Ndr2 knock-out
Figure 1. NDR2 is strongly expressed in the colonic epithelium. Colon sections of Ndr2 wild type (A) and Ndr2 knock-out (B)
littermate males (4 months old) were stained with the isoform-specific NDR2 antibody; magnification: 200x  
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fl/fl +/ /
A
fl/fl +/ / fl/fl +/ / fl/fl +/ /
E
C
D
B
Figure 2. Specific ablation of NDR2 protein in the colonic epithelium. A Westernblot analysis of Ndr2 flox/flox (fl/fl), flox/flox Vil-
Cre (/) and +/flox Vil-Cre (+/) tissues. HSC70 served as loading control. Cre-recombinase should only be expressed in intestinal
epithelium. As expected, NDR2 levels are specifically decreased in the colon of / mice, but not in the colon of control mice. NDR2
levels remain constant in other tissues of / mice, indicating that Cre is specifically expressed in the colon. B-E Immuno-
histochemical detection of NDR2. B, D: colon sections of fl/fl mouse, 40x and 200x, respectively. C, E: colon sections of / mouse,
40x and 200x, respectively. The data confirm that NDR2 is specifically ablated in epithelium but not in other layers of the colon  
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Tissue-specific deletion of Ndr2 in the intestinal epithelium of Ndr1-null mice 
induces colonic prolapse 
As reported earlier, NDR kinase isoforms mutually compensate fore each other and the 
systemic Ndr1/2 double KO is embryonic lethal ((1), section 3.1). Therefore, we made 
use of the conditionally targeted Ndr2 gene to establish a mouse line with an intestinal-
epithelium specific deletion of Ndr1/2 (Ndr1-/-Ndr2Δ/ΔCVilCre). To that end, we crossed 
conditional Ndr1/2 double KO (Ndr1-/-Ndr2flox/flox) mice with the Vilin-Cre deleter strain. 
The villin promoter drives Cre expression in the intestinal epithelium from E12.5 (16). 
Westernblot analysis of Ndr1+/-Ndr2Δ/ΔVilCre tissues showed that NDR2 levels were 
decreased in the colon but not in the brain or the thymus (Figure 2A). Subsequent 
immuno-histochemical analysis confirmed that NDR2 protein was lost specifically in the 
colonic epithelium but not in other layers of the colon (Figure 2C,E). At weaning, Ndr1-/-
Ndr2Δ/ΔVilCre mice were indistinguishable from control littermates that retained one or 
both Ndr2 alleles in the intestinal epithelium. In particular, crypt morphology in Ndr1-/-
Ndr2Δ/ΔVilCre colons was not changed (data not shown). However, 90% of male and 40% 
of female homozygous Ndr1-/-Ndr2Δ/ΔVilCre mice developed rectal prolapse (Figure 3B). 
Significantly, neither male nor female heterozygous Ndr1-/-Ndr2+/ΔVilCre  mice developed 
prolapse, indicating that prolapse incidence was not linked to unspecific Cre activity but 
resulted from loss of NDR2 protein. Moreover, loss of Ndr2 alone in Ndr1 wild type mice 
was not sufficient to induce colonic prolapse, suggesting that increased levels of NDR1 
functionally compensated for loss of NDR2. We did not observe spontaneous colon 
cancer formation in either heterozygous or homozygous Ndr1-/-Ndr2Δ/ΔVilCre mice. 
Importantly, mice with prolapse did not display any signs of weight loss, malaise or 
98 
 
untimely morbidity, indicating that the prolapsed rectum did not impair gastro-intestinal 
function.  
 
As described in detail below, homozygous Ndr1-/-Ndr2Δ/ΔVilCre and control mice were 
treated with azoxymethane (AOM) to induce colon cancer formation. Importantly, AOM 
treatment increased the incidence of rectal prolapse in Ndr1-/-Ndr2Δ/ΔVilCre females to 
88% (Figure 3C). AOM treatment did not induce rectal prolapse in either male or female 
heterozygous Ndr1-/-Ndr2+/ΔVilCre control mice. In summary, complete loss of NDR 
kinases in the intestinal epithelium predisposes male mice to rectal prolapse.  Ndr1-/-
Ndr2Δ/ΔVilCre females are moderately resistant to rectal prolapse unless treated with the 
carcinogen AOM. Loss of NDR is not sufficient to induce colon cancer formation. How 
B Naïve mice
Ndr2 GT Δ/Δ Cre +/Δ Cre -/-
male 10/11 0/20 0/20
female 4/10 0/21 0/26
C   AOM-treated mice
Ndr2 GT Δ/Δ Cre +/Δ Cre -/-
male 5/8 1/9 0/3
female 7/8 0/10 0/2
A
Figure 4. Rectal prolapsed incidence in Ndr2 / Cre mice. A Male with rectal prolapsed (white arrow, left) and control littermate
(right). B Rectal prolapse incidence in naïve mice older than 150 days. Ndr2 / Cre and Ndr2 +/ Cre mice are on an Ndr1-null
background, -/- mice are NDR1 proficient. Male Ndr2 / Cre mice develop prolapse with nearly complete penetrance, females are
less affected. Loss of Ndr2 in NDR1-proficient mice does not cause prolapse. C Rectal prolapse incidence in AOM (Azoxymethane)
treated mice. AOM treatment induces rectal prolapse in Ndr2 / Cre females but not in Ndr2 +/ Cre or -/- control mice. GT:
genotype.  Picture in A taken by D. Hynx.  
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NDR kinases protect against rectal prolapse and why males and females display 
differences in prolapse susceptibility remains to be addressed. 
 
Combined loss of Ndr1 and Ndr2 in the intestinal epithelium increases the 
frequency of AOM induced nodule formation in the colon 
As combined loss of Ndr1 and Ndr2 in the intestinal epithelium was not sufficient to 
induce colon carcinogenesis, we treated homozygous Ndr1-/-Ndr2Δ/ΔVilCre and control 
mice with the colon carcinogen AOM according to a protocol established by Neufert et 
al. (13) (detailed in Materials and Methods). In a pilot experiment, we noticed 
significantly higher treatment-related mortality than predicted by the protocol, 
particularly in females with low bodyweight. Moreover, we did not observe robust nodule 
formation after 30 weeks as indicated in the protocol. Therefore, we only included mice 
with a bodyweight superior to 20 g into the following studies and increased the study 
duration to 37 - 41 weeks. The changes decreased treatment-related mortality and 
resulted in macroscopic nodule formation. Results for AOM study 6, 7 and 8 are 
summarized in Supplementary Materials (Table 1). One or more nodules were detected 
in 25% of Ndr2 wild type (Ndr1-/-Ndr2+/+VilCre), 43% of heterozygous (Ndr1-/-Ndr2+/ΔVilCre) 
and 78% of homozygous (Ndr1-/-Ndr2Δ/ΔVilCre) mice (Figure 4). However, due to 
unexpected losses of control mice, the observed differences exhibit rather high P-values, 
namely 0.23 when all three genotypes are compared and 0.09 (Fisher exact test) when 
Ndr2 pro- versus Ndr2 deficient animals are compared. In summary, our data suggest 
that NDR kinases might act as tumor suppressors in the colonic epithelium. Additional 
studies have to be performed to confirm the statistical significance of our findings. 
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3.2.3 Discussion 
Mammalian NDR kinases are implicated in centrosome duplication, mitotic chromosome 
alignment, proliferation and apoptosis (1, 5-8). Loss of Ndr1 in the mouse leads to T-cell 
lymphoma (1). NDR isoforms mutually compensate for each other and combined loss of 
Ndr1/2 in the mouse is embryonic lethal (section 3.1). NDR2 protein is highly expressed 
in the colonic epithelium (Figure 1, 2). Therefore, we have generated an intestinal 
epithelium-specific Ndr1/Ndr2 double KO mouse model (Ndr1-/-Ndr2Δ/ΔVilCre) to study the 
potential tumor suppressive function of NDR kinases in colon cancer. We find that 
NDR2 protein is efficiently and specifically deleted in the colonic epithelium of Ndr1-/-
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Figure 4. Colonic nodule formation in mice treated with AOM. Animals which had developed one or more macroscopic nodules
in the colon were counted as positive. The Ndr2 genotype in the intestinal epithelium is indicated on the x-axis. All mice were on an
Ndr1-null background. Mouse numbers in the three groups: wt = 4; het = 7; ko = 9. The indicated p-value describes the statistical
significance of nodule development in NDR2 proficient (wt and het) versus NDR2 deficient (ko) mice. If all three Ndr2 genotype
groups are compared separately, the p-value is 0.23. A detailed summary of experimental conditions including exact treatment
duration, age and gender is shown in Table S1 (Supplementary Materials). 
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Ndr2Δ/ΔVilCre mice (Figure 2). Ndr1-/-Ndr2Δ/ΔVilCre mice are viable and fertile but develop 
rectal prolapse starting from around 4 months of age (Figure 3). Males are significantly 
more susceptible to prolapse development than females (90% versus 40%, Figure 3B). 
However, Ndr1-/-Ndr2Δ/ΔVilCre females also develop rectal prolapse with almost complete 
penetrance if treated with the colon carcinogen AOM (Figure 3C).  
In experimental mouse models, rectal prolapse is often associated with a 
deregulation of the immune system and inflammation. It has been reported in mice 
deficient for interleukin 2 (IL-2), IL-10, or TCRα/β (17-19). Similarly, transgenic over-
expression of hepatocyte growth factor (HGF) in mice results in decreased IL-2 levels 
and rectal prolapse (20). In the IL-2, IL-10 and TCRα/β models, prolapse incidence is 
significantly decreased when mice are housed under germ-free conditions, indicating 
that prolapse might be caused by an infection of the immuno-compromised host (21-23). 
We did not detect common mouse pathogens in the Ndr1-/-Ndr2Δ/ΔVilCre colony, indicating 
that prolapse development in Ndr1-/-Ndr2Δ/ΔVilCre mice is independent of infection status. 
Mice carrying the Δ14 APC mutation develop tumors in the distal colon and the rectum, 
more closely resembling human CRC (24). In this model, prolapse incidence correlates 
with the severity of colorectal carcinogenesis and inflammatory cells are present both in 
lesions and in the prolapsed tissue (24). In summary, these data suggest that 
deregulated immune function in the colon contributes to rectal prolapse formation. 
NDR1 is highly expressed in organs of the immune system and loss of Ndr1 results in 
T-cell lymphoma (1). Therefore, rectal prolapse in Ndr1-/-Ndr2Δ/ΔVilCre mice could arise 
from the combination of a general defect of the immune system due to systemic loss of 
Ndr1 and a local defect in the colonic epithelium due to loss of Ndr2. Detailed 
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characterization of tissue morphology and inflammation status in prolapsed rectum are 
warranted to confirm this hypothesis. Importantly, patients suffering from chronic 
inflammation of the colon are at increased risk for developing CRC (25). However, we 
did not observe spontaneous CRC formation in Ndr1-/-Ndr2Δ/ΔVilCre mice. Therefore, we 
treated Ndr1-/-Ndr2Δ/ΔVilCre and Ndr1-/-Ndr2+/ΔVilCre control mice with AOM to induce CRC 
formation. Although additional studies have to be performed to confirm the statistical 
significance of our data, Ndr1-/-Ndr2Δ/ΔVilCre mice appear to be more susceptible to AOM 
induced CRC (Figure 4). As none of the Ndr1-/-Ndr2+/ΔVilCre control mice developed rectal 
prolapse (Figure 3) we cannot discriminate whether NDR kinases function as 
conventional tumor suppressors in this context or whether increased CRC susceptibility 
is a secondary effect of chronic inflammation.  
 In summary, we show that NDR2 kinase is prominently expressed in the colonic 
epithelium. Combined loss of NDR1 and NDR2 in the intestinal epithelium leads to 
rectal prolapse formation with almost complete penetrance in male mice. We 
hypothesize that rectal prolapse is the result of an abnormal inflammatory response in 
the colonic epithelium of Ndr1-/-Ndr2Δ/ΔVilCre mice. Histological and inflammatory marker 
analyses of prolapsed rectum are warranted to confirm this hypothesis. Ndr1-/-
Ndr2Δ/ΔVilCre mice do not develop spontaneous CRC but appear to be more susceptible 
to AOM induced CRC. Assuming that future AOM studies confirm the observed trend, 
Ndr1-/-Ndr2Δ/ΔVilCre mice could constitute a new model system to study the molecular 
mechanisms that underlie the increased risk of CRC formation in patients with chronic 
colonic inflammation. 
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3.2.4 Materials and Methods 
Immuno-histochemical detection of NDR2 protein in murine colon sections 
Colons were dissected out, cleaned in PBS and fixed with 4% PFA over night at 4°C. 
Subsequently, colons were washed in PBS and dehydrated for 30 min in 
50%EtOH/PBS, then 70%EtOH/PBS. Paraffin embedding was performed in a Medite 
Tissue Processor TPC 15 (Medite) according to the standard protocol of the 
manufacturer. Paraffin blocks were sectioned at 5 µm and mounted on poly-lysine 
coated slides. Sections were pre-treated with CC1 buffer (Ventana) for 30 minutes to 
unmask epitopes. NDR2 protein was detected with a polyclonal rabbit antibody (1) at a 
1:100 dilution using the DAB detection method on the Discovery XT system (Ventana). 
After the staining procedure, slides were extensively washed, dehydrated, cleared in 
Ultraclear (Medite) and mounted with Ultrakitt mounting medium (J.T.Baker). Sections 
were analyzed on a Nikon Eclipse E600 microscope. 
 
Generation of the Ndr1-/-Ndr2Δ/ΔVilCre mouse line 
The Villin-Cre deleter strain ((16), B6.SJL-Tg(Vil-cre)997Gum/J) was obtained from 
Jackson Laboratories. Genotyping of the cre transgene was performed according to the 
protocol provided by Jackson Laboratories. Ndr1-/-Ndr2flox/flox mice (described in 3.1) 
were crossed with Vil-Cre mice to generate the Ndr1-/-Ndr2Δ/ΔVilCre mouse line. Mice 
were maintained on a mixed C57BL/6 background. 
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AOM colon carcinogenesis 
AOM colon carcinogenesis was performed according to the protocol by Neufert et al. 
(13) with some modifications. Experimental mice between 6 and 8 weeks of age and a 
bodyweight of at least 20 g were injected weekly with AOM (SIGMA) at 10 mg/kg 
bodyweight for 6 consecutive weeks. Animals were monitored weekly for weight loss 
and signs of malaise. At the end of the study, 37 – 41 weeks after the first injection, 
mice were sacrificed. Following gross general organ analysis, the colon was removed, 
washed in PBS and cut open longitudinally to assess and count nodule formation. 
Subsequently, colons fixed and paraffin embedded as described above. All AOM 
carcinogenesis experiments were performed under Tumor license 2044.  
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4 General Discussion 
The aim of this thesis was to identify in vivo functions of mammalian NDR kinases in 
general and their impact on tumorigenesis in particular. Using mouse models for 
combined Ndr1/Ndr2 deficiency we can show that NDR kinases are essential for 
embryonic survival beyond E10. They positively regulate embryonic growth, 
somitogenesis and heart development. Tissue-specific ablation of Ndr1/Ndr2 in the 
intestinal epithelium appears to sensitize mice to AOM induced colon carcinogenesis. 
 Mammalian NDR kinases function in centrosome duplication, mitotic 
chromosome alignment, apoptosis and proliferation (27, 36-38). However, the 
majority of the studies that led to the identification of these roles were performed in 
transformed tissue cultured cell lines (27, 37, 38). Therefore, it was important to 
generate an in vivo model to address the physiological relevance of these functions. 
Given that MST1/2 kinases function as up-stream regulators of mammalian NDR 
kinases, similar phenotypes could be expected for the respective knock-out mouse 
models. Both NDR1 and MST1 are highly abundant in lymphoid tissue (36, 115). 
Ndr1-null mice are morphologically indistinguishable from normal littermates at 
weaning, but develop T-cell lymphoma at old age (36). Similarly, loss of Mst1 
specifically affects T-cell development (113, 115). Moreover, loss of Ndr2 or Mst2 
does not cause any overt morphological phenotype (Section 1, Figure 1; (105-107)). 
A single allele of either Ndr1/2 or Mst1/2 is sufficient for normal embryonic 
development, but complete loss of Ndr1/2 or Mst1/2 is embryonic lethal, indicating 
that both NDR1/2 and MST1/2 can efficiently compensate for each other (Section 1, 
Table 1 and 2; (105-107)). Detailed comparison of mutant Ndr1/2 and Mst1/2 
embryos reveals that their respective phenotypes are also generally similar. Both 
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Ndr1/2 and Mst1/2-null embryos are growth retarded and developmentally delayed at 
E8.5 (Section 1, Figure 3; (105-107)). By E9.5 mutant embryos show pericardial 
edema and their yolk sac vasculature has failed to undergo remodeling, indicating 
cardiac insufficiency (Section 1, Figure 4; (105-107)). While we specifically observe 
arrested heart development in Ndr1/2 mutant embryos at the onset of cardiac looping 
(Section 1, Figure 10), specific heart defects are not reported in any of the Mst1/2 
double KO studies (105-107). However, pericardial edema and un-remodeled yolk 
sac vasculature of Mst1/2-null embryos suggest that cardiac development is equally 
affected by loss of MST1/2. MST1/2 kinases are core components of the mammalian 
Hippo pathway. At present, the majority of studies addressing mammalian Hippo-
signaling designates LATS1/2 kinases as main substrates and down-stream effectors 
of MST1/2 (99, 116, 117). However, Lats2-null mice die only around E12.5 (118) and 
Lats1 KO mice are still detected in the expected Mendelian ratio at E18.5 (119). 
Taken together, these findings suggest that NDR kinases rather than LATS kinases 
are important down-stream effectors of MST1/2 signaling during organogenesis. 
The first obvious defect of Ndr-null embryos is their reduced size at E8.5. 
Microarray analysis revealed that the CDK inhibitors p21 and p27 are up-regulated in 
mutant embryos (Section 1, Table 3), suggesting that NDR kinases positively 
regulate proliferation. An independent study recently found that NDR kinases 
regulate G1/S transition in HeLa cells (10). They do so by directly phosphorylating 
p21 which results in its destabilization and subsequently decreased p21 levels. 
Moreover, the study shows that NDR stabilizes c-myc protein in a kinase-
independent manner (10). C-myc was shown to repress p21 and p27 at the 
transcriptional level (120). Therefore, it is tempting to speculate that the increased 
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levels of p21 and p27 in Ndr-null embryos reflect that NDR kinases regulate 
proliferation in vivo by means of controlling G1/S transition. Alternatively, loss of NDR 
could potentially affect cell size. Although we do not detect gross cell size difference 
by visual examination of the embryo sections, further analyses are required to 
exclude that loss of NDR negatively affects cell growth. Mutant embryos do not show 
signs of over-proliferation, indicating that the role of NDR kinases in apoptosis 
induction is not essential for embryonic development prior to E10. Although 
technically challenging, it would be interesting to analyze centrosome and 
chromosome status of cells in NDR-deficient embryos, because loss of NDR was 
shown to interfere with centrosome duplication (37) and mitotic chromosome 
alignment (38). Primary mouse embryonic fibroblasts with a conditional deletion of 
Ndr1/2 represent a valuable tool to address the role of NDR kinases in the regulation 
of cell cycle progression in future studies. Moreover, they can be used to identify 
substrates of NDR kinases using the NDR-Shokat mutant generated by R. Kohler 
(unpublished work). 
 Ndr-null embryos display small and irregularly shaped somites (Section 1, 
Figure 6, 7) and arrest heart development at the onset of cardiac looping (Figure 10), 
revealing previously unknown roles for mammalian NDR kinases as positive 
regulators of somitogenesis and heart development. Importantly, members of the 
Notch pathway that are implicated in somitogenesis are asymmetrically expressed in 
the presomitic mesoderm of Ndr-null embryos at E8.5 (Section 1, Figure 9). Both 
somitogenesis and cardiac looping depend on properly established symmetry axes in 
the embryo (121-123). Therefore, a symmetry defect could be the common 
underlying cause for abnormal somitogenesis and arrested cardiac development in 
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NDR-deficient embryos. Retinoic acid (RA), a derivative of vitamin A, is indispensable 
for symmetric somitogenesis (124-127). Transcript levels of Raldh2, an essential 
enzyme for RA synthesis in the embryo (128), are down-regulated 1.3 fold in Ndr-null 
embryos (Section 3.1, Table 3B). However, we do not detect changes in Raldh2 
expression patterns as reported for a mouse mutant with a somite symmetry defect 
due to impaired RA signaling (129). Moreover, Lunatic fringe (Lnfg) expression 
domains are asymmetrically shifted in this mutant while we observe asymmetric loss 
of Lnfg expression in NDR-deficient embryos ((129) and Section 3.1, Figure 8). 
Therefore, the symmetry defects observed in Ndr-null mutants are most likely not due 
to impaired RA signaling. Conversely, our microarray data indicate that several 
members of the Notch pathway are down-regulated in Ndr-null embryos at E8.5 
(Section 1, Table 3B). On the one hand, these proteins are essential for proper 
somitogenesis (130-133), as reflected by altered somite morphology of mutant 
embryos (Section 1, Figure 6 and 7). On the other hand, Notch signaling is essential 
for left-side specific expression of Nodal (134), the initial molecular manifestation of 
the left / right axis in the embryo. Interestingly, the intracellular domain of all four 
Notch receptors (NICD) contains a putative phosphorylation site for NDR kinases 
(R.Tamaskovic, unpublished observation), representing a potential entry point for 
NDR kinases to impact on Notch signaling. Moreover, NDR kinases are required for 
centriole duplication (37), providing an additional putative link to the establishment of 
left / right symmetry up-stream of left-sided Nodal expression. Modified centrioles, so-
called basal bodies are a core component of primary cilia (135). Therefore, loss of 
NDR might result in defective primary cilia. Primary cilia in the node generate leftward 
flow of extra-embryonic fluid which induces left-restricted expression of Nodal (136-
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142). Impaired primary cilia function results in laterality defects in mice (143-148) and 
humans (summarized in (149)). Primary cilia are absent from cells in the node of 
mice that lack intraflagellar transport proteins, such as KIF3A, KIF3B or Ift88. These 
mice show random heart looping and die by mid-gestation due to cardiovascular 
malformation (143, 144, 147). Therefore, future studies will analyze the expression 
patterns of symmetry markers (Nodal, Lefty-2) in Ndr-null embryos to address 
whether NDR kinases play a role in the establishment of left / right symmetry. 
Moreover, we will determine whether NDR can phosphorylate the Notch receptor as 
suggested by bioinformatic phospho-site prediction. Alternatively, NDR kinases could 
mediate cardiac looping more directly via interactions with the actin cytoskeleton. 
Although the exact mechanism that drives rightward looping of the heart tube is 
unknown, one line of evidence attributes an important role to the actin cytoskeleton 
(150-153). Mammalian NDR2 was shown to directly bind actin (154), and Cbk1, the 
NDR homolog in yeast, interacts with the cytoskeleton to control polarized growth (19, 
28, 155). In summary, NDR kinases are essential for cardiac looping, arguably their 
most relevant function for survival of the developing embryo. Based on our 
observations, NDR kinases might contribute to establish left / right symmetry in the 
embryo, a prerequisite for rightward cardiac looping. Alternatively, they could mediate 
morphogenic looping by modulating cytoskeleton architecture. However, both 
hypotheses remain speculative and have to be evaluated in future studies of heart-
specific Ndr knock-out mice. 
 While the complete Ndr1/2 double KO strategy has revealed previously 
unknown roles of NDR kinases in cardiac development and somitogenesis, early 
embryonic lethality precludes the analysis of other functions in development and 
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tumorigenesis. As described earlier, Ndr homologs in worm and fly orchestrate 
dendritic tiling, a process that ensures complete but non-redundant dendritic 
coverage of receptive fields (31, 33). Importantly, abnormal dendritic tiling has been 
linked to neurological and neurodevelopmental disorders in humans (156). NDR2 is 
the major isoform expressed in murine brain (Section 3.1, Figure 2). Contrary to other 
tissues with high intrinsic NDR2 levels, NDR1 levels are not up-regulated in brains of 
adult mice. The adult brain is thus the only tissue that does not counteract total loss 
of NDR protein. Studies in Drosophila indicate that Trc, the fly homolog of NDR, is 
essential for dendritic tiling but dispensable for dendrite maintenance (32). Similarly, 
NDR levels might only be required for earlier stages of neural development in mice. 
Therefore, compensatory up-regulation of NDR1 in brains of Ndr2-null mice might be 
transient and no longer detectable in adult mice. Nevertheless, Ndr2-null mice should 
be subjected to standard behavioral tests such as fear conditioning to assess 
whether loss of NDR2 affects brain function. Experimental evidence for a role of 
mammalian NDR kinases in neuronal development comes from our observation that 
pax6 levels are down-regulated 1.5 fold in Ndr-null embryos at E8.5. The Pax6 
transcription factor controls the development of the eye and other sensory organs 
(157). Importantly, Pax6 KO mice display axonal wiring defects (158). A collaboration 
with the group of Jeroen Pasterkamp at the UMC Utrecht has been initiated to 
generate neuron-specific Ndr1/2 KO models to specifically study the role of 
mammalian NDR kinases in the brain. 
 
 In addition to investigating the roles of mammalian NDR kinases in normal 
development, we have also made use of the Ndr1/2 double KO model to study the 
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impact of NDR kinases on tumorigenesis. Several lines of evidence suggest that 
mammalian NDR kinases play a role in cancer development. However, while certain 
reports describe up-regulated Ndr transcript levels in a particular cancer which would 
suggest an oncogenic function, others report down-regulated Ndr transcript levels, 
reflecting a tumor suppressive role (summarized in (90)). This controversy is mirrored 
by the different functions of mammalian NDR kinases, namely the positive regulation 
of centrosome duplication (37) and proliferation (10) which could provide oncogenic 
properties as opposed to its role in apoptosis induction (27, 36), endowing the kinase 
with tumor suppressive qualities. Moreover, aged Ndr1-null mice develop T-cell 
lymphoma (36). Although this last observation would favor a tumor suppressive 
function of NDR1, the concurrent robust up-regulation of NDR2 levels in thymus, 
spleen and lymph nodes obviates this straightforward conclusion. Furthermore, data 
obtained in the context of the present study indicate that MOB2 levels are 
significantly down-regulated in thymus, spleen and lymph nodes by an unknown 
mechanism when Ndr1 is ablated (data not shown). As MOB2 was recently shown to 
function as a negative regulator of NDR kinases (16), this could indicate an 
alternative scenario, namely that unrestricted activation of NDR2 induces T-cell 
lymphoma in the absence of NDR1, in line with an oncogenic role of NDR kinases. 
To study the role of NDR kinases in colorectal cancer (CRC) and to circumvent the 
effect of compensatory up-regulation of the remaining NDR isoform, we have 
generated an intestinal-epithelium specific Ndr1/2 double KO mouse line (Ndr1-/-
Ndr2Δ/ΔVilCre). Ndr1-/-Ndr2Δ/ΔVilCre mice are initially indistinguishable from control 
littermates, but develop rectal prolapse at around five months of age (Section 3.2, 
Figure 3).  Rectal prolapse has been reported in the context of deregulated immune 
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function (159-162). NDR1 is highly expressed in organs of the immune system and 
loss of Ndr1 results in abnormal T-cell development ((36), Section 3.1, Figure 2). 
Therefore, rectal prolapse in Ndr1-/-Ndr2Δ/ΔVilCre mice could arise from the combination 
of a general defect of the immune system due to systemic loss of Ndr1 and a local 
defect in the colonic epithelium due to loss of Ndr2. Detailed characterization of 
tissue morphology and inflammation status in prolapsed rectum are warranted to 
confirm this hypothesis. Importantly, patients suffering from chronic inflammation of 
the colon are at increased risk for developing CRC (163). As we did not observe 
spontaneous CRC formation in Ndr1-/-Ndr2Δ/ΔVilCre mice, we treated Ndr1-/-Ndr2Δ/ΔVilCre 
and Ndr1-/-Ndr2+/ΔVilCre control mice with AOM to induce CRC formation. Although 
additional studies have to be performed to confirm the statistical significance of our 
data, Ndr1-/-Ndr2Δ/ΔVilCre mice appear to be more susceptible to AOM induced CRC 
(Section 3.2, Figure 4). As none of the Ndr1-/-Ndr2+/ΔVilCre control mice developed 
rectal prolapse (Section 3.2, Figure 3) we cannot discriminate whether NDR kinases 
function as conventional tumor suppressors in this context or whether increased CRC 
susceptibility is a secondary effect of chronic inflammation. Taken together, our initial 
data from the study of tissue-specific ablation of Ndr1/2 in the intestinal epithelium 
add yet another layer of complexity to the role of NDR kinases in the context of 
tumorigenesis. Ndr1-/-Ndr2Δ/ΔVilCre mice do not contribute a decisive argument to the 
tumor suppressor versus oncogene debate. However, they could represent a new 
model system to study the molecular mechanisms that underlie the increased risk of 
CRC formation in patients with chronic colonic inflammation. Although time 
constraints have restricted the use of the conditional Ndr1/2 mouse model, tissue-
specific deletion of NDR kinases in other organ systems is warranted. MST1/2, the 
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mammalian hippo homologs (see General Introduction, Figure 8) were shown to 
regulate quiescence and tumor suppression in the liver via a currently unknown YAP-
kinase that is distinct from LATS (105). Therefore, conditional ablation of Ndr1/2 in 
the liver could provide insights into the putative role of NDR kinases in liver 
tumorigenesis.  
In summary, the mouse model for combined Ndr1/Ndr2 deficiency generated 
in the context of this thesis demonstrates for the first time that NDR kinases play 
essential roles in mammalian biology. It establishes NDR kinases as physiological 
regulators of growth and cardiac development. Moreover, the conditional Ndr1/Ndr2 
double knock-out mouse line represents a valuable tool for future research 
addressing the roles of NDR kinases in normal physiology and disease.  
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“MOB proteins are integral components of signaling pathways controlling important 
cellular processes, such as mitotic exit, centrosome duplication, apoptosis, and cell 
proliferation in eukaryotes. The human MOB protein family consists of six distinct 
members (human MOB1A [hMOB1A], -1B, -2, -3A, -3B, and -3C), with hMOB1A/B 
the best studied due to their putative tumor-suppressive functions through the 
regulation of NDR/LATS kinases. The roles of the other MOB proteins are less well 
defined. Accordingly, we characterized all six human MOB proteins in the context of 
NDR/LATS binding and their abilities to activate NDR/LATS kinases. hMOB3A/B/C 
proteins neither bind nor activate any of the four human NDR/LATS kinases. We 
found that both hMOB2 and hMOB1A bound to the N-terminal region of NDR1. 
However, our data suggest that the binding modes differ significantly. Our work 
revealed that hMOB2 competes with hMOB1A for NDR binding. hMOB2, in contrast 
to hMOB1A/B, is bound to unphosphorylated NDR. Moreover, RNA interference 
(RNAi) depletion of hMOB2 resulted in increased NDR kinase activity. Consistent 
with these findings, hMOB2 overexpression interfered with the functional roles of 
NDR in death receptor signaling and centrosome overduplication. In summary, our 
data indicate that hMOB2 is a negative regulator of human NDR kinases in 
biochemical and biological settings.” 
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MOB proteins are integral components of signaling pathways controlling important cellular processes, such
as mitotic exit, centrosome duplication, apoptosis, and cell proliferation in eukaryotes. The human MOB
protein family consists of six distinct members (human MOB1A [hMOB1A], -1B, -2, -3A, -3B, and -3C), with
hMOB1A/B the best studied due to their putative tumor-suppressive functions through the regulation of
NDR/LATS kinases. The roles of the other MOB proteins are less well defined. Accordingly, we characterized
all six human MOB proteins in the context of NDR/LATS binding and their abilities to activate NDR/LATS
kinases. hMOB3A/B/C proteins neither bind nor activate any of the four human NDR/LATS kinases. We found
that both hMOB2 and hMOB1A bound to the N-terminal region of NDR1. However, our data suggest that the
binding modes differ significantly. Our work revealed that hMOB2 competes with hMOB1A for NDR binding.
hMOB2, in contrast to hMOB1A/B, is bound to unphosphorylated NDR. Moreover, RNA interference (RNAi)
depletion of hMOB2 resulted in increased NDR kinase activity. Consistent with these findings, hMOB2
overexpression interfered with the functional roles of NDR in death receptor signaling and centrosome
overduplication. In summary, our data indicate that hMOB2 is a negative regulator of human NDR kinases in
biochemical and biological settings.
The first MOB (Mps one binder) protein was identified in
Saccharomyces cerevisiae more than a decade ago (22, 25).
Since then, members of the MOB protein family have been
found in unicellular organisms to mammals. Initially, the bio-
logical roles of MOB proteins were mainly investigated using
budding and fission yeasts, revealing that Mob1p plays a vital
role in the control of mitotic exit (3, 8, 23). Drosophila MOB1
(dMOB1)/Mats (MOB as tumor suppressor) emerged as an
integral part of the Hippo tumor-suppressing pathway control-
ling cell proliferation and apoptosis from recent work in Dro-
sophila melanogaster (24, 37). Interestingly, the functions of
MOB proteins seem to be evolutionarily conserved, since the
lethality and overgrowth phenotypes in Drosophila mats mu-
tants can be rescued by the human homolog human MOB1A
(hMOB1A) (24). This suggests that the Hippo signaling path-
way is highly conserved from flies to humans (9, 12, 30, 31, 40).
However, the biological roles of hMOB1A/B seem to be more
diverse, as they function in cellular proliferation (29), apop-
tosis (36), and centrosome duplication (13). Mob2p in budding
and fission yeasts is an essential part of a signaling network
responsible for polarized cell growth and transcriptional asym-
metry (6, 20, 38). In flies, the biological functions of dMOB2
and dMOB3 are less understood. However, dMOB2 seems to
play a role in wing hair morphogenesis (10). In mammals, the
biological roles of MOB2 proteins have so far proved elusive.
A conserved property of MOB proteins is the association
with and activation of the NDR (nuclear-Dbf2-related) kinases
of the AGC family (16, 28). In yeast, Mob1p binds to and is
necessary for the activation of Dbf2/Dbf20 and Sid2 kinases
(19, 22, 26). Similarly, Mob2p binds to and activates Cbk1 and
Orb6 (20, 38). Furthermore, yeast MOB proteins and NDR
kinases form restricted heterodimers of signaling complexes in
which the subunits are not interchangeable (18, 20). In con-
trast, in multicellular organisms, the binding of MOB proteins
is not restricted to a unique NDR kinase. For example, three
MOB proteins exist in flies: dMOB1/Mats, dMOB2, and
dMOB3 (10). dMOB1/Mats was shown to interact physically
with warts, the fly homolog of human LATS1/2, and to be
necessary for warts activity (24, 37). Moreover, dMOB1/Mats
also genetically interacts with the second NDR kinase in flies,
tricornered (trc) (10). Furthermore, it was shown in coimmu-
noprecipitation experiments that dMOB2 physically associates
with trc (10).
The molecular mechanisms by which MOB proteins bind to
and activate NDR kinases are best understood in mammals.
hMOB1A binds to and activates human NDR1/2 kinases by
stimulating autophosphorylation on the activation segment (2).
Similarly, hMOB1A also binds to and activates LATS1 and -2
(4, 15, 39). In contrast, hMOB2 was shown to bind to NDR1
and NDR2, but not to LATS1 (4, 15). Importantly, hMOB1A/B
are also required for efficient phosphorylation of the hydro-
phobic motif (T444/442) of NDR1/2 kinases by MST1 kinase
(mammalian STE-20-like 1) (13, 36). Spatial relocalization of
NDR kinases seems to be a further level of regulation, because
membrane targeting of hMOB1 proteins leads to rapid activa-
tion of NDR1/2 and LATS1 kinases (11, 15). Indeed, mem-
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brane targeting of dMOB1/Mats in Drosophila activates warts
kinase and inhibits tissue growth by increasing apoptosis and
reducing proliferation (17). Further, membrane-targeted tri-
cornered kinase rescues the dendritic tiling defect in trc mu-
tant flies (21). These observations indicate that activation of
NDR kinases by relocalization to the plasma membrane is an
important step in NDR/LATS kinase activation and function.
Here, we study for the first time all six human MOB proteins
(hMOB1A/B, hMOB2, and hMOB3A/B/C) with respect to
their abilities to bind and activate all four human NDR ki-
nases. Surprisingly, we found that three out of the six MOBs
neither bind to nor activate human NDR1/2 or LATS1/2 ki-
nases. By focusing on the NDR1/2-specific binder hMOB2, we
found that hMOB2 competes with hMOB1A/B for NDR bind-
ing. Furthermore, we provide evidence that overexpression of
hMOB2 impairs NDR1/2 activation in a binding-dependent
manner and affects functions of NDR, such as centrosome
duplication and apoptotic signaling. Significantly, RNA inter-
ference (RNAi)-mediated reduction of the hMOB2 protein
resulted in increased NDR kinase activity. These data indicate
that hMOB2, in contrast to hMOB1A/B, plays an inhibitory
role in the regulation of human NDR1/2 kinases.
MATERIALS AND METHODS
Construction of plasmids. Human NDR1 and NDR2 and hMOB1A, hMOB1B,
hMOB2, hMOB3A, hMOB3B, and hMOB3C cDNAs were subcloned into
pcDNA3, pGEX-4T1, or pMal-2c using BamHI and XhoI restriction sites. Ac-
cession numbers for hMOB3 reference cDNAs are 3A, NM_130807; 3B,
NM_024761; and 3C, NM_201403. The cloning of hMOB3 cDNAs has been
described previously (13). Plasmids containing human LATS1 and LATS2 were
described elsewhere (14). pcDNA3 derivatives contained a hemagglutinin (HA)
or a myc epitope alone or the myristolyation/palmitylation motif of the Lck
tyrosine kinase (MGCVCSSN) combined with a myc epitope (mp-myc). Mutants
of NDR1 and hMOB2 were generated by site-directed mutagenesis according to
the manufacturer’s instructions (Stratagene). Deletion mutants of NDR1 were
cloned via PCR. Individual PCR products were digested with BamHI and XhoI
and cloned into pcDNA3 derivatives. To generate a construct expressing the N
terminus of NDR1 or NDR2 with a C-terminal tag, the coding sequences for
amino acids 1 to 83 of NDR1/2 were amplified by PCR, digested by NheI and
KpnI, and cloned into pcDNA3.1-myc-RFP as described elsewhere (27). To
generate hMOB3 proteins containing a C-terminal myc tag, hMOB3A/B/C
cDNAs were cloned into pcDNA3.1-myc-RFP as described above, and the red
fluorescent protein (RFP) was removed by PCR. To generate tetracycline-reg-
ulated mammalian expression vectors, cDNAs encoding myc-hMOB2(wt) or
myc-hMOB2(H157A) were digested with KpnI and XhoI and ligated into
pENTR 3C (Invitrogen). N-terminally tagged hMOB2 cDNAs were finally
inserted into pT-Rex-DEST30 using Gateway technology (Invitrogen). To
obtain pTER-shMOB2 vectors that express short hairpin RNAs (shRNAs)
against human MOB2, the following oligonucleotide pairs were inserted into
pTER using BglII and HindIII: 5-GATCCCGCTGGTGACGGATGAGGA
CTTCAAGAGAGTCCTCATCCGTCACCAGCTTTTTGGAAA-3 (target-
ing sequences of the hMOB2 coding sequence are underlined) and 5-AGC
TTTTCCAAAAAGCTGGTGACGGATGAGGACTCTCTTGAAGTCCT
CATCCGTCACCAGCGG-3. The generation of the pTER-shLuc control
vector has been described previously (14). All constructs were confirmed by
sequence analysis.
Cell culture, transfections, and chemicals. COS-7, HEK 293, U2-OS, and
HeLa cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum. Exponentially growing COS-7 cells
were plated at consistent confluence (1  106 cells/10-cm dish) and transfected
the next day using Fugene 6 (Roche) as described by the manufacturer. Expo-
nentially growing HEK 293 cells were transfected in solution at consistent con-
fluence (5  106 cells/10-cm dish) using jetPEI (PolyPlus Transfections) accord-
ing to the manufacturer’s instruction. Exponentially growing U2-OS cells were
plated at consistent confluence and transfected the next day using Lipofectamine
2000 (Invitrogen) as described by the manufacturer. Aphidicolin was from Cal-
biochem, and okadaic acid (OA) was purchased from Alexis Biochemicals (Enzo
Life Sciences). Apoptosis of U2-OS cells was induced by the addition of activat-
ing anti-Fas antibody clone CH-11 (0.5 g/ml) in combination with cyclohexi-
mide (CHX) (10 g/ml).
Generation of stable cell lines. To generate inducible cell lines, U2-OS T-Rex
cells were transfected with pT-Rex-DEST30 vectors encoding hMOB2 variants.
Cell clones were selected by growth in the presence of 1 mg/ml G418 (Gibco) and
50 g/ml hygromycin B (Invivogen). Stable transformants were maintained in
DMEM supplemented with 0.5 mg/ml G418 and 50 g/ml hygromycin B. Ex-
pression of myc-hMOB2 variants was induced by the addition of 2 g/ml tetra-
cycline.
Antibodies. The generation and purification of anti-T444-P, anti-S281-P, anti-
NDR2, anti-NDRNT, anti-NDRCTD, and anti-hMOB1A/B antibodies has been
described previously (13, 14, 35, 36). It is important to note that the anti-T444-P
antibody recognizes the phosphorylated hydrophobic motifs of both NDR iso-
forms, NDR1 (T444-P) and NDR2 (T442-P). Anti-HA 12CA5 and 42F13, anti-
myc 9E10, and anti--tubulin YL1/2 were used as hybridoma supernatants.
Further, anti-HA antibody (Y-11) and anti--actin were purchased from Santa
Cruz and anti-Fas (CH-11) from Millipore. Anti-LATS1 antibody was purchased
from Cell Signaling and anti-cleaved poly(ADP-ribose) polymerase (PARP)
from BD Bioscience. Anti-p63(G1/296) antibody was from Alexis Biochemicals
(Enzo Life Sciences). Anti-hMOB2 antibody was raised against purified, bacte-
rially produced full-length hMOB2 fused C terminally to maltose-binding protein
(MBP). Rabbit injections and bleed collections were done by Eurogentec. Anti-
protein antibody was purified by preabsorbing the bleeds against 10 mg of
immobilized MBP and then binding them to 5 to 10 mg of GST-hMOB2 co-
valently coupled to glutathione-Sepharose 4B beads. Antibodies were eluted with
0.2 M glycine (pH 2.2).
Immunoblotting and immunoprecipitation. Immunoblotting experiments were
performed as described previously (11). For immunoprecipitation, cells were
harvested, pelleted at 1,000  g for 3 min, and washed with cold phosphate-
buffered saline (PBS) before lysis in immunoprecipitation (IP) buffer (20 mM
Tris, 150 mM NaCl, 10% glycerol, 1% NP-40, 5 mM EDTA, 0.5 mM EGTA, 20
mM -glycerophosphate, 50 mM NaF, 1 mM Na3VO4, 1 mM benzamidine, 4 M
leupeptin, 0.5 mM phenylmethylsulfonyl fluoride [PMSF], 1 M microcystine,
and 1 mM dithiothreitol [DTT] at pH 8.0). Lysates were centrifuged for 10 min
at 16,000  g at 4°C before being precleared with protein A-Sepharose. The
beads were washed twice with IP buffer, once with IP buffer containing 1 M NaCl,
and finally once with IP buffer before samples were analyzed by SDS-PAGE. To
analyze the association of NDR1/2 or LATS1/2 and hMOB species by coimmu-
noprecipitation, cells coexpressing HA-NDR or HA-LATS and myc-hMOB spe-
cies were subjected to immunoprecipitation using anti-HA 12CA5 antibody as
described above, omitting the wash with 1 M NaCl IP buffer, before analysis by
SDS-PAGE and immunoblotting. For immunoprecipitation of endogenous pro-
teins, cells were processed for immunoprecipitation as described above. Lysates
were preincubated with control rabbit IgG, anti-hMOB2, anti-NDR2, anti-
LATS1, or anti-T444-P antibody overnight, and then protein A-Sepharose was
added for 3 h and the beads were washed four times in IP buffer containing 150
mM NaCl before analysis by SDS-PAGE. To analyze the association of NDR1
mutants and hMOB2, coimmunoprecipitation experiments were performed as
described above, including one wash with IP buffer containing 1 M NaCl. Char-
acterization of hMOB2 mutants by IP was performed in low-stringency buffer (30
mM HEPES, pH 7.4, 20 mM -glycerophosphate, 20 mM KCl, 1 mM EGTA, 2
mM NaF, 1 mM Na3VO4, 1% TX-100) supplemented with protease inhibitors.
HA-NDR kinase assay and HA-LATS kinase assay. Analysis of HA-NDR or
HA-LATS kinase activities after immunoprecipitation was performed as de-
scribed previously (11, 15).
HA-LATS autophosphorylation assay. Analysis of immunoprecipitated HA-
LATS autophosphorylation was also carried out as reported previously (15).
Fractionation of cells. Cytosolic and membrane-associated proteins were sep-
arated by S100/P100 fractionation as described previously (11).
Immunofluorescence microscopy. Cells were processed for immunofluores-
cence analysis as defined elsewhere (14).
RESULTS
Human NDR and LATS kinases do not interact with
hMOB3A, -B, or -C protein. MOB proteins are evolutionarily
highly conserved from yeast to humans. Unfortunately, human
MOB proteins have been named inconsistently in the literature
(Table 1). Alignments, as well as phylogenetic analysis of the
human MOB family (data not shown), revealed a close rela-
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tionship of hMOB3 proteins with hMOB1A. Many biochemi-
cal properties of hMOB1A and -B have been described (2, 11,
15), suggesting that hMOB3A/B or -C proteins might display
some of these properties. In order to test whether hMOB3
proteins can physically interact with human NDR or LATS
kinases, HA-NDR1/2 or HA-LATS1/2 were coexpressed with
N-terminally myc-tagged hMOB proteins prior to being pro-
cessed for immunoprecipitation and subsequent immunoblot-
ting (Fig. 1). As expected, we observed interactions between
HA-NDR1 and myc-hMOB2 (Fig. 1A, top, lane 1) as well as
HA-NDR2 and myc-hMOB2 (Fig. 1B, top, lane 1). To our
surprise, none of the hMOB3 proteins interacted with HA-
NDR1 (Fig. 1A, top, lanes 2 to 4) or HA-NDR2 (Fig. 1B, top,
lanes 2 to 4) in these settings. In addition, hMOB3A, -B, and
-C did not associate with HA-LATS1 or HA-LATS2 (Fig. 1C
and D, top, lanes 2 to 4). In full agreement with the existing
literature (4, 15), we confirmed that HA-LATS1 and myc-
MOB2 do not interact in cells (Fig. 1C, top, lane 5) and also
demonstrated that myc-hMOB2 cannot associate with HA-
LATS2 (Fig. 1D, top, lane 5), thus illustrating that hMOB2 is
a specific binder of NDR1/2. Significantly, these data were fully
confirmed using hMOB proteins containing a C-terminal myc
tag (data not shown).
Membrane-targeted variants of hMOB3 proteins do not ac-
tivate human NDR and LATS kinases. We have demonstrated
that hMOB3A, -B, and -C do not bind to NDR1/2 or LATS1/2
in our settings (Fig. 1). In order to exclude possible postlysis
effects we applied a second experimental setting as described
previously (11, 15). Briefly, fusion of the myristoylation/palmi-
toylation motif (mp) from the Lck kinase to the N terminus
of myc-tagged hMOB1A (mp-myc-hMOB1A) led to efficient
plasma membrane localization. Importantly, the resulting activa-
tion of NDR/LATS is dependent on hMOB1A-NDR/LATS in-
teraction and takes place within the cells before subsequent ma-
nipulations, such as cell lysis and immunoprecipitation. To
address whether membrane-targeted variants of hMOB3 pro-
teins are able to activate either human NDR1/2 or LATS1/2
kinases, we transfected HEK 293 cells with the respective
NDR/LATS kinase and membrane-targeted hMOBs. As re-
ported previously (11), mp-myc-MOB1A robustly activated
HA-NDR1, as reflected in increased Thr444 phosphorylation
at the hydrophobic motif of NDR1 (Fig. 2A, top, lane 2),
paralleled by increased kinase activity (Fig. 2B, lane 2). Coex-
pressing membrane-targeted hMOB3 variants produced no in-
crease in phosphorylation (Fig. 2A, top panel, lanes 3 to 5) or
kinase activity (Fig. 2B, lanes 3 to 5). Comparable results were
obtained when cells were transfected with HA-NDR2 and mp-
myc-hMOB3A, -B, or -C (Fig. 2C, top, lanes 3 to 5, and D,
lanes 3 to 5). This is consistent with the coimmunoprecipitation
TABLE 1. Human MOB proteins
Protein %identity
No. of
amino acids Alternative names
hMOB1A 100 216 MOB1, MOBKL1B, MOBK1B,
MOB4B, hMats1
hMOB1B 95 216 MOB1, MOBKL1A, MOB4A,
hMats2, MOB1
hMOB2 38 237 HCCA2, hMOB3
hMOB3A 50 217 MOBKL2A, MOB-LAK,
MOB1C, hMOB2A
hMOB3B 51 216 MOBKL2B, MOB1D, hMOB2B
hMOB3C 49 216 MOBKL2C, MOB1E, hMOB2C
FIG. 1. Human NDR and LATS kinases do not interact with hMOB3A/B/C proteins. (A and B) Lysates of HEK 293 cells coexpressing the
indicated combinations of HA-tagged NDR1 wild-type (wt), HA-tagged NDR2(wt), and myc-tagged hMOB species were analyzed by IP using
anti-HA 12CA5 antibody. Complexes were assayed by immunoblotting using anti-myc antibody (top) or anti-HA antibody (middle). Input lysates
were analyzed by immunoblotting using anti-myc antibody (bottom). hMOB2 served as a positive control. (C and D) Lysates of HEK 293 cells
coexpressing the indicated HA-tagged LATS1(wt) or LATS2(wt) and myc-tagged human MOB species were analyzed as described for panels A
and B, except that hMOB1A served as the positive control and hMOB2 as the negative control.
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FIG. 2. Membrane-targeted variants of hMOB3A/B/C do not activate human NDR and LATS kinases. (A) Lysates of HEK 293 cells
coexpressing the indicated combinations of HA-tagged NDR1(wt) and membrane-targeted human MOB proteins (mp-myc-hMOB) were analyzed
by IP using anti-HA 12CA5 antibody. Complexes were assayed by immunoblotting using anti-T444-P antibody (top) or anti-HA antibody (middle).
Input lysates were immunoblotted with anti-myc antibody (bottom). (B) In parallel, complexes were subjected to kinase assays. The results of two
independent experiments are shown. The error bars indicate standard deviations. (C) Lysates of HEK 293 cells coexpressing the indicated
combinations of HA-tagged NDR2(wt) and mp-myc-hMOB proteins were analyzed as described for panel A. (D) In parallel, complexes were
subjected to kinase assays as described for panel B. (E) Lysates of HEK 293 cells coexpressing the indicated combinations of HA-tagged
LATS1(wt) and mp-myc-hMOB species were analyzed by IP using anti-HA 12CA5 antibody before being assayed by immunoblotting using
anti-HA antibody (middle) or an autophosphorylation assay (top). Input lysates were analyzed by immunoblotting with anti-myc antibody. (F) In
parallel, complexes were subjected to peptide kinase assays. The result from one representative experiment performed in duplicate is shown.
(G) Lysates of HEK 293 cells coexpressing the indicated combinations of HA-tagged LATS2(wt) and mp-myc-hMOB species were analyzed as
described above for panel E. (H) In parallel, complexes were subjected to peptide kinase assays. The results from two independent experiments
are shown. The error bars indicate standard deviations.
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experiments (Fig. 1A and B) and indicates that hMOB3s can-
not interact with human NDR1/2 kinases in cultured mamma-
lian cells despite the significant similarity to hMOB1A. Fur-
thermore, we addressed whether membrane-targeted hMOB3
variants are able to activate HA-LATS1 or HA-LATS2 (Fig.
2E to H). As already reported (15), HA-LATS1 was substan-
tially activated by mp-myc-hMOB1A (Fig. 2E and F, lanes 2),
as illustrated by increased autophosphorylation and kinase ac-
tivity, whereas mp-hMOB3 proteins were unable to activate
HA-LATS1 (Fig. 2E and F, lanes 4 to 6). We observed similar
results in the case of HA-LATS2 (Fig. 2G and H). In combi-
nation with the coimmunoprecipitation experiments (Fig. 1),
these findings strongly suggest that none of the three hMOB3
proteins physically interacts with or activates human NDR1/2
or LATS1/2 kinases.
hMOB2 binds to the amino terminus of human NDR1/2
kinases in a mode distinct from hMOB1A/B binding. We have
shown that hMOB3s do not associate with human NDR1/2
kinases (Fig. 1 and 2), despite their higher degree of similarity
to hMOB1A/B than to hMOB2 (Table 1). Interestingly,
hMOB2 appears to be an NDR-specific binder, since it did not
bind to human LATS1 (4, 15) or LATS2 (Fig. 1 and 2) but
readily bound to NDR1 and 2 (Fig. 1). Therefore, we investi-
gated the interaction of hMOB2 with NDR1/2 in more detail
using a series of NDR1 mutants (Fig. 3A and Table 2). We
deleted the N or C terminus of NDR1 to determine which region
was necessary for the interaction with hMOB2 (Fig. 3B).
NDR1(wt) and NDR1(1-380) coprecipitated hMOB2 (Fig. 3B,
top, lanes 2 and 4), whereas NDR1 lacking the conserved N-
terminal regulatory domain (NTR), HA-NDR1(NTR), did not
(Fig. 3B, top, lane 3). Conversely, we addressed whether the N
terminus of NDR (amino acids 1 to 83) was sufficient for
association with hMOB2. Indeed, NDR1(1-83)-myc-RFP in-
teracted with HA-hMOB2 (Fig. 3C, top, lane 2), and NDR2(1-
83)-myc-RFP also bound HA-hMOB2 (Fig. 3D, top, lane 2).
Remarkably, hMOB1A/B binds to the same N-terminal region
of NDR (2). Therefore, since the key residues essential for
interaction between NDR1/LATS1 kinases and hMOB1A
have been described (2, 15), we investigated whether hMOB2
utilized the same conserved binding motif. Interestingly, point
mutations in the NDR1 N terminus that abolish or diminish
the interaction with hMOB1A did not impair binding of
hMOB2 (Fig. 3E, top, lanes 5 and 6, and Table 2). Since
hMOB2 appeared to bind to NDR separately from hMOB1A,
we aimed to define the N-terminal region on human NDR1
necessary for the hMOB2 interaction via N-terminal mutagen-
esis of NDR1 (Fig. 3F). We observed that NDR1 lacking the
first 26 amino acids [NDR1(26)] still interacted with hMOB2
(Fig. 3F, top, lane 3), whereas an NDR1 mutant lacking the
first 33 residues [NDR1(33)] was no longer able to bind to
hMOB2 (Fig. 3F, top, lane 2), arguing that the amino acids
between residues 27 and 33 of human NDR1 are necessary for
the interaction. We sought to further analyze this region and
mutated 5 residues within this stretch to alanines (HA-NDR1
5A: Leu27, Glu28, Asn29, Phe30, and Ser32, respectively) and
examined whether this mutant was still able to bind to hMOB2
(Fig. 3G). Unexpectedly, the NDR1 mutant carrying 5 point
mutations bound to hMOB2 but lost the ability to bind to
hMOB1A (Fig. 3G, top, lanes 4 and 5). Neither single point
mutations in this stretch nor multiple mutations led to the loss
of hMOB2 interaction (Table 2). Therefore, we attempted to
create an NDR1 mutant incapable of binding to hMOB2 by
mutating residues in the N terminus that differ significantly
from the N-terminal region of LATS1. However, this effort
remained ineffective, since all tested mutants bound to
hMOB2 (Table 2), leaving a defined binding motif of hMOB2
on NDR1 yet to be determined. Nevertheless, these data dem-
onstrate that while hMOB2 and hMOB1 proteins utilize iden-
tical regions of human NDR1/2 kinases to bind, the interac-
tions differ significantly between these two hMOB isoforms.
hMOB2 competes with hMOB1A for binding to NDR and
interferes with the activation of endogenous NDR by okadaic
acid. We showed that hMOB2, like hMOB1A, binds to the N
terminus of NDR (Fig. 3), suggesting that hMOB1A and
hMOB2 might function competitively in binding NDR kinases.
Thus, we examined whether the coimmunoprecipitation of
myc-tagged hMOB1A by HA-NDR1 is affected by expressing
increasing amounts of myc-hMOB2 (Fig. 4A). In the absence
of myc-hMOB2, a substantial amount of myc-hMOB1A coim-
munoprecipitated with HA-NDR1 (Fig. 4A, top, lane 2). On
the other hand, coexpression of increasing amounts of myc-
hMOB2 led to a significant decrease in myc-hMOB1A coim-
munoprecipitating with HA-NDR1 (Fig. 4A, lanes 3 to 6),
despite the fact that the overall amount of expressed myc-
hMOB1A was not changed (Fig. 4A, bottom, lanes 2 to 6).
Interestingly, hMOB2 displaced hMOB1A even though it was
expressed at a lower level than hMOB1A (Fig. 4A, lanes 3 and
4). This indicates that hMOB2 can efficiently compete with
hMOB1A for binding to NDR1.
Activation of NDR kinases by the protein phosphatase 2A
inhibitor OA was shown to depend on intact interaction of
NDR1/2 and hMOB1 proteins (2). Since hMOB2 is able to
partially displace hMOB1A from NDR, we investigated the
effect of hMOB2 expression on OA-induced activation of en-
dogenous NDR species (Fig. 4B and C). As expected, treat-
ment of HEK293 cells with OA strongly increased Thr-444
phosphorylation of NDR (Fig. 4B, top, lane 3) and elevated
the kinase activity of endogenous NDR2 (Fig. 4C, lane 3).
Interestingly, expression of hMOB2(wt) impaired NDR phos-
phorylation (Fig. 4B, top, lane 4) and led to an 50% reduc-
tion in endogenous NDR2 activity (Fig. 4C, lane 4). Overall,
these data suggest that hMOB2 competes with hMOB1 for
NDR binding and interferes with OA-induced activation of
NDR, in contrast to hMOB1, which was previously shown to
enhance OA-induced activation (2).
hMOB2 interferes with the activation of ectopic and endog-
enous NDR kinases by membrane-targeted hMOB1A in a
binding-dependent manner. Next, we investigated whether the
competition with hMOB1 and the inhibitory effect on NDR
activation by hMOB2 depended on an intact NDR-hMOB2
interaction. For this, we generated an hMOB2 variant deficient
in NDR binding (Fig. 5A). Mutating His157 to alanine abol-
ished binding to NDR1 and -2 despite similar expression levels
(Fig. 5A, top, compare lanes 2 and 3, 5 and 6). Subsequently,
we investigated whether hMOB2 can interfere with the activa-
tion of NDR by membrane-targeted hMOB1A in an interac-
tion-dependent manner (Fig. 5B and C). As previously re-
ported (11), mp-myc-hMOB1A potently activates HA-NDR1
(Fig. 5B and C). Intriguingly, myc-tagged hMOB2(wt) expres-
sion almost completely abolished the activation of HA-NDR1
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FIG. 3. hMOB2 binds to the N terminus of NDR but in a manner distinct from that for hMOB1A/B. (A) Primary structures of human NDR1
and overview of HA-tagged NDR1 mutant derivatives. (B) Lysates of COS-7 cells containing the indicated combinations of HA-tagged NDR1
forms and myc-tagged hMOB2(wt) were analyzed by IP using anti-HA antibody. Complexes were analyzed by immunoblotting using anti-myc (top)
or anti-HA (middle) antibody. Input lysates were analyzed using anti-myc antibody. NTR denotes deletion of amino acids 1 to 83 of NDR1, the
NTR (N-terminal regulatory domain). (C) Lysates of HEK 293 cells coexpressing the indicated combinations of HA-tagged hMOB2(wt), the N
terminus of NDR1 (amino acids 1 to 83) fused N terminally to myc-RFP, or myc-RFP alone were analyzed by IP using anti-HA antibody.
Complexes were assayed by immunoblotting using anti-myc (top) and anti-HA (middle) antibodies. The lysates were analyzed using anti-myc
antibody. (D) Lysates of HEK 293 cells coexpressing combinations of HA-tagged hMOB2(wt), the N terminus of NDR2 (amino acids 1 to 83)
containing a C-terminal myc-RFP tag, or myc-RFP alone were analyzed as described for panel C. (E) Lysates of COS-7 cells coexpressing
HA-tagged NDR1(wt), NDR1(NTR), NDR1(E73A), NDR1(T74A), NDR1(R78A), and myc-tagged hMOB2(wt) were analyzed by IP using
anti-HA antibody. Complexes were analyzed by immunoblotting using anti-myc or anti-HA antibody. Input lysates were assayed by immunoblotting
using anti-myc antibody. (F) Lysates of HEK 293 cells coexpressing HA-tagged NDR1(wt), NDR1 containing a deletion of amino acids 1 to 33
[NDR1(33)], NDR1(26), and myc-tagged hMOB2(wt) were analyzed by IP using anti-HA antibody. Complexes were assayed using anti-myc or
anti-HA antibody. Input lysates were assayed by immunoblotting using anti-myc antibody. (G) Lysates of HEK 293 cells containing the indicated
combinations of HA-tagged NDR1(wt), NDR1 5A mutant, myc-tagged hMOB1A, or hMOB2 were analyzed by IP using anti-HA antibody. NDR1
5A mutant denotes mutation of amino acids Leu27, Glu28, Asn29, Phe30, and Ser32 to alanine. Complexes were assayed by immunoblotting using
anti-myc (top) or anti-HA (middle) antibody. Input lysates were assayed by immunoblotting using anti-myc antibody (bottom).
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by mp-myc-hMOB1A (Fig. 5B and C, lanes 3), even though the
expression of mp-myc-hMOB1A remained unchanged (Fig.
5B, bottom, lane 3). However, coexpression of myc-tagged
hMOB2(H157A), which cannot bind to NDR1/2 kinases, did
not interfere with mp-myc-hMOB1A-driven activation of HA-
NDR1 (Fig. 5B and C, lanes 4). In conclusion, the negative
effect of hMOB2 on NDR1 activation by membrane-targeted
hMOB1A is likely to be binding dependent.
We have previously shown that expression of membrane-
targeted hMOB1A in U2OS cells leads to the membrane re-
cruitment and activation of endogenous NDR1 species (11).
To address the effect of hMOB2 on membrane recruitment
and activation of endogenous NDR species, HEK 293 cells
transfected with mp-myc-hMOB1A, myc-hMOB2(wt), or myc-
hMOB2(H157A) were separated into cytoplasmic and mem-
branous fractions prior to analysis by immunoblotting (Fig.
5D). While in untransfected cells native phospho-T444/442
proteins were found almost exclusively in the cytoplasmic frac-
tion (Fig. 5D, lane 1), in cells expressing mp-myc-hMOB1A
NDR, phosphospecies were enriched at the membrane (Fig.
5D, lane 4). Congruently, endogenous NDR1/2 was recruited
to the membrane by mp-myc-hMOB1A (Fig. 5D, lane 4).
Upon coexpression of myc-tagged hMOB2(wt) the phos-
phosignal of endogenous NDR species at the membrane dis-
appeared (Fig. 5D, lane 6), although we still observed residual
NDR2 in the membranous fraction (Fig. 5D, lane 6). To ad-
dress whether this effect was dependent on the interaction
between hMOB2 and endogenous NDR species, we coex-
pressed NDR binding-deficient hMOB2(H157A) with mp-
myc-hMOB1A. Confirming the result with overexpressed HA-
NDR1 (Fig. 5B), myc-hMOB2(H157A) did not interfere with
FIG. 4. hMOB2 competes with hMOB1A and interferes with okadaic
acid-induced activation of endogenous NDR kinases. (A) hMOB1A-
NDR1 and hMOB2-NDR1 interactions are mutually exclusive. Lysates
of HEK 293 cells coexpressing HA-tagged NDR1(wt) and myc-tagged
hMOB1A and hMOB2 were analyzed by IP using anti-HA antibody.
Complexes were assayed by immunoblotting using anti-myc (top) and
anti-HA (middle) antibodies. Input lysates were analyzed by immuno-
blotting using anti-myc antibody. (B) HEK 293 cells transfected with
empty vector () or hMOB2(wt) were treated with 1 M OA for 45
min before input lysates were processed for immunoblotting with the
indicated antibodies. (C) In parallel, samples were subjected to immu-
noprecipitation using rabbit IgG or anti-NDR2 antibody before pep-
tide kinase assays were performed. Data from at least two independent
experiments with two replicates per experiment are shown. The error
bars represent standard deviations.
TABLE 2. Summary of coimmunoprecipitation experiments
NDR1 mutation
Binding toa:
hMOB2 hMOB1A
Y31A 	 
R41A 	 
R44A 	 (	)
T74A 	 
R78A 	 
K24A 	 	
T26A 	 ND
T26F 	 ND
L27A 	 ND
E28A 	 	
N29A 	 ND
F30A 	 ND
S32A 	 ND
A36K 	 ND
E40A 	 	
V51E 	 ND
E54R 	 ND
D59A 	 ND
E60A 	 	
E61A 	 	
R63A 	 	
E73A 	 	
TVT23/25/26FFF 	 ND
FY30/31HV 	 ND
EE39/40AA 	 ND
Q45K/K47Q 	 ND
EEE53-55RRR 	 ND
EEKR60-63AAAA 	 ND
KRR62/63/65QDM 	 ND
H69D/R71D 	 ND
SAHAR67-71KMLCQ 	 ND
a HA-tagged NDR1 mutants were coexpressed with either myc-hMOB2 or
myc-hMOB1A in HEK 293 or COS7 cells before coimmunoprecipitation exper-
iments were performed. 	, interaction; , no interaction; (	), impaired inter-
action; ND, not determined.
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either membrane recruitment of endogenous NDRs by mp-
myc-hMOB1A (Fig. 5D, lane 8) or the activation of endoge-
nous NDR at the membrane (Fig. 5D, top, lane 8). We con-
clude that hMOB2 competes with hMOB1A for NDR binding
and can interfere with the activation of human NDR kinases in
a binding-dependent manner.
Endogenous hMOB2 physically interacts with human NDR,
but not with LATS1. In overexpression settings, hMOB2 readily
coimmunoprecipitates with human NDR1/2 kinases (Fig. 1). In
order to address the interaction of endogenous proteins, we
raised a rabbit polyclonal antibody against hMOB2 (Fig. 6A
and B). The affinity-purified anti-hMOB2 antibody detected a
band at approximately 27 kDa, the predicted molecular size of
the hMOB2 protein, which was reduced in cells expressing
shRNA against hMOB2 (Fig. 6A, top). Furthermore, the anti-
hMOB2 detected only recombinant glutathione S-transferase
(GST)-hMOB2, but none of the other hMOBs (Fig. 6B, top).
Endogenous hMOB2 coprecipitated with NDR2 when an anti-
NDR2 antibody was used for immunoprecipitation, but not
with control antibody (Fig. 6C, top). Conversely, when an anti-
hMOB2 antibody was used to immunoprecipitate endogenous
hMOB2, endogenous NDR2 coprecipitated in HEK293 cells
(Fig. 6D, top). Similar results were observed using HeLa cell
lysates (data not shown). Moreover, endogenous hMOB2
could not be coimmunoprecipitated using an anti-LATS1 an-
tibody (Fig. 6E, top, lane 3). Therefore, our data show for the
first time that endogenous hMOB2 is a specific binder of
NDR1/2 kinases.
hMOB2 is found preferentially in unphosphorylated NDR
complexes, while hMOB1A/B is associated with active NDR
kinases. Given that we observed a putative negative role for
hMOB2 in the course of NDR activation and that endogenous
hMOB2-NDR complexes are readily detectable (Fig. 4, 5, and
6), we examined endogenous total NDR-hMOB complexes
and active NDR-hMOB complexes by immunoprecipitation
experiments using anti-NDR2 and anti-T444-P antibodies (Fig.
7). The anti-T444-P antibody recognizes only phosphorylated
hydrophobic motifs of active NDR1/2 kinases (14). HEK 293
cells were subjected to immunoprecipitation with the two dif-
ferent anti-NDR antibodies described above and to subse-
quent immunoblotting experiments. When the anti-NDR2 an-
tibody was used, a small fraction of the immunoprecipitated
NDR2 protein was phosphorylated at the hydrophobic motif
(T444-P), indicating that mostly inactive NDR species were
immunoprecipitated (Fig. 7, lane 2). In contrast, using the
anti-T444-P antibody to immunoprecipitate active NDR spe-
cies, we obtained a significant amount of phospho-T444 species
despite the small amount of total NDR2 pulled down (Fig. 7,
FIG. 5. hMOB2 interferes with the activation of human NDR ki-
nases by membrane-targeted hMOB1A in an NDR binding-dependent
manner. (A) COS-7 cell lysates expressing HA-tagged NDR1(wt)
(lanes 1 to 3), HA-NDR2(wt) (lanes 4 to 6), myc-tagged hMOB2(wt),
or myc-hMOB(His157Ala) were lysed in low-stringency lysis buffer
and then subjected to IP using anti-HA 12CA5 antibody. Complexes
were analyzed by immunoblotting with anti-HA (middle) and anti-myc
(top) antibodies. Input lysates were analyzed by immunoblotting using
anti-myc and anti--tubulin antibodies (bottom). (B) Lysates of COS-7
cells containing the indicated combinations of HA-tagged NDR1(wt),
membrane-targeted hMOB1A (mp-myc-hMOB1A), and myc-tagged
hMOB2(wt) and hMOB2(H157A) were analyzed by immunoprecipi-
tation using anti-HA antibody. Complexes were assayed by immuno-
blotting and probed with anti-T444-P, anti-S281-P, and anti-HA anti-
bodies. The input lysate was analyzed by immunoblotting using anti-
myc antibody. (C) In parallel, complexes were subjected to peptide
kinase assays. The results from two independent experiments are
shown. The error bars indicate standard deviations. (D) HEK 293
cells transfected with membrane-targeted hMOB1A (mp-myc-
hMOB1A) and the indicated myc-tagged hMOB2 constructs were
subjected to S100/P100 (S, cytoplasm; P, membrane) fractionation
before being immunoblotted with anti-T444-P, anti-NDR2, anti-
myc, anti-CLIMP63 (p63) (a marker for membranous fraction), and
anti--tubulin (a marker for the cytoplasmic fraction) antibodies.
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lane 3). Interestingly, endogenous hMOB2 was enriched using
anti-NDR2 antibody (Fig. 7, lane 2), whereas when anti-
T444-P antibody was used to pull down active NDR species,
hMOB2 was not detectable (Fig. 7, lane 3). On the other hand,
hMOB1A was almost exclusively detected in phosphorylated
complexes of NDR (Fig. 7, compare lanes 2 and 3). This
finding is in agreement with previous reports demonstrating
enhanced complex formation of hMOB1A/B and NDR kinases
upon activation (36). Overall, we conclude that hMOB2 pref-
erentially associates with unphosphorylated NDR and, in con-
trast, hMOB1A/B associates with phosphorylated NDR.
Reduction of hMOB2 protein results in increased NDR1/2
kinase activity. hMOB2 is found in complex with unphosphor-
ylated NDR kinases (Fig. 7), and ectopically expressed
hMOB2 competes with hMOB1A/B, interfering with the acti-
vation of human NDR kinases (Fig. 4 and 5). Therefore, we
addressed the role of endogenous hMOB2 by RNAi. HEK293
cells, untransfected or transfected with plasmids encoding
shRNAs against firefly luciferase (Fig. 8A, lane 2) or hMOB2
(Fig. 8A, lane 3), were analyzed by immunoblotting and kinase
assays on endogenous NDR proteins performed in parallel
(Fig. 8A and B). hMOB2 protein levels were reduced upon
transfection with shMOB2, whereas hMOB1A/B levels were
not changed (Fig. 8A, lane 3). Interestingly, knockdown of
hMOB2 proteins resulted in an increase of phosphorylated
NDR species (Fig. 8A, top, lane 3), despite a slight reduction
in total NDR protein (Fig. 8A, lane 3). The increase of phos-
phorylated NDR was reflected in a significant increase in ki-
nase activity when a peptide kinase assay using immunopre-
cipitated NDR2 was performed (Fig. 8B, lane 3). Therefore,
we conclude that endogenous hMOB2 has inhibitory proper-
ties. However, the precise mechanism by which hMOB1A/B
FIG. 6. Endogenous hMOB2 interacts with NDR, but not with LATS1, in tissue-cultured cells. (A) Characterization of anti-hMOB2 rabbit
polyclonal antibody. HEK 293 cells transfected with short hairpin targeting either firefly luciferase (shLuc) or hMOB2 (shMOB2) were analyzed
72 h after transfection by immunoblotting using affinity-purified anti-hMOB2 antibody (top) and anti--tubulin antibody (bottom). Molecular
masses are indicated. (B) Recombinant GST-tagged human MOB proteins were separated by SDS-PAGE and analyzed by immunoblotting using
anti-hMOB2 (top) and anti-GST (bottom) antibodies. (C) Interaction of endogenous hMOB2 and NDR2. Whole-cell extracts of HEK 293 cells
were subjected to immunoprecipitation using control rabbit IgG or anti-NDR2 antibody. Complexes were analyzed by immunoblotting using
anti-hMOB2 (top) and anti-NDR2 (middle) antibodies. Input lysates were probed with anti-hMOB2 antibody. (D) Endogenous NDR2 was
coimmunoprecipitated with hMOB2. Lysates of HEK 293 cells were assayed by immunoprecipitation using control rabbit IgG or anti-hMOB2
antibody. Complexes were assayed by immunoblotting using anti-NDR2 (top) or anti-hMOB2 (bottom) antibody. Antibody heavy chains are
marked with an asterisk. Input lysates were analyzed with anti-NDR2 antibody. (E) Endogenous hMOB2 coimmunoprecipitates with NDR2, but
not with LATS1. Lysates of HEK 293 cells were subjected to immunoprecipitation with the indicated antibodies and analyzed by immunoblotting
using anti-NDR2, anti-LATS1, and anti-hMOB2 antibodies. Antibody heavy chains are marked with an asterisk.
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and hMOB2 complex formation with NDR is regulated re-
mains unknown, since analysis of HEK293 cells treated with OA
showed that hMOB2 protein levels remained unchanged (Fig.
8C) during the course of NDR activation (Fig. 8C, top) whereas
hMOB1A protein levels increased with time during the treatment
(Fig. 8C). Further, we did not observe significant changes in
either hMOB2 or hMOB1A/B protein levels during the course of
NDR activation upon induction of apoptosis (Fig. 8D).
hMOB2 expression affects biological functions of human NDR
kinases. Recent studies suggest that binding of hMOB1A/B to
human NDR1/2 kinases is necessary for apoptosis signaling
(36) and efficient centrosome duplication (13) in human cells.
Our findings show that hMOB2 is preferentially located in
inactive complexes with NDR (Fig. 7) and competes with
hMOB1A/B for NDR binding, thereby interfering with activa-
tion of NDR (Fig. 5 and 6). Therefore, we tested whether
hMOB2 binding to NDR kinases affects NDR function in
apoptosis and centrosome duplication. To examine the effect
of hMOB2 on apoptotic signaling, we generated U2-OS cell
lines expressing myc-hMOB2(wt) or myc-hMOB2(H157A) in a
tetracycline-inducible manner (Fig. 9). Cells were treated with
or without tetracycline for 24 h before anti-Fas antibody in
combination with cycloheximide was added. Cells were har-
vested at the time points indicated and analyzed by immuno-
blotting (Fig. 9). Unexpectedly, the hMOB2(H157A) variant
displayed reduced protein stability, since no residual protein
could be detected after the addition of a combination of anti-
Fas antibody and CHX or CHX alone (data not shown). Over-
expression of hMOB2(wt) resulted in reduced phosphorylation
of the hydrophobic motif of NDR1 (T444) after 4 and 6 h of
treatment compared with control cells (Fig. 9, top, compare
FIG. 7. Endogenous hMOB2 preferentially associates with inactive
NDR kinases. Whole-cell extracts of HEK 293 cells were subjected to
IP using the indicated antibodies and analyzed by immunoblotting with
anti-T444-P, anti-NDR2, anti-hMOB2, and anti-hMOB1A/B. Input
lysates were assayed by immunoblotting using the antibodies listed
above. Antibody heavy chains are marked with an asterisk.
FIG. 8. Reduction of hMOB2 protein results in increased NDR1/2 activity. (A) HEK 293 cells were transfected with plasmids encoding shLuc
or shMOB2 and were processed 72 h later for immunoblotting with the indicated antibodies. (B) In parallel, samples were subjected to IP using
rabbit IgG or anti-NDR2 antibody before peptide kinase assays were performed. Data from at least two independent experiments with two
replicates per experiment are shown. The error bars represent standard deviations. (C) HEK 293 cells were treated with 1 M OA for the indicated
times before being processed for immunoblotting with the indicated antibodies. A background band is marked by an asterisk. (D) Apoptosis was
induced in U2-OS cells by adding Fas antibody in combination with CHX for the indicated time and analyzed as for panel C.
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lines 2 and 3 to 6 and 7). Concurrently, we investigated
whether this decrease in NDR activation was matched by a
reduction in apoptotic markers. Indeed, the signal for cleaved
PARP was reduced in cells overexpressing hMOB2(wt) com-
pared with control cells (Fig. 9, compare lanes 3 and 4 to 7 and
8). These results indicate that hMOB2(wt) can interfere with
the physiological activation of NDR kinases and consequently
also interfere with NDR kinase apoptotic function.
We then sought to determine whether hMOB2 can also
affect NDR functions in centrosome duplication. As previously
reported (1), centrosomes overduplicate in U2-OS cells upon
S-phase arrest. Therefore, U2-OS cells transiently expressing
empty vector, myc-tagged hMOB2(wt), or hMOB2(H157A)
were arrested in S phase for 72 h and then analyzed by
immunoblotting and immunofluorescence (Fig. 10A and B).
As expected centrosome overduplication was observed in
control cells (Fig. 10C) but was reduced by overexpression
of hMOB2(wt) (Fig. 10C, lane 3). Overexpression of the NDR
binding-deficient mutant hMOB2(H157A) had no effect (Fig.
10C, lane 4), despite expression and localization patterns sim-
ilar to those of hMOB2(wt) (Fig. 10A and B). Overall, these
results suggest that wild-type hMOB2 also negatively affects
centrosome overduplication during S phase in an NDR bind-
ing-dependent manner. Therefore, two biological functions of
human NDR kinases can be negatively regulated by increased
hMOB2 expression.
DISCUSSION
MOB proteins are critical regulators of kinases of the NDR
family and are conserved from yeast to humans (16). In bud-
ding yeast, two distinct complexes of MOB-NDR modules ex-
ist, Mob1p-Dbf2p and Mob2p-Cbk1p. Moreover, MOB pro-
teins are essential activating subunits of the respective NDR
kinases (19, 20, 22, 38). In multicellular organisms, such as
Drosophila, dMOB1/Mats is required for the function of both
warts and trc kinase (10, 24), indicating that MOB1 proteins do
not specifically bind to a single NDR kinase, as in yeast. Also,
in human cells, hMOB1A/B bind to and activate all four
NDR kinases (2, 4, 13, 15, 29) and are essential for the
function of NDR1/2 kinases in apoptosis and centrosome
duplication (13, 36).
FIG. 9. Overexpression of hMOB2(wt) impairs death receptor-in-
duced activation of NDR kinases and interferes with apoptosis signal-
ing. U2-OS cells expressing myc-hMOB2(wt) in a tetracycline-induc-
ible manner were incubated without (lanes 1 to 4) or with (lanes 5 to
8) tetracycline for 24 h before apoptosis was induced by the addition of
Fas antibody in combination with CHX. Cells were harvested after 0,
4, 6, and 12 h and processed for immunoblotting using the indicated
antibodies.
FIG. 10. Ectopic expression of hMOB2(wt) impairs centrosome overduplication. (A and B) U2-OS cells transfected with myc-tagged
hMOB2(wt) or hMOB2(H157A) were treated with aphidicolin (2 g/ml) for 72 h before being processed for immunoblotting (A) or immuno-
fluorescence assay (B) with the indicated antibodies. The insets show enlargements of centrosomes in red. Myc-hMOB2 variants are in green. DNA
is stained blue. (C) Histograms showing percentages of cells with excess centrosomes (3, more than three per mononucleated cell). Shown are
cumulative data from at least three independent experiments with at least two replicates of 100 cells counted per experiment. The error bars
indicate standard deviations.
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However, human cells express six MOB proteins (Table 1)
and four NDR kinases. We show here that hMOB3A, -B, and
-C do not physically interact with or activate any of the four
NDR/LATS kinases (Fig. 1 and 2). Despite their significant
homology to hMOB1 proteins compared with hMOB2 (Table
1), hMOB3 proteins display significant sequence variation in or
around amino acids previously shown to be important in con-
ditional mutants in budding yeast MOB1p (32). Such variation
might explain why hMOB3 proteins did not associate with
NDR/LATS kinases. In support of this, it was shown recently
that overexpression of hMOB3 proteins did not significantly
affect centrosome duplication, a known function of NDR1/2
kinases (13). Therefore, the physiological binding partners and
functions of hMOB3 proteins remain undefined.
Our data demonstrated that hMOB2 is a specific interaction
partner of human NDR1/2 and not LATS1/2 (Fig. 1 and 2).
Accordingly, we focused our investigation on hMOB2 and
NDR1/2. Our findings demonstrate that hMOB2 binds to the
N-terminal regulatory domain of NDR1/2 kinases (Fig. 3), the
same region reported earlier for hMOB1A/B (2). Interestingly,
mutational analysis of the N-terminal region of NDR1/2 re-
vealed that the mode of binding of hMOB2 differs significantly
from that of hMOB1A/B, because mutations in the NDR1/2
protein that interfere with hMOB1 binding (2) do not affect
hMOB2 association (Fig. 3 and Table 2). hMOB2 binds
NDR1/2, most likely through multiple contact points, since the
interaction could not be ablated by single or combined point
mutations (Fig. 3 and Table 2). Therefore, structural analysis
of NDR1/2 kinases in complex with hMOB1 and hMOB2 pro-
teins will be required in the future to examine differences in
the two modes of interaction and also the mechanistic differ-
ences in activation/inhibition of these two complexes.
Additionally, we described for the first time competitive
binding of hMOB2 and hMOB1 proteins to the N terminus of
human NDR1/2 kinases (Fig. 4). Moreover, hMOB2 impaired
okadaic acid-induced activation of endogenous NDR species
(Fig. 4B), indicating distinct functions for different human
MOB proteins in the regulation of NDR1/2 kinases, since
hMOB1A was shown to potentiate NDR activity in a similar
experiment (2). In addition, these data are strengthened by the
concurrent use of a phosphospecific antibody to the hydropho-
bic motif phosphorylation (anti-T444-P) and by our biological
experiments. However, in the literature, conflicting reports on
the effects of hMOB2 overexpression on NDR activity describe
overexpressed hMOB2 activating NDR1/2 kinases upon OA
stimulation (5, 7). This could be due to the assays used to
measure NDR kinase activity. In both studies, the nonspecific
kinase substrates myelin basic protein and histone H1 were
used. Therefore, the presence of an associated kinase may have
contributed to the increase in phosphorylation of these sub-
strates, whereas in our assays, an established NDR kinase
substrate peptide was used (11, 13, 33, 34).
hMOB2 interferes with the activation of ectopic and endog-
enous NDR1/2 kinases by membrane-targeted hMOB1A in an
NDR binding-dependent manner (Fig. 5), since an hMOB2
variant incapable of binding to NDR1/2 did not affect activa-
tion of NDR (Fig. 5). The expression of hMOB2(wt) retained
NDR in the cytoplasm, and also, a fraction of mp-hMOB1A
was observed in the cytoplasmic fraction (Fig. 5D). Therefore,
it is possible that hMOB2 inhibits activation of NDR by mp-
hMOB1A by retention of the NDR-MOB1 complex, or even
by retaining mp-hMOB1A itself in the cytoplasm. However,
the analysis of this observation requires further investigation.
Moreover, we analyzed endogenous complexes of NDR1/2 and
hMOB1A/B or hMOB2 (Fig. 6 and 7). In full agreement with
previous work (36), we showed that phosphorylated endoge-
nous NDR species associate with hMOB1A/B. Interestingly,
unphosphorylated NDR proteins coimmunoprecipitated with
hMOB2, in contrast to active NDR species, which were found
to be associated mostly with hMOB1A/B (Fig. 7). This finding
uncovers a novel and distinct role of hMOB2 in the regulation
of NDR1/2 kinases.
Strikingly, by RNAi depletion of hMOB2 in HEK293 cells,
we found evidence that the endogenous role of hMOB2 is to
inhibit NDR kinases, since knockdown of hMOB2 increased
phosphorylation and kinase activity of endogenous NDR
species (Fig. 8A and B). We did not observe an effect on
hMOB1A/B protein, but we detected a decrease in total NDR
protein. Therefore, it is tempting to speculate that hMOB2
might also play a role in NDR protein stability. Nevertheless,
we describe for the first time an endogenous inhibitory func-
tion of a human MOB protein. We tried to address the mech-
anism through which hMOB1A/B and hMOB2 regulate NDR
activation and inhibition by analyzing the abundance of
hMOB1A/B and hMOB2 during the activation of NDR ki-
nases (Fig. 8C and D and 10A). Whereas the hMOB2 protein
level did not change during both treatments, hMOB1A/B pro-
tein increased during okadaic acid stimulation (Fig. 8), despite
activation of NDR in both treatments (Fig. 8). Therefore,
the endogenous mechanism through which hMOB1A/B and
hMOB2 regulate activation/inhibition of NDR kinases remains
unknown, since the total protein level might not represent the
composition of NDR-MOB complexes during the course of
activation. Future research in this direction is warranted.
We subsequently addressed the putative inhibitory func-
tion of hMOB2 in the context of two biological functions of
NDR1/2 kinases, the proapoptotic role of NDR and the contri-
bution of NDR to centrosome duplication (13, 36). Importantly,
both functions depend on the interaction of hMOB1A/B proteins
and NDR1/2 kinases.
First, inducible expression of hMOB2 interfered with the
activation of NDR1 in U2-OS cells after anti-Fas treatment
and in turn delayed apoptotic progression, as assessed by
cleaved PARP (Fig. 9). Since cleaved PARP is a marker for
apoptotic cells, this indicates that hMOB2 expression delayed
the onset of apoptosis and most likely reduced the total apop-
totic cell population in our settings. Furthermore, ectopic
hMOB2 impaired centrosome overduplication in an NDR
binding-dependent manner (Fig. 10). Significantly, the expres-
sion of kinase-dead NDR1 had a comparable effect on centro-
some overduplication in a similar assay (13). This is indicative
of an inhibitory effect of hMOB2 on NDR1 activity, which in
turn was necessary for centrosome duplication in our experi-
mental settings.
Interestingly, the role of the MOB2 protein in flies, dMOB2,
appears to also differ from that of dMOB1/Mats, because mu-
tations in the dMOB2 gene do not significantly enhance a
phenotype of trc mutants or overexpression of a dominant-
negative trc kinase (10). More precisely, overexpression of a
truncated form of dMOB2 (amino acids 148 to 354) leads to a
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phenotype similar to the trc mutant in fly wings (10), suggest-
ing a dominant-negative role of dMOB2 in NDR kinase reg-
ulation in flies. Intriguingly, the truncated variant of dMOB2
shares high similarity with the full-length human MOB2 pro-
tein (data not shown). Therefore, it is tempting to speculate
that dMOB2 has competitive properties similar to those of
hMOB2 shown in our study. Determining whether dMOB2
negatively regulates trc kinase by competing with dMOB1/
Mats is a question for future studies.
Our data show for the first time that hMOB2 has inhibitory
effects on NDR1/2 functions. hMOB2 is found in unphosphor-
ylated NDR complexes, and when overexpressed, hMOB2 can
compete with hMOB1A/B, possibly physically displacing en-
dogenous hMOB1A/B from NDR. hMOB2-NDR1/2 com-
plexes that accumulate also appear to be inactive/quiescent. As
a result, the activation of NDR1/2 by hMOB1A/B and possibly
also by upstream kinases, such as MST1, could be impaired.
Future challenges will be to address whether hMOB2 hinders
NDR activation by mechanisms other than competition and
steric restriction of the access of hMOB1 to the N terminus of
NDR1/2, which in turn will have to be addressed by highly
defined quantitative biochemical and biological assays. More-
over, the role of dMOB2 in flies has yet to be clarified. In light
of our findings, the investigation by Drosophila geneticists of a
negative function of dMOB2 on tricornered, warts, or even
hippo kinase, will be of considerable interest.
In conclusion, our data indicate a novel role for hMOB2
in the regulation of NDR1/2 kinases. In contrast to hMOB1,
hMOB2 is present in unphosphorylated NDR complexes.
RNAi-mediated reduction of hMOB2 resulted in increased
NDR activity. Overexpression negatively affects biological
functions of NDR kinases, such as apoptotic progression and
centrosome duplication. Altogether, our data indicate that
hMOB2 plays an inhibitory role in the regulation of human
NDR1/2 kinases.
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A.2. Ablation of the kinase NDR1 predisposes mice to the development of 
T cell lymphoma 
 
Cornils H, Stegert MR, Hergovich A, Hynx D, Schmitz D, Dirnhofer S, Hemmings BA 
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“Defective apoptosis contributes to the development of various human malignancies. 
The kinases nuclear Dbf2-related 1 (NDR1) and NDR2 mediate apoptosis 
downstream of the tumor suppressor proteins RASSF1A (Ras association domain 
family member 1A) and MST1 (mammalian Ste20-like kinase 1). To further analyze 
the role of NDR1 in apoptosis, we generated NDR1-deficient mice. Although NDR1 is 
activated by both intrinsic and extrinsic proapoptotic stimuli, which indicates a role for 
NDR1 in regulating apoptosis, NDR1-deficient T cells underwent apoptosis in a 
manner similar to that of wild-type cells in response to different proapoptotic stimuli. 
Analysis of the abundances of NDR1 and NDR2 proteins revealed that loss of NDR1 
was functionally compensated for by an increase in the abundance of NDR2 protein. 
Despite this compensation, NDR1(-/-) and NDR1(+/-) mice were more prone to the 
development of T cell lymphomas than were wild-type mice. Tumor development in 
mice and humans was accompanied by a decrease in the overall amounts of NDR 
proteins in T cell lymphoma samples. Thus, reduction in the abundance of NDR1 
triggered a decrease in the total amount of both isoforms. Together, our data suggest 
that a reduction in the abundances of the NDR proteins results in defective 
responses to proapoptotic stimuli, thereby facilitating the development of tumors.” 
 
This report shows that NDR2 protein levels are up-regulated in several tissues of 
Ndr1 knock-out mice. Conversely, found that NDR1 protein levels are conversely up-
regulated in Ndr2 knock-out mice (see Chapter I). To investigate whether the 
observed up-regulation is a result of increased transcription, I designed and validated 
quantitative real time PCR primers for Ndr1 and Ndr2. We find that neither Ndr1 nor 
Ndr2 transcripts are increased, indicating that the up-regulation is mediated by a 
post-transcriptional mechanism. 
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A.3. NDR kinase is activated by RASSF1A/MST1 in response to Fas 
receptor stimulation and promotes apoptosis  
 
Vichalkovski A, Gresko E, Cornils H, Hergovich A, Schmitz D, Hemmings BA. 
Published in Current Biology; 2008 Dec 9;18(23):1889-95 
 
“Human NDR1 and 2 (NDR1/2) are serine-threonine protein kinases in a subgroup of 
the AGC kinase family. The mechanisms of physiological NDR1/2 activation and their 
function remain largely unknown. Here we report that Fas and TNF-alpha receptor 
stimulation activates human NDR1/2 by promoting phosphorylation at the 
hydrophobic motif (Thr444/442). Moreover, NDR1/2 are essential for Fas receptor-
induced apoptosis as shown by the fact that NDR knockdown significantly reduced 
cell death whereas overexpression of the NDR1 kinase further potentiated apoptosis. 
Activation of NDR1/2 by death receptor stimulation is mediated by the tumor 
suppressor RASSF1A. Furthermore, RASSF1A-induced apoptosis largely depends 
on the presence of NDR1/2. Fas receptor stimulation promoted direct 
phosphorylation and activation of NDR1/2 by the mammalian STE20-like kinase 1 
(MST1), a downstream effector of RASSF1A. Concurrently, the NDR1/2 coactivator 
MOB1 induced MST1-NDR-MOB1 complex formation, which is crucial for MST1-
induced NDR1/2 phosphorylation upon induction of apoptosis. Our findings identify 
NDR1/2 as novel proapoptotic kinases and key members of the RASSF1A/MST1 
signaling cascade.” 
 
The 31G14 monoclonal mouse antibody is extensively used in this report to detect 
NDR1 and NDR2. I produced and purified recombinant MBP-NDR2 protein which 
was used to immunize Balb/C mice. Subsequently, I screened numerous hybridoma 
supernatants and isolated and characterize the 31G14 clone which detects 
endogenous levels of human NDR1 and NDR2 in Westernblotting. 
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A.4. The MST1 and hMOB1 tumor suppressors control human 
centrosome duplication by regulating NDR kinase phosphorylation  
 
Hergovich A, Kohler RS, Schmitz D, Vichalkovski A, Cornils H, Hemmings BA 
Published in Current Biology; 2009 Nov 3;19(20):1692-702  
 
“BACKGROUND: Human MST/hSAV/LATS/hMOB tumor suppressor cascades are 
regulators of cell death and proliferation; however, little is known about other 
functions of MST/hMOB signaling. Mob1p, one of two MOB proteins in yeast, 
appears to play a role in spindle pole body duplication (the equivalent of mammalian 
centrosome duplication). We therefore investigated the role of human MOB proteins 
in centrosome duplication. We also addressed the regulation of human centrosome 
duplication by mammalian serine/threonine Ste20-like (MST) kinases, considering 
that MOB proteins can function together with Ste20-like kinases in eukaryotes. 
RESULTS: By studying the six human MOB proteins and five MST kinases, we found 
that MST1/hMOB1 signaling controls centrosome duplication. Overexpression of 
hMOB1 caused centrosome overduplication, whereas RNAi depletion of hMOB1 or 
MST1 impaired centriole duplication. Significantly, we delineated an 
hMOB1/MST1/NDR1 signaling pathway regulating centrosome duplication. More 
specifically, analysis of shRNA-resistant hMOB1 and NDR1 mutants revealed that a 
functional NDR/hMOB1 complex is critical for MST1 to phosphorylate NDR on the 
hydrophobic motif that in turn is required for human centrosome duplication. 
Furthermore, shRNA-resistant MST1 variants revealed that MST1 kinase activity is 
crucial for centrosome duplication whereas MST1 binding to the hSAV and RASSF1A 
tumor suppressor proteins is dispensable. Finally, by studying the PLK4/HsSAS-
6/CP110 centriole assembly machinery, we also observed that normal daughter 
centriole formation depends on intact MST1/hMOB1/NDR signaling, although 
HsSAS-6 centriolar localization is not affected. CONCLUSIONS: Our observations 
propose a novel pathway in control of human centriole duplication after recruitment of 
HsSAS-6 to centrioles.” 
 
I cloned the MOB3 isoforms 3A, 3B and 3C which were first used in this report from 
cDNA libraries. Moreover, I contributed to the editing of the manuscript. 
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A.5. The human tumour suppressor LATS1 is activated by human MOB1 
at the membrane  
 
Hergovich A, Schmitz D, Hemmings BA 
Published in Biochemical and Biophysical Research communications;  
2006 Jun 23;345(1):50-8 
 
“Downregulation of the LATS1 tumour suppressor protein kinase contributes to 
tumour formation in mammals and flies. Strikingly, the tumour suppressor activity 
depends on the interaction with Dmob (Drosphila Mps1-One binder) in Drosophila 
melanogaster. Recently, human LATS1 was reported to interact with human MOB1 
(hMOB1), but the activation of LATS1 was not addressed. Here, we identified a 
highly conserved hMOB1-binding motif within LATS1's primary structure. While co-
expression of LATS1 with hMOB1 did not elevate LATS1 kinase activity in 
mammalian cells, membrane-targeting of hMOB1 resulted in a significant increase of 
LATS1 activity. This stimulation was dependent on intact activation segment and 
hydrophobic motif phosphorylation sites, and was further found to occur a few 
minutes after membrane association. Therefore, we suggest a potential in vivo 
mechanism of LATS1 activation through rapid recruitment to the plasma membrane 
by hMOB1 followed by multi-site phosphorylation, thereby providing insight into the 
molecular regulation of the LATS tumour suppressor.” 
 
I performed sequence validation of all LATS mutants described in this report. 
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A.6. NDR kinases regulate essential cell processes from yeast to humans  
 
Hergovich A, Stegert MR, Schmitz D, Hemmings, Brian A 
Published in Nature Reviews Molecular Cell Biology 2006 Apr;7(4):253-64. 
 
“Members of the NDR (nuclear Dbf2-related) protein-kinase family are essential 
components of pathways that control important cellular processes, such as 
morphological changes, mitotic exit, cytokinesis, cell proliferation and apoptosis. 
Recent progress has shed light on the mechanisms that underlie the regulation and 
function of the NDR family members. Combined data from yeast, worms, flies, mice 
and human cells now highlight the conserved and important roles of the different 
NDR kinases in distinct cellular processes.” 
 
 
I generated Figure 1 of this review which has been widely used and cited to illustrate 
the common characteristics of NDR kinases. Moreover, I contributed to the 
paragraph that describes the structural characteristics of NDR kinases and to general 
editing of the review. 
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